id	sid	tid	token	lemma	pos
aiua-6073	1	1	archivio	archivio	PROPN
aiua-6073	1	2	italiano	italiano	X
aiua-6073	1	3	di	di	X
aiua-6073	1	4	urologia	urologia	PROPN
aiua-6073	1	5	e	e	PROPN
aiua-6073	1	6	andrologia	andrologia	NOUN
aiua-6073	1	7	2016	2016	NUM
aiua-6073	1	8	;	;	PUNCT
aiua-6073	1	9	88	88	NUM
aiua-6073	1	10	,	,	PUNCT
aiua-6073	1	11	2128	2128	NUM
aiua-6073	1	12	original	original	ADJ
aiua-6073	1	13	paper	paper	NOUN
aiua-6073	1	14	a	a	DET
aiua-6073	1	15	survey	survey	NOUN
aiua-6073	1	16	on	on	ADP
aiua-6073	1	17	the	the	DET
aiua-6073	1	18	experience	experience	NOUN
aiua-6073	1	19	of	of	ADP
aiua-6073	1	20	136	136	NUM
aiua-6073	1	21	italian	italian	ADJ
aiua-6073	1	22	urologists	urologist	NOUN
aiua-6073	1	23	in	in	ADP
aiua-6073	1	24	the	the	DET
aiua-6073	1	25	treatment	treatment	NOUN
aiua-6073	1	26	of	of	ADP
aiua-6073	1	27	erectile	erectile	ADJ
aiua-6073	1	28	dysfunction	dysfunction	NOUN
aiua-6073	1	29	with	with	ADP
aiua-6073	1	30	pde5	pde5	NOUN
aiua-6073	1	31	inhibitors	inhibitor	NOUN
aiua-6073	1	32	and	and	CCONJ
aiua-6073	1	33	recommendations	recommendation	NOUN
aiua-6073	1	34	for	for	ADP
aiua-6073	1	35	the	the	DET
aiua-6073	1	36	use	use	NOUN
aiua-6073	1	37	of	of	ADP
aiua-6073	1	38	avanafil	avanafil	PROPN
aiua-6073	1	39	in	in	ADP
aiua-6073	1	40	the	the	DET
aiua-6073	1	41	clinical	clinical	ADJ
aiua-6073	1	42	practice	practice	NOUN
aiua-6073	1	43	vincenzo	vincenzo	NOUN
aiua-6073	1	44	mirone	mirone	VERB
aiua-6073	1	45	1	1	NUM
aiua-6073	1	46	,	,	PUNCT
aiua-6073	1	47	ferdinando	ferdinando	NOUN
aiua-6073	1	48	fusco	fusco	PROPN
aiua-6073	1	49	1	1	NUM
aiua-6073	1	50	,	,	PUNCT
aiua-6073	1	51	fabio	fabio	PROPN
aiua-6073	1	52	parazzini	parazzini	PROPN
aiua-6073	1	53	2	2	NUM
aiua-6073	1	54	,	,	PUNCT
aiua-6073	1	55	alessandro	alessandro	PROPN
aiua-6073	1	56	zucchi	zucchi	PROPN
aiua-6073	1	57	3	3	NUM
aiua-6073	1	58	1	1	NUM
aiua-6073	1	59	dipartimento	dipartimento	ADP
aiua-6073	1	60	ostetricia	ostetricia	NOUN
aiua-6073	1	61	,	,	PUNCT
aiua-6073	1	62	ginecologia	ginecologia	NOUN
aiua-6073	1	63	,	,	PUNCT
aiua-6073	1	64	urologia	urologia	PROPN
aiua-6073	1	65	clinica	clinica	PROPN
aiua-6073	1	66	urologica	urologica	PROPN
aiua-6073	1	67	università	università	PROPN
aiua-6073	1	68	di	di	PROPN
aiua-6073	1	69	napoli	napoli	PROPN
aiua-6073	1	70	federico	federico	PROPN
aiua-6073	1	71	ii	ii	PROPN
aiua-6073	1	72	,	,	PUNCT
aiua-6073	1	73	italy	italy	PROPN
aiua-6073	1	74	;	;	PUNCT
aiua-6073	1	75	2	2	NUM
aiua-6073	1	76	i	i	PROPN
aiua-6073	1	77	clinica	clinica	PROPN
aiua-6073	1	78	ginecologica	ginecologica	PROPN
aiua-6073	1	79	,	,	PUNCT
aiua-6073	1	80	fondazione	fondazione	PROPN
aiua-6073	1	81	irccs	irccs	NOUN
aiua-6073	1	82	ca	ca	NOUN
aiua-6073	1	83	'	'	PART
aiua-6073	1	84	granda	granda	NOUN
aiua-6073	1	85	,	,	PUNCT
aiua-6073	1	86	ospedale	ospedale	NOUN
aiua-6073	1	87	maggiore	maggiore	NOUN
aiua-6073	1	88	policlinico	policlinico	NOUN
aiua-6073	1	89	,	,	PUNCT
aiua-6073	1	90	università	università	PROPN
aiua-6073	1	91	di	di	PROPN
aiua-6073	1	92	milano	milano	PROPN
aiua-6073	1	93	,	,	PUNCT
aiua-6073	1	94	italy	italy	PROPN
aiua-6073	1	95	;	;	PUNCT
aiua-6073	1	96	3	3	NUM
aiua-6073	1	97	clinica	clinica	PROPN
aiua-6073	1	98	urologica	urologica	PROPN
aiua-6073	1	99	ed	ed	PROPN
aiua-6073	1	100	andrologica	andrologica	PROPN
aiua-6073	1	101	,	,	PUNCT
aiua-6073	1	102	università	università	PROPN
aiua-6073	1	103	di	di	PROPN
aiua-6073	1	104	perugia	perugia	PROPN
aiua-6073	1	105	,	,	PUNCT
aiua-6073	1	106	italy	italy	PROPN
aiua-6073	1	107	.	.	PUNCT
aiua-6073	2	1	introduction	introduction	NOUN
aiua-6073	2	2	:	:	PUNCT
aiua-6073	2	3	pde5	pde5	NOUN
aiua-6073	2	4	inhibitors	inhibitor	NOUN
aiua-6073	2	5	are	be	AUX
aiua-6073	2	6	the	the	DET
aiua-6073	2	7	firstline	firstline	ADJ
aiua-6073	2	8	treatment	treatment	NOUN
aiua-6073	2	9	for	for	ADP
aiua-6073	2	10	erectile	erectile	ADJ
aiua-6073	2	11	dysfunction	dysfunction	NOUN
aiua-6073	2	12	.	.	PUNCT
aiua-6073	3	1	although	although	SCONJ
aiua-6073	3	2	all	all	DET
aiua-6073	3	3	these	these	DET
aiua-6073	3	4	drugs	drug	NOUN
aiua-6073	3	5	share	share	VERB
aiua-6073	3	6	the	the	DET
aiua-6073	3	7	same	same	ADJ
aiua-6073	3	8	mechanism	mechanism	NOUN
aiua-6073	3	9	of	of	ADP
aiua-6073	3	10	action	action	NOUN
aiua-6073	3	11	,	,	PUNCT
aiua-6073	3	12	each	each	DET
aiua-6073	3	13	agent	agent	NOUN
aiua-6073	3	14	could	could	AUX
aiua-6073	3	15	have	have	VERB
aiua-6073	3	16	different	different	ADJ
aiua-6073	3	17	characteristics	characteristic	NOUN
aiua-6073	3	18	in	in	ADP
aiua-6073	3	19	terms	term	NOUN
aiua-6073	3	20	of	of	ADP
aiua-6073	3	21	selectivity	selectivity	NOUN
aiua-6073	3	22	,	,	PUNCT
aiua-6073	3	23	pharmacokinetics	pharmacokinetic	NOUN
aiua-6073	3	24	and	and	CCONJ
aiua-6073	3	25	tolerability	tolerability	NOUN
aiua-6073	3	26	profile	profile	NOUN
aiua-6073	3	27	.	.	PUNCT
aiua-6073	4	1	materials	material	NOUN
aiua-6073	4	2	and	and	CCONJ
aiua-6073	4	3	methods	method	NOUN
aiua-6073	4	4	:	:	PUNCT
aiua-6073	4	5	this	this	DET
aiua-6073	4	6	manuscript	manuscript	NOUN
aiua-6073	4	7	illustrates	illustrate	VERB
aiua-6073	4	8	a	a	DET
aiua-6073	4	9	project	project	NOUN
aiua-6073	4	10	,	,	PUNCT
aiua-6073	4	11	undertaken	undertake	VERB
aiua-6073	4	12	by	by	ADP
aiua-6073	4	13	the	the	DET
aiua-6073	4	14	italian	italian	ADJ
aiua-6073	4	15	society	society	NOUN
aiua-6073	4	16	of	of	ADP
aiua-6073	4	17	urology	urology	NOUN
aiua-6073	4	18	in	in	ADP
aiua-6073	4	19	order	order	NOUN
aiua-6073	4	20	to	to	PART
aiua-6073	4	21	obtain	obtain	VERB
aiua-6073	4	22	a	a	DET
aiua-6073	4	23	“	"	PUNCT
aiua-6073	4	24	snapshot	snapshot	NOUN
aiua-6073	4	25	”	"	PUNCT
aiua-6073	4	26	of	of	ADP
aiua-6073	4	27	the	the	DET
aiua-6073	4	28	experience	experience	NOUN
aiua-6073	4	29	of	of	ADP
aiua-6073	4	30	italian	italian	ADJ
aiua-6073	4	31	urologists	urologist	NOUN
aiua-6073	4	32	with	with	ADP
aiua-6073	4	33	the	the	DET
aiua-6073	4	34	use	use	NOUN
aiua-6073	4	35	of	of	ADP
aiua-6073	4	36	pde5	pde5	NOUN
aiua-6073	4	37	inhibitors	inhibitor	NOUN
aiua-6073	4	38	in	in	ADP
aiua-6073	4	39	the	the	DET
aiua-6073	4	40	clinical	clinical	ADJ
aiua-6073	4	41	practice	practice	NOUN
aiua-6073	4	42	.	.	PUNCT
aiua-6073	5	1	this	this	DET
aiua-6073	5	2	project	project	NOUN
aiua-6073	5	3	included	include	VERB
aiua-6073	5	4	a	a	DET
aiua-6073	5	5	survey	survey	NOUN
aiua-6073	5	6	,	,	PUNCT
aiua-6073	5	7	targeting	target	VERB
aiua-6073	5	8	a	a	DET
aiua-6073	5	9	sample	sample	NOUN
aiua-6073	5	10	of	of	ADP
aiua-6073	5	11	136	136	NUM
aiua-6073	5	12	italian	italian	ADJ
aiua-6073	5	13	urologists	urologist	NOUN
aiua-6073	5	14	experienced	experience	VERB
aiua-6073	5	15	in	in	ADP
aiua-6073	5	16	the	the	DET
aiua-6073	5	17	treatment	treatment	NOUN
aiua-6073	5	18	of	of	ADP
aiua-6073	5	19	ed	ed	NOUN
aiua-6073	5	20	,	,	PUNCT
aiua-6073	5	21	and	and	CCONJ
aiua-6073	5	22	the	the	DET
aiua-6073	5	23	organization	organization	NOUN
aiua-6073	5	24	of	of	ADP
aiua-6073	5	25	a	a	DET
aiua-6073	5	26	conference	conference	NOUN
aiua-6073	5	27	of	of	ADP
aiua-6073	5	28	experts	expert	NOUN
aiua-6073	5	29	who	who	PRON
aiua-6073	5	30	,	,	PUNCT
aiua-6073	5	31	based	base	VERB
aiua-6073	5	32	on	on	ADP
aiua-6073	5	33	the	the	DET
aiua-6073	5	34	findings	finding	NOUN
aiua-6073	5	35	of	of	ADP
aiua-6073	5	36	the	the	DET
aiua-6073	5	37	survey	survey	NOUN
aiua-6073	5	38	,	,	PUNCT
aiua-6073	5	39	the	the	DET
aiua-6073	5	40	scientific	scientific	ADJ
aiua-6073	5	41	literature	literature	NOUN
aiua-6073	5	42	and	and	CCONJ
aiua-6073	5	43	the	the	DET
aiua-6073	5	44	clinical	clinical	ADJ
aiua-6073	5	45	experience	experience	NOUN
aiua-6073	5	46	,	,	PUNCT
aiua-6073	5	47	would	would	AUX
aiua-6073	5	48	define	define	VERB
aiua-6073	5	49	some	some	DET
aiua-6073	5	50	recommendations	recommendation	NOUN
aiua-6073	5	51	for	for	ADP
aiua-6073	5	52	the	the	DET
aiua-6073	5	53	use	use	NOUN
aiua-6073	5	54	of	of	ADP
aiua-6073	5	55	pde5	pde5	NOUN
aiua-6073	5	56	inhibitors	inhibitor	NOUN
aiua-6073	5	57	in	in	ADP
aiua-6073	5	58	clinical	clinical	ADJ
aiua-6073	5	59	practice	practice	NOUN
aiua-6073	5	60	with	with	ADP
aiua-6073	5	61	a	a	DET
aiua-6073	5	62	particular	particular	ADJ
aiua-6073	5	63	focus	focus	NOUN
aiua-6073	5	64	on	on	ADP
aiua-6073	5	65	avanafil	avanafil	PROPN
aiua-6073	5	66	,	,	PUNCT
aiua-6073	5	67	the	the	DET
aiua-6073	5	68	most	most	ADV
aiua-6073	5	69	recent	recent	ADJ
aiua-6073	5	70	drug	drug	NOUN
aiua-6073	5	71	in	in	ADP
aiua-6073	5	72	this	this	DET
aiua-6073	5	73	class	class	NOUN
aiua-6073	5	74	.	.	PUNCT
aiua-6073	6	1	results	result	NOUN
aiua-6073	6	2	:	:	PUNCT
aiua-6073	6	3	the	the	DET
aiua-6073	6	4	following	follow	VERB
aiua-6073	6	5	recommendations	recommendation	NOUN
aiua-6073	6	6	on	on	ADP
aiua-6073	6	7	the	the	DET
aiua-6073	6	8	use	use	NOUN
aiua-6073	6	9	of	of	ADP
aiua-6073	6	10	avanafil	avanafil	PROPN
aiua-6073	6	11	were	be	AUX
aiua-6073	6	12	issued	issue	VERB
aiua-6073	6	13	:	:	PUNCT
aiua-6073	6	14	1	1	X
aiua-6073	6	15	)	)	PUNCT
aiua-6073	6	16	in	in	ADP
aiua-6073	6	17	patients	patient	NOUN
aiua-6073	6	18	who	who	PRON
aiua-6073	6	19	are	be	AUX
aiua-6073	6	20	candidates	candidate	NOUN
aiua-6073	6	21	for	for	ADP
aiua-6073	6	22	the	the	DET
aiua-6073	6	23	use	use	NOUN
aiua-6073	6	24	of	of	ADP
aiua-6073	6	25	avanafil	avanafil	PROPN
aiua-6073	6	26	,	,	PUNCT
aiua-6073	6	27	it	it	PRON
aiua-6073	6	28	is	be	AUX
aiua-6073	6	29	advisable	advisable	ADJ
aiua-6073	6	30	to	to	PART
aiua-6073	6	31	use	use	VERB
aiua-6073	6	32	the	the	DET
aiua-6073	6	33	200	200	NUM
aiua-6073	6	34	-	-	PUNCT
aiua-6073	6	35	mg	mg	NOUN
aiua-6073	6	36	dose	dose	NOUN
aiua-6073	6	37	from	from	ADP
aiua-6073	6	38	the	the	DET
aiua-6073	6	39	first	first	ADJ
aiua-6073	6	40	administration	administration	NOUN
aiua-6073	6	41	;	;	PUNCT
aiua-6073	6	42	2	2	X
aiua-6073	6	43	)	)	PUNCT
aiua-6073	6	44	when	when	SCONJ
aiua-6073	6	45	used	use	VERB
aiua-6073	6	46	at	at	ADP
aiua-6073	6	47	the	the	DET
aiua-6073	6	48	highest	high	ADJ
aiua-6073	6	49	dose	dose	NOUN
aiua-6073	6	50	(	(	PUNCT
aiua-6073	6	51	200	200	NUM
aiua-6073	6	52	mg	mg	NOUN
aiua-6073	6	53	)	)	PUNCT
aiua-6073	6	54	,	,	PUNCT
aiua-6073	6	55	avanafil	avanafil	PROPN
aiua-6073	6	56	shows	show	VERB
aiua-6073	6	57	a	a	DET
aiua-6073	6	58	favourable	favourable	ADJ
aiua-6073	6	59	tolerability	tolerability	NOUN
aiua-6073	6	60	profile	profile	NOUN
aiua-6073	6	61	with	with	ADP
aiua-6073	6	62	an	an	DET
aiua-6073	6	63	efficacy	efficacy	NOUN
aiua-6073	6	64	similar	similar	ADJ
aiua-6073	6	65	to	to	ADP
aiua-6073	6	66	that	that	PRON
aiua-6073	6	67	of	of	ADP
aiua-6073	6	68	other	other	ADJ
aiua-6073	6	69	agents	agent	NOUN
aiua-6073	6	70	;	;	PUNCT
aiua-6073	6	71	3	3	X
aiua-6073	6	72	)	)	PUNCT
aiua-6073	6	73	the	the	DET
aiua-6073	6	74	patient	patient	NOUN
aiua-6073	6	75	should	should	AUX
aiua-6073	6	76	be	be	AUX
aiua-6073	6	77	instructed	instruct	VERB
aiua-6073	6	78	to	to	PART
aiua-6073	6	79	take	take	VERB
aiua-6073	6	80	avanafil	avanafil	NOUN
aiua-6073	6	81	on	on	ADP
aiua-6073	6	82	an	an	DET
aiua-6073	6	83	empty	empty	ADJ
aiua-6073	6	84	stomach	stomach	NOUN
aiua-6073	6	85	,	,	PUNCT
aiua-6073	6	86	i.e.	i.e.	X
aiua-6073	6	87	,	,	PUNCT
aiua-6073	6	88	30	30	NUM
aiua-6073	6	89	-	-	SYM
aiua-6073	6	90	45	45	NUM
aiua-6073	6	91	minutes	minute	NOUN
aiua-6073	6	92	before	before	ADP
aiua-6073	6	93	or	or	CCONJ
aiua-6073	6	94	2	2	NUM
aiua-6073	6	95	hours	hour	NOUN
aiua-6073	6	96	after	after	ADP
aiua-6073	6	97	a	a	DET
aiua-6073	6	98	meal	meal	NOUN
aiua-6073	6	99	;	;	PUNCT
aiua-6073	6	100	4	4	X
aiua-6073	6	101	)	)	PUNCT
aiua-6073	6	102	the	the	DET
aiua-6073	6	103	efficacy	efficacy	NOUN
aiua-6073	6	104	window	window	NOUN
aiua-6073	6	105	of	of	ADP
aiua-6073	6	106	avanafil	avanafil	PROPN
aiua-6073	6	107	is	be	AUX
aiua-6073	6	108	between	between	ADP
aiua-6073	6	109	30	30	NUM
aiua-6073	6	110	minutes	minute	NOUN
aiua-6073	6	111	and	and	CCONJ
aiua-6073	6	112	6	6	NUM
aiua-6073	6	113	hours	hour	NOUN
aiua-6073	6	114	after	after	ADP
aiua-6073	6	115	dosing	dose	VERB
aiua-6073	6	116	,	,	PUNCT
aiua-6073	6	117	which	which	PRON
aiua-6073	6	118	qualifies	qualify	VERB
aiua-6073	6	119	this	this	DET
aiua-6073	6	120	molecule	molecule	NOUN
aiua-6073	6	121	as	as	ADP
aiua-6073	6	122	a	a	DET
aiua-6073	6	123	new	new	ADJ
aiua-6073	6	124	drug	drug	NOUN
aiua-6073	6	125	with	with	ADP
aiua-6073	6	126	an	an	DET
aiua-6073	6	127	intermediate	intermediate	ADJ
aiua-6073	6	128	duration	duration	NOUN
aiua-6073	6	129	of	of	ADP
aiua-6073	6	130	action	action	NOUN
aiua-6073	6	131	;	;	PUNCT
aiua-6073	6	132	5	5	X
aiua-6073	6	133	)	)	PUNCT
aiua-6073	6	134	avanafil	avanafil	VERB
aiua-6073	6	135	at	at	ADP
aiua-6073	6	136	a	a	DET
aiua-6073	6	137	dose	dose	NOUN
aiua-6073	6	138	of	of	ADP
aiua-6073	6	139	50	50	NUM
aiua-6073	6	140	-	-	SYM
aiua-6073	6	141	100	100	NUM
aiua-6073	6	142	mg	mg	NUM
aiua-6073	6	143	/	/	SYM
aiua-6073	6	144	day	day	NOUN
aiua-6073	6	145	may	may	AUX
aiua-6073	6	146	be	be	AUX
aiua-6073	6	147	a	a	DET
aiua-6073	6	148	therapeutic	therapeutic	ADJ
aiua-6073	6	149	option	option	NOUN
aiua-6073	6	150	in	in	ADP
aiua-6073	6	151	chronic	chronic	ADJ
aiua-6073	6	152	rehabilitation	rehabilitation	NOUN
aiua-6073	6	153	.	.	PUNCT
aiua-6073	7	1	conclusions	conclusion	NOUN
aiua-6073	7	2	:	:	PUNCT
aiua-6073	7	3	among	among	ADP
aiua-6073	7	4	pde5	pde5	NOUN
aiua-6073	7	5	inhibitors	inhibitor	NOUN
aiua-6073	7	6	,	,	PUNCT
aiua-6073	7	7	avanafil	avanafil	PROPN
aiua-6073	7	8	is	be	AUX
aiua-6073	7	9	a	a	DET
aiua-6073	7	10	new	new	ADJ
aiua-6073	7	11	agent	agent	NOUN
aiua-6073	7	12	with	with	ADP
aiua-6073	7	13	an	an	DET
aiua-6073	7	14	intermediate	intermediate	ADJ
aiua-6073	7	15	duration	duration	NOUN
aiua-6073	7	16	of	of	ADP
aiua-6073	7	17	action	action	NOUN
aiua-6073	7	18	,	,	PUNCT
aiua-6073	7	19	characterized	characterize	VERB
aiua-6073	7	20	by	by	ADP
aiua-6073	7	21	high	high	ADJ
aiua-6073	7	22	efficacy	efficacy	NOUN
aiua-6073	7	23	and	and	CCONJ
aiua-6073	7	24	good	good	ADJ
aiua-6073	7	25	tolerability	tolerability	NOUN
aiua-6073	7	26	even	even	ADV
aiua-6073	7	27	at	at	ADP
aiua-6073	7	28	the	the	DET
aiua-6073	7	29	highest	high	ADJ
aiua-6073	7	30	dose	dose	NOUN
aiua-6073	7	31	(	(	PUNCT
aiua-6073	7	32	200	200	NUM
aiua-6073	7	33	mg	mg	NOUN
aiua-6073	7	34	)	)	PUNCT
aiua-6073	7	35	.	.	PUNCT
aiua-6073	8	1	key	key	ADJ
aiua-6073	8	2	words	word	NOUN
aiua-6073	8	3	:	:	PUNCT
aiua-6073	8	4	erectile	erectile	ADJ
aiua-6073	8	5	dysfunction	dysfunction	NOUN
aiua-6073	8	6	;	;	PUNCT
aiua-6073	8	7	pde5	pde5	NOUN
aiua-6073	8	8	inhibitors	inhibitor	NOUN
aiua-6073	8	9	;	;	PUNCT
aiua-6073	8	10	avanafil	avanafil	X
aiua-6073	8	11	;	;	PUNCT
aiua-6073	8	12	italian	italian	ADJ
aiua-6073	8	13	survey	survey	NOUN
aiua-6073	8	14	;	;	PUNCT
aiua-6073	8	15	recommendations	recommendation	NOUN
aiua-6073	8	16	;	;	PUNCT
aiua-6073	8	17	dosage	dosage	NOUN
aiua-6073	8	18	.	.	PUNCT
aiua-6073	8	19	submitted	submit	VERB
aiua-6073	8	20	1	1	NUM
aiua-6073	8	21	june	june	PROPN
aiua-6073	8	22	2016	2016	NUM
aiua-6073	8	23	;	;	PUNCT
aiua-6073	8	24	accepted	accept	VERB
aiua-6073	8	25	10	10	NUM
aiua-6073	8	26	june	june	PROPN
aiua-6073	8	27	2016	2016	NUM
aiua-6073	8	28	summary	summary	NOUN
aiua-6073	8	29	no	no	DET
aiua-6073	8	30	conflict	conflict	NOUN
aiua-6073	8	31	of	of	ADP
aiua-6073	8	32	interest	interest	NOUN
aiua-6073	8	33	declared	declare	VERB
aiua-6073	8	34	.	.	PUNCT
aiua-6073	9	1	tion	tion	PROPN
aiua-6073	9	2	with	with	ADP
aiua-6073	9	3	a	a	DET
aiua-6073	9	4	high	high	ADJ
aiua-6073	9	5	prevalence	prevalence	NOUN
aiua-6073	9	6	worldwide	worldwide	ADV
aiua-6073	9	7	;	;	PUNCT
aiua-6073	9	8	it	it	PRON
aiua-6073	9	9	has	have	AUX
aiua-6073	9	10	been	be	AUX
aiua-6073	9	11	estimated	estimate	VERB
aiua-6073	9	12	that	that	SCONJ
aiua-6073	9	13	5	5	NUM
aiua-6073	9	14	-	-	SYM
aiua-6073	9	15	20	20	NUM
aiua-6073	9	16	%	%	NOUN
aiua-6073	9	17	of	of	ADP
aiua-6073	9	18	men	man	NOUN
aiua-6073	9	19	are	be	AUX
aiua-6073	9	20	affected	affect	VERB
aiua-6073	9	21	by	by	ADP
aiua-6073	9	22	moderate	moderate	ADJ
aiua-6073	9	23	-	-	PUNCT
aiua-6073	9	24	tosevere	tosevere	NOUN
aiua-6073	9	25	ed	ed	NOUN
aiua-6073	9	26	at	at	ADP
aiua-6073	9	27	some	some	DET
aiua-6073	9	28	time	time	NOUN
aiua-6073	9	29	during	during	ADP
aiua-6073	9	30	their	their	PRON
aiua-6073	9	31	sexual	sexual	ADJ
aiua-6073	9	32	life	life	NOUN
aiua-6073	9	33	(	(	PUNCT
aiua-6073	9	34	1	1	NUM
aiua-6073	9	35	)	)	PUNCT
aiua-6073	9	36	.	.	PUNCT
aiua-6073	10	1	the	the	DET
aiua-6073	10	2	introduction	introduction	NOUN
aiua-6073	10	3	in	in	ADP
aiua-6073	10	4	the	the	DET
aiua-6073	10	5	clinical	clinical	ADJ
aiua-6073	10	6	practice	practice	NOUN
aiua-6073	10	7	of	of	ADP
aiua-6073	10	8	phosphodiesterase	phosphodiesterase	NOUN
aiua-6073	10	9	type	type	NOUN
aiua-6073	10	10	5	5	NUM
aiua-6073	10	11	inhibitors	inhibitor	NOUN
aiua-6073	10	12	(	(	PUNCT
aiua-6073	10	13	pde5is	pde5is	PROPN
aiua-6073	10	14	)	)	PUNCT
aiua-6073	10	15	,	,	PUNCT
aiua-6073	10	16	in	in	ADP
aiua-6073	10	17	the	the	DET
aiua-6073	10	18	early	early	ADJ
aiua-6073	10	19	1990s	1990	NOUN
aiua-6073	10	20	,	,	PUNCT
aiua-6073	10	21	represented	represent	VERB
aiua-6073	10	22	a	a	DET
aiua-6073	10	23	milestone	milestone	NOUN
aiua-6073	10	24	in	in	ADP
aiua-6073	10	25	the	the	DET
aiua-6073	10	26	treatment	treatment	NOUN
aiua-6073	10	27	of	of	ADP
aiua-6073	10	28	ed	ed	NOUN
aiua-6073	10	29	.	.	PUNCT
aiua-6073	11	1	penile	penile	ADJ
aiua-6073	11	2	erection	erection	NOUN
aiua-6073	11	3	is	be	AUX
aiua-6073	11	4	a	a	DET
aiua-6073	11	5	complex	complex	ADJ
aiua-6073	11	6	neurovascular	neurovascular	ADJ
aiua-6073	11	7	event	event	NOUN
aiua-6073	11	8	that	that	PRON
aiua-6073	11	9	occurs	occur	VERB
aiua-6073	11	10	due	due	ADJ
aiua-6073	11	11	to	to	ADP
aiua-6073	11	12	relaxation	relaxation	NOUN
aiua-6073	11	13	of	of	ADP
aiua-6073	11	14	cavernosal	cavernosal	ADJ
aiua-6073	11	15	helicine	helicine	NOUN
aiua-6073	11	16	arteries	artery	NOUN
aiua-6073	11	17	and	and	CCONJ
aiua-6073	11	18	smooth	smooth	ADJ
aiua-6073	11	19	muscle	muscle	NOUN
aiua-6073	11	20	of	of	ADP
aiua-6073	11	21	corpora	corpora	ADJ
aiua-6073	11	22	cavernosa	cavernosa	NOUN
aiua-6073	11	23	in	in	ADP
aiua-6073	11	24	combination	combination	NOUN
aiua-6073	11	25	with	with	ADP
aiua-6073	11	26	a	a	DET
aiua-6073	11	27	coincident	coincident	ADJ
aiua-6073	11	28	veno	veno	NOUN
aiua-6073	11	29	-	-	PUNCT
aiua-6073	11	30	occlusion	occlusion	NOUN
aiua-6073	11	31	,	,	PUNCT
aiua-6073	11	32	leading	lead	VERB
aiua-6073	11	33	to	to	ADP
aiua-6073	11	34	blood	blood	NOUN
aiua-6073	11	35	distension	distension	NOUN
aiua-6073	11	36	of	of	ADP
aiua-6073	11	37	the	the	DET
aiua-6073	11	38	corporal	corporal	ADJ
aiua-6073	11	39	sinusoid	sinusoid	NOUN
aiua-6073	11	40	and	and	CCONJ
aiua-6073	11	41	resultant	resultant	VERB
aiua-6073	11	42	penile	penile	ADJ
aiua-6073	11	43	rigidity	rigidity	NOUN
aiua-6073	11	44	(	(	PUNCT
aiua-6073	11	45	2	2	NUM
aiua-6073	11	46	)	)	PUNCT
aiua-6073	11	47	.	.	PUNCT
aiua-6073	12	1	the	the	DET
aiua-6073	12	2	primary	primary	ADJ
aiua-6073	12	3	mediator	mediator	NOUN
aiua-6073	12	4	of	of	ADP
aiua-6073	12	5	this	this	DET
aiua-6073	12	6	process	process	NOUN
aiua-6073	12	7	is	be	AUX
aiua-6073	12	8	the	the	DET
aiua-6073	12	9	nitric	nitric	ADJ
aiua-6073	12	10	oxide	oxide	NOUN
aiua-6073	12	11	(	(	PUNCT
aiua-6073	12	12	no)/cyclic	no)/cyclic	PROPN
aiua-6073	12	13	guanosin	guanosin	NOUN
aiua-6073	12	14	-	-	PUNCT
aiua-6073	12	15	monophosphate	monophosphate	NOUN
aiua-6073	12	16	(	(	PUNCT
aiua-6073	12	17	cgmp	cgmp	NOUN
aiua-6073	12	18	)	)	PUNCT
aiua-6073	12	19	pathway	pathway	NOUN
aiua-6073	12	20	.	.	PUNCT
aiua-6073	13	1	phosphodiesterase	phosphodiesterase	NOUN
aiua-6073	13	2	type	type	NOUN
aiua-6073	13	3	5	5	NUM
aiua-6073	13	4	(	(	PUNCT
aiua-6073	13	5	pde5	pde5	PROPN
aiua-6073	13	6	)	)	PUNCT
aiua-6073	13	7	,	,	PUNCT
aiua-6073	13	8	the	the	DET
aiua-6073	13	9	enzyme	enzyme	NOUN
aiua-6073	13	10	which	which	PRON
aiua-6073	13	11	breakdowns	breakdown	NOUN
aiua-6073	13	12	cgmp	cgmp	VERB
aiua-6073	13	13	in	in	ADP
aiua-6073	13	14	the	the	DET
aiua-6073	13	15	corpus	corpus	NOUN
aiua-6073	13	16	cavernosum	cavernosum	NOUN
aiua-6073	13	17	,	,	PUNCT
aiua-6073	13	18	regulates	regulate	VERB
aiua-6073	13	19	the	the	DET
aiua-6073	13	20	no	no	ADV
aiua-6073	13	21	-	-	PUNCT
aiua-6073	13	22	mediated	mediate	VERB
aiua-6073	13	23	relaxation	relaxation	NOUN
aiua-6073	13	24	of	of	ADP
aiua-6073	13	25	smooth	smooth	ADJ
aiua-6073	13	26	muscle	muscle	NOUN
aiua-6073	13	27	cells	cell	NOUN
aiua-6073	13	28	.	.	PUNCT
aiua-6073	14	1	the	the	DET
aiua-6073	14	2	mechanism	mechanism	NOUN
aiua-6073	14	3	of	of	ADP
aiua-6073	14	4	action	action	NOUN
aiua-6073	14	5	of	of	ADP
aiua-6073	14	6	pde5is	pde5is	PROPN
aiua-6073	14	7	consists	consist	VERB
aiua-6073	14	8	precisely	precisely	ADV
aiua-6073	14	9	in	in	ADP
aiua-6073	14	10	the	the	DET
aiua-6073	14	11	inhibition	inhibition	NOUN
aiua-6073	14	12	of	of	ADP
aiua-6073	14	13	pde5	pde5	NOUN
aiua-6073	14	14	,	,	PUNCT
aiua-6073	14	15	which	which	PRON
aiua-6073	14	16	results	result	VERB
aiua-6073	14	17	in	in	ADP
aiua-6073	14	18	increased	increase	VERB
aiua-6073	14	19	cgmp	cgmp	NOUN
aiua-6073	14	20	concentrations	concentration	NOUN
aiua-6073	14	21	with	with	ADP
aiua-6073	14	22	continued	continue	VERB
aiua-6073	14	23	activation	activation	NOUN
aiua-6073	14	24	of	of	ADP
aiua-6073	14	25	the	the	DET
aiua-6073	14	26	no	no	NOUN
aiua-6073	14	27	/	/	SYM
aiua-6073	14	28	cgmp	cgmp	NOUN
aiua-6073	14	29	pathway	pathway	NOUN
aiua-6073	14	30	and	and	CCONJ
aiua-6073	14	31	subsequent	subsequent	ADJ
aiua-6073	14	32	increase	increase	NOUN
aiua-6073	14	33	in	in	ADP
aiua-6073	14	34	blood	blood	NOUN
aiua-6073	14	35	flow	flow	NOUN
aiua-6073	14	36	into	into	ADP
aiua-6073	14	37	the	the	DET
aiua-6073	14	38	corpora	corpora	NOUN
aiua-6073	14	39	cavernosa	cavernosa	NOUN
aiua-6073	14	40	(	(	PUNCT
aiua-6073	14	41	3	3	NUM
aiua-6073	14	42	)	)	PUNCT
aiua-6073	14	43	.	.	PUNCT
aiua-6073	15	1	the	the	DET
aiua-6073	15	2	efficacy	efficacy	NOUN
aiua-6073	15	3	of	of	ADP
aiua-6073	15	4	pde5	pde5	NOUN
aiua-6073	15	5	inhibitors	inhibitor	NOUN
aiua-6073	15	6	is	be	AUX
aiua-6073	15	7	independent	independent	ADJ
aiua-6073	15	8	of	of	ADP
aiua-6073	15	9	patient	patient	ADJ
aiua-6073	15	10	age	age	NOUN
aiua-6073	15	11	,	,	PUNCT
aiua-6073	15	12	etiology	etiology	NOUN
aiua-6073	15	13	of	of	ADP
aiua-6073	15	14	ed	ed	PROPN
aiua-6073	15	15	(	(	PUNCT
aiua-6073	15	16	organic	organic	ADJ
aiua-6073	15	17	,	,	PUNCT
aiua-6073	15	18	psychogenic	psychogenic	ADJ
aiua-6073	15	19	,	,	PUNCT
aiua-6073	15	20	mixed	mixed	ADJ
aiua-6073	15	21	)	)	PUNCT
aiua-6073	15	22	,	,	PUNCT
aiua-6073	15	23	and	and	CCONJ
aiua-6073	15	24	baseline	baseline	VERB
aiua-6073	15	25	severity	severity	NOUN
aiua-6073	15	26	of	of	ADP
aiua-6073	15	27	the	the	DET
aiua-6073	15	28	condition	condition	NOUN
aiua-6073	15	29	(	(	PUNCT
aiua-6073	15	30	4	4	NUM
aiua-6073	15	31	)	)	PUNCT
aiua-6073	15	32	.	.	PUNCT
aiua-6073	16	1	four	four	NUM
aiua-6073	16	2	pde5is	pde5is	ADJ
aiua-6073	16	3	(	(	PUNCT
aiua-6073	16	4	sildenafil	sildenafil	X
aiua-6073	16	5	,	,	PUNCT
aiua-6073	16	6	tadalafil	tadalafil	PROPN
aiua-6073	16	7	,	,	PUNCT
aiua-6073	16	8	vardenafil	vardenafil	NOUN
aiua-6073	16	9	,	,	PUNCT
aiua-6073	16	10	and	and	CCONJ
aiua-6073	16	11	avanafil	avanafil	PROPN
aiua-6073	16	12	)	)	PUNCT
aiua-6073	16	13	have	have	AUX
aiua-6073	16	14	so	so	ADV
aiua-6073	16	15	far	far	ADV
aiua-6073	16	16	been	be	AUX
aiua-6073	16	17	approved	approve	VERB
aiua-6073	16	18	for	for	ADP
aiua-6073	16	19	clinical	clinical	ADJ
aiua-6073	16	20	use	use	NOUN
aiua-6073	16	21	in	in	ADP
aiua-6073	16	22	italy	italy	PROPN
aiua-6073	16	23	.	.	PUNCT
aiua-6073	17	1	avanafil	avanafil	PROPN
aiua-6073	17	2	,	,	PUNCT
aiua-6073	17	3	the	the	DET
aiua-6073	17	4	most	most	ADV
aiua-6073	17	5	recently	recently	ADV
aiua-6073	17	6	marketed	market	VERB
aiua-6073	17	7	molecule	molecule	NOUN
aiua-6073	17	8	,	,	PUNCT
aiua-6073	17	9	differs	differ	VERB
aiua-6073	17	10	pharmacologically	pharmacologically	ADV
aiua-6073	17	11	from	from	ADP
aiua-6073	17	12	the	the	DET
aiua-6073	17	13	other	other	ADJ
aiua-6073	17	14	agents	agent	NOUN
aiua-6073	17	15	of	of	ADP
aiua-6073	17	16	the	the	DET
aiua-6073	17	17	same	same	ADJ
aiua-6073	17	18	class	class	NOUN
aiua-6073	17	19	due	due	ADP
aiua-6073	17	20	to	to	ADP
aiua-6073	17	21	its	its	PRON
aiua-6073	17	22	higher	high	ADJ
aiua-6073	17	23	selectivity	selectivity	NOUN
aiua-6073	17	24	for	for	ADP
aiua-6073	17	25	the	the	DET
aiua-6073	17	26	pde5	pde5	NOUN
aiua-6073	17	27	isoenzyme	isoenzyme	NOUN
aiua-6073	17	28	.	.	PUNCT
aiua-6073	18	1	indeed	indeed	ADV
aiua-6073	18	2	,	,	PUNCT
aiua-6073	18	3	pde5	pde5	NOUN
aiua-6073	18	4	inhibitors	inhibitor	NOUN
aiua-6073	18	5	have	have	VERB
aiua-6073	18	6	different	different	ADJ
aiua-6073	18	7	selectivities	selectivity	NOUN
aiua-6073	18	8	for	for	ADP
aiua-6073	18	9	this	this	DET
aiua-6073	18	10	isoenzyme	isoenzyme	NOUN
aiua-6073	18	11	,	,	PUNCT
aiua-6073	18	12	as	as	SCONJ
aiua-6073	18	13	they	they	PRON
aiua-6073	18	14	may	may	AUX
aiua-6073	18	15	exert	exert	VERB
aiua-6073	18	16	inhibitory	inhibitory	ADJ
aiua-6073	18	17	effects	effect	NOUN
aiua-6073	18	18	on	on	ADP
aiua-6073	18	19	other	other	ADJ
aiua-6073	18	20	pde	pde	NOUN
aiua-6073	18	21	isoforms	isoform	NOUN
aiua-6073	18	22	resulting	result	VERB
aiua-6073	18	23	in	in	ADP
aiua-6073	18	24	potential	potential	ADJ
aiua-6073	18	25	side	side	NOUN
aiua-6073	18	26	effects	effect	NOUN
aiua-6073	18	27	,	,	PUNCT
aiua-6073	18	28	sometimes	sometimes	ADV
aiua-6073	18	29	serious	serious	ADJ
aiua-6073	18	30	enough	enough	ADV
aiua-6073	18	31	to	to	PART
aiua-6073	18	32	require	require	VERB
aiua-6073	18	33	treatment	treatment	NOUN
aiua-6073	18	34	discontinuation	discontinuation	NOUN
aiua-6073	18	35	.	.	PUNCT
aiua-6073	19	1	on	on	ADP
aiua-6073	19	2	the	the	DET
aiua-6073	19	3	other	other	ADJ
aiua-6073	19	4	end	end	NOUN
aiua-6073	19	5	,	,	PUNCT
aiua-6073	19	6	the	the	PRON
aiua-6073	19	7	greater	great	ADJ
aiua-6073	19	8	the	the	DET
aiua-6073	19	9	selectivity	selectivity	NOUN
aiua-6073	19	10	for	for	ADP
aiua-6073	19	11	the	the	DET
aiua-6073	19	12	pde5	pde5	NOUN
aiua-6073	19	13	isoenzyme	isoenzyme	NOUN
aiua-6073	19	14	,	,	PUNCT
aiua-6073	19	15	the	the	DET
aiua-6073	19	16	less	less	ADV
aiua-6073	19	17	likely	likely	ADJ
aiua-6073	19	18	is	be	AUX
aiua-6073	19	19	the	the	DET
aiua-6073	19	20	occurrence	occurrence	NOUN
aiua-6073	19	21	of	of	ADP
aiua-6073	19	22	adverse	adverse	ADJ
aiua-6073	19	23	events	event	NOUN
aiua-6073	19	24	potentially	potentially	ADV
aiua-6073	19	25	related	relate	VERB
aiua-6073	19	26	to	to	ADP
aiua-6073	19	27	the	the	DET
aiua-6073	19	28	inhibition	inhibition	NOUN
aiua-6073	19	29	of	of	ADP
aiua-6073	19	30	other	other	ADJ
aiua-6073	19	31	pde	pde	NOUN
aiua-6073	19	32	isoforms	isoform	NOUN
aiua-6073	19	33	(	(	PUNCT
aiua-6073	19	34	5	5	NUM
aiua-6073	19	35	)	)	PUNCT
aiua-6073	19	36	.	.	PUNCT
aiua-6073	20	1	experimental	experimental	ADJ
aiua-6073	20	2	studies	study	NOUN
aiua-6073	20	3	have	have	AUX
aiua-6073	20	4	shown	show	VERB
aiua-6073	20	5	that	that	SCONJ
aiua-6073	20	6	avanafil	avanafil	PROPN
aiua-6073	20	7	has	have	VERB
aiua-6073	20	8	higher	high	ADJ
aiua-6073	20	9	selectivity	selectivity	NOUN
aiua-6073	20	10	for	for	ADP
aiua-6073	20	11	pde5	pde5	NOUN
aiua-6073	20	12	than	than	ADP
aiua-6073	20	13	for	for	ADP
aiua-6073	20	14	other	other	ADJ
aiua-6073	20	15	isoenzymes	isoenzyme	NOUN
aiua-6073	20	16	.	.	PUNCT
aiua-6073	21	1	it	it	PRON
aiua-6073	21	2	is	be	AUX
aiua-6073	21	3	generally	generally	ADV
aiua-6073	21	4	believed	believe	VERB
aiua-6073	21	5	that	that	SCONJ
aiua-6073	21	6	the	the	DET
aiua-6073	21	7	high	high	ADJ
aiua-6073	21	8	selectivity	selectivity	NOUN
aiua-6073	21	9	of	of	ADP
aiua-6073	21	10	avanafil	avanafil	PROPN
aiua-6073	21	11	results	result	NOUN
aiua-6073	21	12	in	in	ADP
aiua-6073	21	13	better	well	ADJ
aiua-6073	21	14	tolerability	tolerability	NOUN
aiua-6073	21	15	compared	compare	VERB
aiua-6073	21	16	with	with	ADP
aiua-6073	21	17	other	other	ADJ
aiua-6073	21	18	less	less	ADJ
aiua-6073	21	19	selective	selective	ADJ
aiua-6073	21	20	agents	agent	NOUN
aiua-6073	21	21	(	(	PUNCT
aiua-6073	21	22	5	5	NUM
aiua-6073	21	23	,	,	PUNCT
aiua-6073	21	24	6	6	NUM
aiua-6073	21	25	)	)	PUNCT
aiua-6073	21	26	.	.	PUNCT
aiua-6073	22	1	doi	doi	NOUN
aiua-6073	22	2	:	:	PUNCT
aiua-6073	22	3	10.4081	10.4081	NUM
aiua-6073	22	4	/	/	SYM
aiua-6073	22	5	aiua.2016.2.128	aiua.2016.2.128	NOUN
aiua-6073	22	6	introduction	introduction	NOUN
aiua-6073	22	7	erectile	erectile	NOUN
aiua-6073	22	8	dysfunction	dysfunction	NOUN
aiua-6073	22	9	(	(	PUNCT
aiua-6073	22	10	ed	ed	NOUN
aiua-6073	22	11	)	)	PUNCT
aiua-6073	22	12	,	,	PUNCT
aiua-6073	22	13	defined	define	VERB
aiua-6073	22	14	as	as	ADP
aiua-6073	22	15	the	the	DET
aiua-6073	22	16	consistent	consistent	ADJ
aiua-6073	22	17	or	or	CCONJ
aiua-6073	22	18	recurrent	recurrent	ADJ
aiua-6073	22	19	inability	inability	NOUN
aiua-6073	22	20	to	to	PART
aiua-6073	22	21	attain	attain	VERB
aiua-6073	22	22	and	and	CCONJ
aiua-6073	22	23	maintain	maintain	VERB
aiua-6073	22	24	an	an	DET
aiua-6073	22	25	erection	erection	NOUN
aiua-6073	22	26	sufficient	sufficient	ADJ
aiua-6073	22	27	for	for	ADP
aiua-6073	22	28	satisfactory	satisfactory	ADJ
aiua-6073	22	29	sexual	sexual	ADJ
aiua-6073	22	30	performance	performance	NOUN
aiua-6073	22	31	,	,	PUNCT
aiua-6073	22	32	is	be	AUX
aiua-6073	22	33	a	a	DET
aiua-6073	22	34	condimirone_stesura	condimirone_stesura	NOUN
aiua-6073	22	35	seveso	seveso	NOUN
aiua-6073	22	36	01/07/16	01/07/16	PROPN
aiua-6073	22	37	11:08	11:08	NUM
aiua-6073	22	38	pagina	pagina	NOUN
aiua-6073	22	39	128	128	NUM
aiua-6073	22	40	129archivio	129archivio	PROPN
aiua-6073	22	41	italiano	italiano	NOUN
aiua-6073	22	42	di	di	X
aiua-6073	22	43	urologia	urologia	PROPN
aiua-6073	22	44	e	e	PROPN
aiua-6073	22	45	andrologia	andrologia	NOUN
aiua-6073	22	46	2016	2016	NUM
aiua-6073	22	47	;	;	PUNCT
aiua-6073	22	48	88	88	NUM
aiua-6073	22	49	,	,	PUNCT
aiua-6073	22	50	2	2	NUM
aiua-6073	22	51	avanafil	avanafil	NOUN
aiua-6073	22	52	and	and	CCONJ
aiua-6073	22	53	ed	ed	NOUN
aiua-6073	22	54	:	:	PUNCT
aiua-6073	22	55	a	a	DET
aiua-6073	22	56	survey	survey	NOUN
aiua-6073	22	57	on	on	ADP
aiua-6073	22	58	italian	italian	ADJ
aiua-6073	22	59	urologists	urologist	NOUN
aiua-6073	22	60	the	the	DET
aiua-6073	22	61	efficacy	efficacy	NOUN
aiua-6073	22	62	of	of	ADP
aiua-6073	22	63	avanafil	avanafil	PROPN
aiua-6073	22	64	in	in	ADP
aiua-6073	22	65	the	the	DET
aiua-6073	22	66	treatment	treatment	NOUN
aiua-6073	22	67	of	of	ADP
aiua-6073	22	68	ed	ed	NOUN
aiua-6073	22	69	is	be	AUX
aiua-6073	22	70	confirmed	confirm	VERB
aiua-6073	22	71	by	by	ADP
aiua-6073	22	72	a	a	DET
aiua-6073	22	73	number	number	NOUN
aiua-6073	22	74	of	of	ADP
aiua-6073	22	75	double	double	ADJ
aiua-6073	22	76	-	-	PUNCT
aiua-6073	22	77	blind	blind	ADJ
aiua-6073	22	78	,	,	PUNCT
aiua-6073	22	79	placebo	placebo	NOUN
aiua-6073	22	80	-	-	PUNCT
aiua-6073	22	81	controlled	control	VERB
aiua-6073	22	82	,	,	PUNCT
aiua-6073	22	83	randomized	randomize	VERB
aiua-6073	22	84	clinical	clinical	ADJ
aiua-6073	22	85	trials	trial	NOUN
aiua-6073	22	86	,	,	PUNCT
aiua-6073	22	87	conducted	conduct	VERB
aiua-6073	22	88	both	both	PRON
aiua-6073	22	89	in	in	ADP
aiua-6073	22	90	the	the	DET
aiua-6073	22	91	general	general	ADJ
aiua-6073	22	92	population	population	NOUN
aiua-6073	22	93	(	(	PUNCT
aiua-6073	22	94	7	7	NUM
aiua-6073	22	95	)	)	PUNCT
aiua-6073	22	96	and	and	CCONJ
aiua-6073	22	97	in	in	ADP
aiua-6073	22	98	“	"	PUNCT
aiua-6073	22	99	difficult	difficult	ADJ
aiua-6073	22	100	”	"	PUNCT
aiua-6073	22	101	patient	patient	ADJ
aiua-6073	22	102	subgroups	subgroup	NOUN
aiua-6073	22	103	,	,	PUNCT
aiua-6073	22	104	such	such	ADJ
aiua-6073	22	105	as	as	ADP
aiua-6073	22	106	those	those	PRON
aiua-6073	22	107	with	with	ADP
aiua-6073	22	108	diabetes	diabetes	NOUN
aiua-6073	22	109	mellitus	mellitus	NOUN
aiua-6073	22	110	(	(	PUNCT
aiua-6073	22	111	8)	8)	NUM
aiua-6073	22	112	or	or	CCONJ
aiua-6073	22	113	those	those	PRON
aiua-6073	22	114	who	who	PRON
aiua-6073	22	115	have	have	AUX
aiua-6073	22	116	undergone	undergo	VERB
aiua-6073	22	117	nerve	nerve	NOUN
aiua-6073	22	118	-	-	PUNCT
aiua-6073	22	119	sparing	spare	VERB
aiua-6073	22	120	radical	radical	ADJ
aiua-6073	22	121	prostatectomy	prostatectomy	NOUN
aiua-6073	22	122	(	(	PUNCT
aiua-6073	22	123	9	9	NUM
aiua-6073	22	124	)	)	PUNCT
aiua-6073	22	125	.	.	PUNCT
aiua-6073	23	1	in	in	ADP
aiua-6073	23	2	these	these	DET
aiua-6073	23	3	clinical	clinical	ADJ
aiua-6073	23	4	trials	trial	NOUN
aiua-6073	23	5	,	,	PUNCT
aiua-6073	23	6	avanafil	avanafil	PROPN
aiua-6073	23	7	demonstrated	demonstrate	VERB
aiua-6073	23	8	a	a	DET
aiua-6073	23	9	rapid	rapid	ADJ
aiua-6073	23	10	onset	onset	NOUN
aiua-6073	23	11	of	of	ADP
aiua-6073	23	12	action	action	NOUN
aiua-6073	23	13	,	,	PUNCT
aiua-6073	23	14	often	often	ADV
aiua-6073	23	15	as	as	ADV
aiua-6073	23	16	early	early	ADJ
aiua-6073	23	17	as	as	ADP
aiua-6073	23	18	15	15	NUM
aiua-6073	23	19	minutes	minute	NOUN
aiua-6073	23	20	after	after	ADP
aiua-6073	23	21	dosing	dose	VERB
aiua-6073	23	22	,	,	PUNCT
aiua-6073	23	23	a	a	DET
aiua-6073	23	24	prolonged	prolonged	ADJ
aiua-6073	23	25	therapeutic	therapeutic	ADJ
aiua-6073	23	26	effect	effect	NOUN
aiua-6073	23	27	(	(	PUNCT
aiua-6073	23	28	in	in	ADP
aiua-6073	23	29	some	some	DET
aiua-6073	23	30	cases	case	NOUN
aiua-6073	23	31	up	up	ADP
aiua-6073	23	32	to	to	PART
aiua-6073	23	33	6	6	NUM
aiua-6073	23	34	hours	hour	NOUN
aiua-6073	23	35	after	after	ADP
aiua-6073	23	36	administration	administration	NOUN
aiua-6073	23	37	)	)	PUNCT
aiua-6073	23	38	,	,	PUNCT
aiua-6073	23	39	and	and	CCONJ
aiua-6073	23	40	a	a	DET
aiua-6073	23	41	good	good	ADJ
aiua-6073	23	42	tolerability	tolerability	NOUN
aiua-6073	23	43	(	(	PUNCT
aiua-6073	23	44	10	10	NUM
aiua-6073	23	45	)	)	PUNCT
aiua-6073	23	46	.	.	PUNCT
aiua-6073	24	1	after	after	ADP
aiua-6073	24	2	approximately	approximately	ADV
aiua-6073	24	3	two	two	NUM
aiua-6073	24	4	years	year	NOUN
aiua-6073	24	5	from	from	ADP
aiua-6073	24	6	the	the	DET
aiua-6073	24	7	avanafil	avanafil	PROPN
aiua-6073	24	8	launch	launch	NOUN
aiua-6073	24	9	in	in	ADP
aiua-6073	24	10	italy	italy	PROPN
aiua-6073	24	11	,	,	PUNCT
aiua-6073	24	12	urologists	urologist	NOUN
aiua-6073	24	13	have	have	AUX
aiua-6073	24	14	now	now	ADV
aiua-6073	24	15	developed	develop	VERB
aiua-6073	24	16	a	a	DET
aiua-6073	24	17	specific	specific	ADJ
aiua-6073	24	18	clinical	clinical	ADJ
aiua-6073	24	19	experience	experience	NOUN
aiua-6073	24	20	with	with	ADP
aiua-6073	24	21	the	the	DET
aiua-6073	24	22	use	use	NOUN
aiua-6073	24	23	of	of	ADP
aiua-6073	24	24	this	this	DET
aiua-6073	24	25	drug	drug	NOUN
aiua-6073	24	26	.	.	PUNCT
aiua-6073	25	1	however	however	ADV
aiua-6073	25	2	,	,	PUNCT
aiua-6073	25	3	there	there	PRON
aiua-6073	25	4	are	be	VERB
aiua-6073	25	5	still	still	ADV
aiua-6073	25	6	some	some	DET
aiua-6073	25	7	“	"	PUNCT
aiua-6073	25	8	uncertainties	uncertainty	NOUN
aiua-6073	25	9	”	"	PUNCT
aiua-6073	25	10	about	about	ADP
aiua-6073	25	11	the	the	DET
aiua-6073	25	12	best	good	ADJ
aiua-6073	25	13	use	use	NOUN
aiua-6073	25	14	of	of	ADP
aiua-6073	25	15	avanafil	avanafil	PROPN
aiua-6073	25	16	,	,	PUNCT
aiua-6073	25	17	particularly	particularly	ADV
aiua-6073	25	18	with	with	ADP
aiua-6073	25	19	regard	regard	NOUN
aiua-6073	25	20	to	to	ADP
aiua-6073	25	21	dosage	dosage	NOUN
aiua-6073	25	22	,	,	PUNCT
aiua-6073	25	23	efficacy	efficacy	NOUN
aiua-6073	25	24	,	,	PUNCT
aiua-6073	25	25	and	and	CCONJ
aiua-6073	25	26	safety	safety	NOUN
aiua-6073	25	27	profile	profile	NOUN
aiua-6073	25	28	compared	compare	VERB
aiua-6073	25	29	with	with	ADP
aiua-6073	25	30	older	old	ADJ
aiua-6073	25	31	pde5is	pde5is	PROPN
aiua-6073	25	32	.	.	PUNCT
aiua-6073	26	1	in	in	ADP
aiua-6073	26	2	order	order	NOUN
aiua-6073	26	3	to	to	PART
aiua-6073	26	4	obtain	obtain	VERB
aiua-6073	26	5	a	a	DET
aiua-6073	26	6	“	"	PUNCT
aiua-6073	26	7	snapshot	snapshot	NOUN
aiua-6073	26	8	”	"	PUNCT
aiua-6073	26	9	of	of	ADP
aiua-6073	26	10	the	the	DET
aiua-6073	26	11	use	use	NOUN
aiua-6073	26	12	of	of	ADP
aiua-6073	26	13	avanafil	avanafil	PROPN
aiua-6073	26	14	in	in	ADP
aiua-6073	26	15	the	the	DET
aiua-6073	26	16	clinical	clinical	ADJ
aiua-6073	26	17	practice	practice	NOUN
aiua-6073	26	18	,	,	PUNCT
aiua-6073	26	19	and	and	CCONJ
aiua-6073	26	20	to	to	PART
aiua-6073	26	21	make	make	VERB
aiua-6073	26	22	recommendations	recommendation	NOUN
aiua-6073	26	23	for	for	ADP
aiua-6073	26	24	its	its	PRON
aiua-6073	26	25	“	"	PUNCT
aiua-6073	26	26	best	good	ADJ
aiua-6073	26	27	”	"	PUNCT
aiua-6073	26	28	use	use	NOUN
aiua-6073	26	29	,	,	PUNCT
aiua-6073	26	30	the	the	DET
aiua-6073	26	31	italian	italian	ADJ
aiua-6073	26	32	society	society	NOUN
aiua-6073	26	33	of	of	ADP
aiua-6073	26	34	urology	urology	NOUN
aiua-6073	26	35	(	(	PUNCT
aiua-6073	26	36	siu	siu	NOUN
aiua-6073	26	37	,	,	PUNCT
aiua-6073	26	38	società	società	PROPN
aiua-6073	26	39	italiana	italiana	PROPN
aiua-6073	26	40	di	di	PROPN
aiua-6073	26	41	urologia	urologia	PROPN
aiua-6073	26	42	)	)	PUNCT
aiua-6073	26	43	started	start	VERB
aiua-6073	26	44	a	a	DET
aiua-6073	26	45	project	project	NOUN
aiua-6073	26	46	involving	involve	VERB
aiua-6073	26	47	:	:	PUNCT
aiua-6073	26	48	1	1	X
aiua-6073	26	49	)	)	PUNCT
aiua-6073	26	50	a	a	DET
aiua-6073	26	51	survey	survey	NOUN
aiua-6073	26	52	,	,	PUNCT
aiua-6073	26	53	targeting	target	VERB
aiua-6073	26	54	a	a	DET
aiua-6073	26	55	sample	sample	NOUN
aiua-6073	26	56	of	of	ADP
aiua-6073	26	57	italian	italian	ADJ
aiua-6073	26	58	urologists	urologist	NOUN
aiua-6073	26	59	experienced	experience	VERB
aiua-6073	26	60	in	in	ADP
aiua-6073	26	61	the	the	DET
aiua-6073	26	62	treatment	treatment	NOUN
aiua-6073	26	63	of	of	ADP
aiua-6073	26	64	ed	ed	NOUN
aiua-6073	26	65	,	,	PUNCT
aiua-6073	26	66	with	with	ADP
aiua-6073	26	67	a	a	DET
aiua-6073	26	68	particular	particular	ADJ
aiua-6073	26	69	focus	focus	NOUN
aiua-6073	26	70	on	on	ADP
aiua-6073	26	71	their	their	PRON
aiua-6073	26	72	clinical	clinical	ADJ
aiua-6073	26	73	experience	experience	NOUN
aiua-6073	26	74	with	with	ADP
aiua-6073	26	75	the	the	DET
aiua-6073	26	76	use	use	NOUN
aiua-6073	26	77	of	of	ADP
aiua-6073	26	78	avanafil	avanafil	NOUN
aiua-6073	26	79	;	;	PUNCT
aiua-6073	26	80	and	and	CCONJ
aiua-6073	26	81	2	2	X
aiua-6073	26	82	)	)	PUNCT
aiua-6073	26	83	the	the	DET
aiua-6073	26	84	organization	organization	NOUN
aiua-6073	26	85	of	of	ADP
aiua-6073	26	86	a	a	DET
aiua-6073	26	87	conference	conference	NOUN
aiua-6073	26	88	of	of	ADP
aiua-6073	26	89	experts	expert	NOUN
aiua-6073	26	90	who	who	PRON
aiua-6073	26	91	,	,	PUNCT
aiua-6073	26	92	based	base	VERB
aiua-6073	26	93	on	on	ADP
aiua-6073	26	94	the	the	DET
aiua-6073	26	95	findings	finding	NOUN
aiua-6073	26	96	of	of	ADP
aiua-6073	26	97	the	the	DET
aiua-6073	26	98	survey	survey	NOUN
aiua-6073	26	99	and	and	CCONJ
aiua-6073	26	100	the	the	DET
aiua-6073	26	101	scientific	scientific	ADJ
aiua-6073	26	102	literature	literature	NOUN
aiua-6073	26	103	,	,	PUNCT
aiua-6073	26	104	would	would	AUX
aiua-6073	26	105	define	define	VERB
aiua-6073	26	106	some	some	DET
aiua-6073	26	107	recommendations	recommendation	NOUN
aiua-6073	26	108	for	for	ADP
aiua-6073	26	109	the	the	DET
aiua-6073	26	110	use	use	NOUN
aiua-6073	26	111	of	of	ADP
aiua-6073	26	112	avanafil	avanafil	PROPN
aiua-6073	26	113	in	in	ADP
aiua-6073	26	114	clinical	clinical	ADJ
aiua-6073	26	115	practice	practice	NOUN
aiua-6073	26	116	.	.	PUNCT
aiua-6073	27	1	this	this	DET
aiua-6073	27	2	paper	paper	NOUN
aiua-6073	27	3	describes	describe	VERB
aiua-6073	27	4	,	,	PUNCT
aiua-6073	27	5	in	in	ADP
aiua-6073	27	6	its	its	PRON
aiua-6073	27	7	first	first	ADJ
aiua-6073	27	8	part	part	NOUN
aiua-6073	27	9	,	,	PUNCT
aiua-6073	27	10	the	the	DET
aiua-6073	27	11	preliminary	preliminary	ADJ
aiua-6073	27	12	results	result	NOUN
aiua-6073	27	13	of	of	ADP
aiua-6073	27	14	the	the	DET
aiua-6073	27	15	survey	survey	NOUN
aiua-6073	27	16	,	,	PUNCT
aiua-6073	27	17	and	and	CCONJ
aiua-6073	27	18	subsequently	subsequently	ADV
aiua-6073	27	19	presents	present	VERB
aiua-6073	27	20	the	the	DET
aiua-6073	27	21	recommendations	recommendation	NOUN
aiua-6073	27	22	made	make	VERB
aiua-6073	27	23	by	by	ADP
aiua-6073	27	24	the	the	DET
aiua-6073	27	25	conference	conference	NOUN
aiua-6073	27	26	of	of	ADP
aiua-6073	27	27	experts	expert	NOUN
aiua-6073	27	28	.	.	PUNCT
aiua-6073	28	1	material	material	NOUN
aiua-6073	28	2	and	and	CCONJ
aiua-6073	28	3	methods	method	NOUN
aiua-6073	28	4	this	this	DET
aiua-6073	28	5	research	research	NOUN
aiua-6073	28	6	was	be	AUX
aiua-6073	28	7	conducted	conduct	VERB
aiua-6073	28	8	from	from	ADP
aiua-6073	28	9	february	february	PROPN
aiua-6073	28	10	to	to	ADP
aiua-6073	28	11	april	april	PROPN
aiua-6073	28	12	2016	2016	NUM
aiua-6073	28	13	through	through	ADP
aiua-6073	28	14	an	an	DET
aiua-6073	28	15	online	online	ADJ
aiua-6073	28	16	survey	survey	NOUN
aiua-6073	28	17	.	.	PUNCT
aiua-6073	29	1	siu	siu	NOUN
aiua-6073	29	2	members	member	NOUN
aiua-6073	29	3	were	be	AUX
aiua-6073	29	4	invited	invite	VERB
aiua-6073	29	5	to	to	PART
aiua-6073	29	6	answer	answer	VERB
aiua-6073	29	7	anonymously	anonymously	ADV
aiua-6073	29	8	a	a	DET
aiua-6073	29	9	number	number	NOUN
aiua-6073	29	10	of	of	ADP
aiua-6073	29	11	questions	question	NOUN
aiua-6073	29	12	included	include	VERB
aiua-6073	29	13	in	in	ADP
aiua-6073	29	14	a	a	DET
aiua-6073	29	15	questionnaire	questionnaire	NOUN
aiua-6073	29	16	.	.	PUNCT
aiua-6073	30	1	in	in	ADP
aiua-6073	30	2	particular	particular	ADJ
aiua-6073	30	3	,	,	PUNCT
aiua-6073	30	4	siu	siu	ADJ
aiua-6073	30	5	local	local	ADJ
aiua-6073	30	6	chairpersons	chairperson	NOUN
aiua-6073	30	7	and	and	CCONJ
aiua-6073	30	8	physicians	physician	NOUN
aiua-6073	30	9	experienced	experience	VERB
aiua-6073	30	10	in	in	ADP
aiua-6073	30	11	the	the	DET
aiua-6073	30	12	treatment	treatment	NOUN
aiua-6073	30	13	of	of	ADP
aiua-6073	30	14	ed	ed	NOUN
aiua-6073	30	15	were	be	AUX
aiua-6073	30	16	invited	invite	VERB
aiua-6073	30	17	to	to	PART
aiua-6073	30	18	participate	participate	VERB
aiua-6073	30	19	.	.	PUNCT
aiua-6073	31	1	the	the	DET
aiua-6073	31	2	questionnaire	questionnaire	NOUN
aiua-6073	31	3	investigated	investigate	VERB
aiua-6073	31	4	the	the	DET
aiua-6073	31	5	number	number	NOUN
aiua-6073	31	6	of	of	ADP
aiua-6073	31	7	ed	ed	NOUN
aiua-6073	31	8	patients	patient	NOUN
aiua-6073	31	9	treated	treat	VERB
aiua-6073	31	10	over	over	ADP
aiua-6073	31	11	the	the	DET
aiua-6073	31	12	past	past	ADJ
aiua-6073	31	13	12	12	NUM
aiua-6073	31	14	months	month	NOUN
aiua-6073	31	15	,	,	PUNCT
aiua-6073	31	16	and	and	CCONJ
aiua-6073	31	17	the	the	DET
aiua-6073	31	18	proportion	proportion	NOUN
aiua-6073	31	19	of	of	ADP
aiua-6073	31	20	them	they	PRON
aiua-6073	31	21	treated	treat	VERB
aiua-6073	31	22	with	with	ADP
aiua-6073	31	23	avanafil	avanafil	PROPN
aiua-6073	31	24	.	.	PUNCT
aiua-6073	32	1	physicians	physician	NOUN
aiua-6073	32	2	were	be	AUX
aiua-6073	32	3	also	also	ADV
aiua-6073	32	4	asked	ask	VERB
aiua-6073	32	5	to	to	PART
aiua-6073	32	6	indicate	indicate	VERB
aiua-6073	32	7	,	,	PUNCT
aiua-6073	32	8	based	base	VERB
aiua-6073	32	9	on	on	ADP
aiua-6073	32	10	their	their	PRON
aiua-6073	32	11	clinical	clinical	ADJ
aiua-6073	32	12	experience	experience	NOUN
aiua-6073	32	13	,	,	PUNCT
aiua-6073	32	14	the	the	DET
aiua-6073	32	15	characteristics	characteristic	NOUN
aiua-6073	32	16	of	of	ADP
aiua-6073	32	17	the	the	DET
aiua-6073	32	18	patients	patient	NOUN
aiua-6073	32	19	(	(	PUNCT
aiua-6073	32	20	expressed	express	VERB
aiua-6073	32	21	in	in	ADP
aiua-6073	32	22	percentage	percentage	NOUN
aiua-6073	32	23	)	)	PUNCT
aiua-6073	32	24	who	who	PRON
aiua-6073	32	25	had	have	AUX
aiua-6073	32	26	been	be	AUX
aiua-6073	32	27	treated	treat	VERB
aiua-6073	32	28	with	with	ADP
aiua-6073	32	29	avanafil	avanafil	PROPN
aiua-6073	32	30	100	100	NUM
aiua-6073	32	31	mg	mg	NOUN
aiua-6073	32	32	and	and	CCONJ
aiua-6073	32	33	200	200	NUM
aiua-6073	32	34	mg	mg	NOUN
aiua-6073	32	35	.	.	PUNCT
aiua-6073	33	1	the	the	DET
aiua-6073	33	2	aim	aim	NOUN
aiua-6073	33	3	of	of	ADP
aiua-6073	33	4	this	this	DET
aiua-6073	33	5	survey	survey	NOUN
aiua-6073	33	6	was	be	AUX
aiua-6073	33	7	to	to	PART
aiua-6073	33	8	collect	collect	VERB
aiua-6073	33	9	information	information	NOUN
aiua-6073	33	10	on	on	ADP
aiua-6073	33	11	physicians	physician	NOUN
aiua-6073	33	12	'	'	PART
aiua-6073	33	13	experience	experience	NOUN
aiua-6073	33	14	in	in	ADP
aiua-6073	33	15	this	this	DET
aiua-6073	33	16	context	context	NOUN
aiua-6073	33	17	;	;	PUNCT
aiua-6073	33	18	therefore	therefore	ADV
aiua-6073	33	19	,	,	PUNCT
aiua-6073	33	20	detailed	detailed	ADJ
aiua-6073	33	21	information	information	NOUN
aiua-6073	33	22	on	on	ADP
aiua-6073	33	23	individual	individual	ADJ
aiua-6073	33	24	patients	patient	NOUN
aiua-6073	33	25	was	be	AUX
aiua-6073	33	26	not	not	PART
aiua-6073	33	27	collected	collect	VERB
aiua-6073	33	28	.	.	PUNCT
aiua-6073	34	1	a	a	DET
aiua-6073	34	2	total	total	NOUN
aiua-6073	34	3	of	of	ADP
aiua-6073	34	4	136	136	NUM
aiua-6073	34	5	urologists	urologist	NOUN
aiua-6073	34	6	responded	respond	VERB
aiua-6073	34	7	to	to	ADP
aiua-6073	34	8	the	the	DET
aiua-6073	34	9	survey	survey	NOUN
aiua-6073	34	10	(	(	PUNCT
aiua-6073	34	11	88.2	88.2	NUM
aiua-6073	34	12	%	%	NOUN
aiua-6073	34	13	male	male	NOUN
aiua-6073	34	14	;	;	PUNCT
aiua-6073	34	15	mean	mean	VERB
aiua-6073	34	16	age	age	NOUN
aiua-6073	34	17	47	47	NUM
aiua-6073	34	18	years	year	NOUN
aiua-6073	34	19	,	,	PUNCT
aiua-6073	34	20	range	range	VERB
aiua-6073	34	21	26	26	NUM
aiua-6073	34	22	-	-	SYM
aiua-6073	34	23	71	71	NUM
aiua-6073	34	24	years	year	NOUN
aiua-6073	34	25	;	;	PUNCT
aiua-6073	34	26	48.5	48.5	NUM
aiua-6073	34	27	%	%	NOUN
aiua-6073	34	28	of	of	ADP
aiua-6073	34	29	the	the	DET
aiua-6073	34	30	respondents	respondent	NOUN
aiua-6073	34	31	stated	state	VERB
aiua-6073	34	32	they	they	PRON
aiua-6073	34	33	worked	work	VERB
aiua-6073	34	34	mainly	mainly	ADV
aiua-6073	34	35	in	in	ADP
aiua-6073	34	36	a	a	DET
aiua-6073	34	37	hospital	hospital	NOUN
aiua-6073	34	38	setting	setting	NOUN
aiua-6073	34	39	)	)	PUNCT
aiua-6073	34	40	.	.	PUNCT
aiua-6073	35	1	overall	overall	ADJ
aiua-6073	35	2	,	,	PUNCT
aiua-6073	35	3	urologists	urologist	NOUN
aiua-6073	35	4	who	who	PRON
aiua-6073	35	5	participated	participate	VERB
aiua-6073	35	6	in	in	ADP
aiua-6073	35	7	this	this	DET
aiua-6073	35	8	survey	survey	NOUN
aiua-6073	35	9	stated	state	VERB
aiua-6073	35	10	that	that	SCONJ
aiua-6073	35	11	they	they	PRON
aiua-6073	35	12	had	have	AUX
aiua-6073	35	13	treated	treat	VERB
aiua-6073	35	14	17.856	17.856	NUM
aiua-6073	35	15	patients	patient	NOUN
aiua-6073	35	16	during	during	ADP
aiua-6073	35	17	the	the	DET
aiua-6073	35	18	12	12	NUM
aiua-6073	35	19	months	month	NOUN
aiua-6073	35	20	prior	prior	ADV
aiua-6073	35	21	to	to	ADP
aiua-6073	35	22	the	the	DET
aiua-6073	35	23	completion	completion	NOUN
aiua-6073	35	24	of	of	ADP
aiua-6073	35	25	the	the	DET
aiua-6073	35	26	questionnaire	questionnaire	NOUN
aiua-6073	35	27	.	.	PUNCT
aiua-6073	36	1	of	of	ADP
aiua-6073	36	2	these	these	PRON
aiua-6073	36	3	,	,	PUNCT
aiua-6073	36	4	13	13	NUM
aiua-6073	36	5	%	%	NOUN
aiua-6073	36	6	were	be	AUX
aiua-6073	36	7	treated	treat	VERB
aiua-6073	36	8	with	with	ADP
aiua-6073	36	9	avanafil	avanafil	PROPN
aiua-6073	36	10	100	100	NUM
aiua-6073	36	11	mg	mg	PROPN
aiua-6073	36	12	,	,	PUNCT
aiua-6073	36	13	and	and	CCONJ
aiua-6073	36	14	26	26	NUM
aiua-6073	36	15	%	%	NOUN
aiua-6073	36	16	with	with	ADP
aiua-6073	36	17	avanafil	avanafil	PROPN
aiua-6073	36	18	200	200	NUM
aiua-6073	36	19	mg	mg	NOUN
aiua-6073	36	20	(	(	PUNCT
aiua-6073	36	21	the	the	DET
aiua-6073	36	22	same	same	ADJ
aiua-6073	36	23	patient	patient	NOUN
aiua-6073	36	24	could	could	AUX
aiua-6073	36	25	have	have	AUX
aiua-6073	36	26	been	be	AUX
aiua-6073	36	27	treated	treat	VERB
aiua-6073	36	28	,	,	PUNCT
aiua-6073	36	29	at	at	ADP
aiua-6073	36	30	different	different	ADJ
aiua-6073	36	31	times	time	NOUN
aiua-6073	36	32	,	,	PUNCT
aiua-6073	36	33	with	with	ADP
aiua-6073	36	34	both	both	DET
aiua-6073	36	35	doses	dose	NOUN
aiua-6073	36	36	of	of	ADP
aiua-6073	36	37	avanafil	avanafil	PROPN
aiua-6073	36	38	)	)	PUNCT
aiua-6073	36	39	.	.	PUNCT
aiua-6073	37	1	table	table	NOUN
aiua-6073	37	2	1	1	NUM
aiua-6073	37	3	shows	show	VERB
aiua-6073	37	4	the	the	DET
aiua-6073	37	5	characteristics	characteristic	NOUN
aiua-6073	37	6	of	of	ADP
aiua-6073	37	7	the	the	DET
aiua-6073	37	8	patients	patient	NOUN
aiua-6073	37	9	treated	treat	VERB
aiua-6073	37	10	with	with	ADP
aiua-6073	37	11	avanafil	avanafil	PROPN
aiua-6073	37	12	100	100	NUM
aiua-6073	37	13	mg	mg	NOUN
aiua-6073	37	14	and	and	CCONJ
aiua-6073	37	15	200	200	NUM
aiua-6073	37	16	mg	mg	NOUN
aiua-6073	37	17	,	,	PUNCT
aiua-6073	37	18	the	the	DET
aiua-6073	37	19	patient	patient	ADJ
aiua-6073	37	20	satisfaction	satisfaction	NOUN
aiua-6073	37	21	,	,	PUNCT
aiua-6073	37	22	and	and	CCONJ
aiua-6073	37	23	the	the	DET
aiua-6073	37	24	frequency	frequency	NOUN
aiua-6073	37	25	of	of	ADP
aiua-6073	37	26	side	side	NOUN
aiua-6073	37	27	effects	effect	NOUN
aiua-6073	37	28	.	.	PUNCT
aiua-6073	38	1	patients	patient	NOUN
aiua-6073	38	2	treated	treat	VERB
aiua-6073	38	3	with	with	ADP
aiua-6073	38	4	avanafil	avanafil	PROPN
aiua-6073	38	5	200	200	NUM
aiua-6073	38	6	mg	mg	NOUN
aiua-6073	38	7	were	be	AUX
aiua-6073	38	8	on	on	ADP
aiua-6073	38	9	average	average	ADJ
aiua-6073	38	10	older	old	ADJ
aiua-6073	38	11	and	and	CCONJ
aiua-6073	38	12	were	be	AUX
aiua-6073	38	13	more	more	ADV
aiua-6073	38	14	likely	likely	ADJ
aiua-6073	38	15	to	to	PART
aiua-6073	38	16	report	report	VERB
aiua-6073	38	17	comorbid	comorbid	NOUN
aiua-6073	38	18	diabetes	diabetes	NOUN
aiua-6073	38	19	mellitus	mellitus	NOUN
aiua-6073	38	20	.	.	PUNCT
aiua-6073	39	1	the	the	DET
aiua-6073	39	2	use	use	NOUN
aiua-6073	39	3	of	of	ADP
aiua-6073	39	4	avanafil	avanafil	PROPN
aiua-6073	39	5	100	100	NUM
aiua-6073	39	6	mg	mg	NUM
aiua-6073	39	7	was	be	AUX
aiua-6073	39	8	more	more	ADV
aiua-6073	39	9	common	common	ADJ
aiua-6073	39	10	in	in	ADP
aiua-6073	39	11	treatment	treatment	NOUN
aiua-6073	39	12	-	-	PUNCT
aiua-6073	39	13	naïve	naïve	ADJ
aiua-6073	39	14	patients	patient	NOUN
aiua-6073	39	15	.	.	PUNCT
aiua-6073	40	1	patient	patient	ADJ
aiua-6073	40	2	satisfaction	satisfaction	NOUN
aiua-6073	40	3	was	be	AUX
aiua-6073	40	4	greater	great	ADJ
aiua-6073	40	5	in	in	ADP
aiua-6073	40	6	those	those	PRON
aiua-6073	40	7	treated	treat	VERB
aiua-6073	40	8	with	with	ADP
aiua-6073	40	9	avanafil	avanafil	PROPN
aiua-6073	40	10	200	200	NUM
aiua-6073	40	11	mg	mg	NOUN
aiua-6073	40	12	.	.	PUNCT
aiua-6073	41	1	likewise	likewise	ADV
aiua-6073	41	2	,	,	PUNCT
aiua-6073	41	3	the	the	DET
aiua-6073	41	4	frequency	frequency	NOUN
aiua-6073	41	5	of	of	ADP
aiua-6073	41	6	side	side	NOUN
aiua-6073	41	7	effects	effect	NOUN
aiua-6073	41	8	was	be	AUX
aiua-6073	41	9	slightly	slightly	ADV
aiua-6073	41	10	higher	high	ADJ
aiua-6073	41	11	in	in	ADP
aiua-6073	41	12	individuals	individual	NOUN
aiua-6073	41	13	treated	treat	VERB
aiua-6073	41	14	with	with	ADP
aiua-6073	41	15	the	the	DET
aiua-6073	41	16	higher	high	ADJ
aiua-6073	41	17	dose	dose	NOUN
aiua-6073	41	18	of	of	ADP
aiua-6073	41	19	avanafil	avanafil	PROPN
aiua-6073	41	20	:	:	PUNCT
aiua-6073	41	21	overall	overall	ADV
aiua-6073	41	22	,	,	PUNCT
aiua-6073	41	23	the	the	DET
aiua-6073	41	24	observed	observe	VERB
aiua-6073	41	25	difference	difference	NOUN
aiua-6073	41	26	in	in	ADP
aiua-6073	41	27	the	the	DET
aiua-6073	41	28	frequency	frequency	NOUN
aiua-6073	41	29	of	of	ADP
aiua-6073	41	30	side	side	NOUN
aiua-6073	41	31	effects	effect	NOUN
aiua-6073	41	32	was	be	AUX
aiua-6073	41	33	essentially	essentially	ADV
aiua-6073	41	34	due	due	ADJ
aiua-6073	41	35	to	to	ADP
aiua-6073	41	36	a	a	DET
aiua-6073	41	37	higher	high	ADJ
aiua-6073	41	38	frequency	frequency	NOUN
aiua-6073	41	39	of	of	ADP
aiua-6073	41	40	headaches	headache	NOUN
aiua-6073	41	41	.	.	PUNCT
aiua-6073	42	1	the	the	DET
aiua-6073	42	2	methodology	methodology	NOUN
aiua-6073	42	3	chosen	choose	VERB
aiua-6073	42	4	for	for	ADP
aiua-6073	42	5	the	the	DET
aiua-6073	42	6	production	production	NOUN
aiua-6073	42	7	of	of	ADP
aiua-6073	42	8	recommendations	recommendation	NOUN
aiua-6073	42	9	was	be	AUX
aiua-6073	42	10	that	that	PRON
aiua-6073	42	11	of	of	ADP
aiua-6073	42	12	the	the	DET
aiua-6073	42	13	“	"	PUNCT
aiua-6073	42	14	consensus	consensus	NOUN
aiua-6073	42	15	conference	conference	NOUN
aiua-6073	42	16	”	"	PUNCT
aiua-6073	42	17	,	,	PUNCT
aiua-6073	42	18	which	which	PRON
aiua-6073	42	19	involves	involve	VERB
aiua-6073	42	20	the	the	DET
aiua-6073	42	21	drafting	drafting	NOUN
aiua-6073	42	22	of	of	ADP
aiua-6073	42	23	recommendations	recommendation	NOUN
aiua-6073	42	24	by	by	ADP
aiua-6073	42	25	a	a	DET
aiua-6073	42	26	“	"	PUNCT
aiua-6073	42	27	jury	jury	NOUN
aiua-6073	42	28	”	"	PUNCT
aiua-6073	42	29	at	at	ADP
aiua-6073	42	30	the	the	DET
aiua-6073	42	31	end	end	NOUN
aiua-6073	42	32	of	of	ADP
aiua-6073	42	33	a	a	DET
aiua-6073	42	34	presentation	presentation	NOUN
aiua-6073	42	35	and	and	CCONJ
aiua-6073	42	36	consultation	consultation	NOUN
aiua-6073	42	37	of	of	ADP
aiua-6073	42	38	experts	expert	NOUN
aiua-6073	42	39	summapatient	summapatient	ADJ
aiua-6073	42	40	characteristics	characteristic	NOUN
aiua-6073	42	41	patients	patient	NOUN
aiua-6073	42	42	treated	treat	VERB
aiua-6073	42	43	with	with	ADP
aiua-6073	42	44	avanafil	avanafil	PROPN
aiua-6073	43	1	100	100	NUM
aiua-6073	43	2	mg	mg	PROPN
aiua-6073	43	3	(	(	PUNCT
aiua-6073	43	4	%	%	INTJ
aiua-6073	43	5	)	)	PUNCT
aiua-6073	43	6	patients	patient	NOUN
aiua-6073	43	7	treated	treat	VERB
aiua-6073	43	8	with	with	ADP
aiua-6073	43	9	avanafil	avanafil	PROPN
aiua-6073	43	10	200	200	NUM
aiua-6073	43	11	mg	mg	PROPN
aiua-6073	43	12	(	(	PUNCT
aiua-6073	43	13	%	%	NOUN
aiua-6073	43	14	)	)	PUNCT
aiua-6073	43	15	age	age	NOUN
aiua-6073	43	16	(	(	PUNCT
aiua-6073	43	17	years	year	NOUN
aiua-6073	43	18	)	)	PUNCT
aiua-6073	43	19	>	>	X
aiua-6073	43	20	50/	50/	PROPN
aiua-6073	43	21	<	<	X
aiua-6073	43	22	50	50	NUM
aiua-6073	43	23	61.6/38.4	61.6/38.4	NOUN
aiua-6073	43	24	65.7/34.3	65.7/34.3	VERB
aiua-6073	43	25	organic	organic	NOUN
aiua-6073	43	26	-	-	PUNCT
aiua-6073	43	27	based	base	VERB
aiua-6073	43	28	ed	ed	NOUN
aiua-6073	43	29	56.6	56.6	NUM
aiua-6073	43	30	51.1	51.1	NUM
aiua-6073	43	31	comorbid	comorbid	NOUN
aiua-6073	43	32	diabetes	diabetes	NOUN
aiua-6073	43	33	mellitus	mellitus	NOUN
aiua-6073	43	34	28.6	28.6	NUM
aiua-6073	43	35	36.2	36.2	NUM
aiua-6073	43	36	first	first	ADJ
aiua-6073	43	37	treatment	treatment	NOUN
aiua-6073	43	38	(	(	PUNCT
aiua-6073	43	39	treatment	treatment	NOUN
aiua-6073	43	40	-	-	PUNCT
aiua-6073	43	41	naïve	naïve	ADJ
aiua-6073	43	42	pts	pts	NOUN
aiua-6073	43	43	)	)	PUNCT
aiua-6073	43	44	45.7	45.7	NUM
aiua-6073	43	45	40.4	40.4	NUM
aiua-6073	43	46	on	on	ADP
aiua-6073	43	47	-	-	PUNCT
aiua-6073	43	48	demand	demand	NOUN
aiua-6073	43	49	use	use	NOUN
aiua-6073	43	50	65.4	65.4	NUM
aiua-6073	43	51	63	63	NUM
aiua-6073	43	52	patient	patient	ADJ
aiua-6073	43	53	satisfaction	satisfaction	NOUN
aiua-6073	43	54	(	(	PUNCT
aiua-6073	43	55	yes	yes	INTJ
aiua-6073	43	56	/	/	SYM
aiua-6073	43	57	no	no	NOUN
aiua-6073	43	58	)	)	PUNCT
aiua-6073	43	59	54.2/45.8	54.2/45.8	NOUN
aiua-6073	43	60	58.4/41.6	58.4/41.6	PROPN
aiua-6073	43	61	frequency	frequency	NOUN
aiua-6073	43	62	of	of	ADP
aiua-6073	43	63	side	side	NOUN
aiua-6073	43	64	effects	effect	NOUN
aiua-6073	43	65	any	any	DET
aiua-6073	43	66	side	side	NOUN
aiua-6073	43	67	effects	effect	NOUN
aiua-6073	43	68	15.9	15.9	NUM
aiua-6073	43	69	22.4	22.4	NUM
aiua-6073	43	70	headache	headache	NOUN
aiua-6073	43	71	*	*	NOUN
aiua-6073	43	72	12.6	12.6	NUM
aiua-6073	43	73	16.5	16.5	NUM
aiua-6073	43	74	hot	hot	ADJ
aiua-6073	43	75	flushes	flush	NOUN
aiua-6073	43	76	5.5	5.5	NUM
aiua-6073	43	77	4.1	4.1	NUM
aiua-6073	43	78	back	back	ADV
aiua-6073	43	79	ache	ache	ADV
aiua-6073	43	80	2.5	2.5	NUM
aiua-6073	43	81	1.1	1.1	NUM
aiua-6073	43	82	rash	rash	ADJ
aiua-6073	43	83	/	/	SYM
aiua-6073	43	84	itching	itch	VERB
aiua-6073	43	85	2.6	2.6	NUM
aiua-6073	43	86	2	2	NUM
aiua-6073	43	87	*	*	PUNCT
aiua-6073	43	88	only	only	ADV
aiua-6073	43	89	the	the	DET
aiua-6073	43	90	side	side	NOUN
aiua-6073	43	91	effects	effect	NOUN
aiua-6073	43	92	reported	report	VERB
aiua-6073	43	93	in	in	ADP
aiua-6073	43	94	more	more	ADJ
aiua-6073	43	95	than	than	ADP
aiua-6073	43	96	2	2	NUM
aiua-6073	43	97	%	%	NOUN
aiua-6073	43	98	of	of	ADP
aiua-6073	43	99	the	the	DET
aiua-6073	43	100	patients	patient	NOUN
aiua-6073	43	101	in	in	ADP
aiua-6073	43	102	at	at	ADV
aiua-6073	43	103	least	least	ADJ
aiua-6073	43	104	one	one	NUM
aiua-6073	43	105	of	of	ADP
aiua-6073	43	106	the	the	DET
aiua-6073	43	107	two	two	NUM
aiua-6073	43	108	groups	group	NOUN
aiua-6073	43	109	are	be	AUX
aiua-6073	43	110	listed	list	VERB
aiua-6073	43	111	.	.	PUNCT
aiua-6073	44	1	the	the	DET
aiua-6073	44	2	percentages	percentage	NOUN
aiua-6073	44	3	shown	show	VERB
aiua-6073	44	4	are	be	AUX
aiua-6073	44	5	mean	mean	NOUN
aiua-6073	44	6	percentages	percentage	NOUN
aiua-6073	44	7	,	,	PUNCT
aiua-6073	44	8	weighted	weight	VERB
aiua-6073	44	9	by	by	ADP
aiua-6073	44	10	the	the	DET
aiua-6073	44	11	number	number	NOUN
aiua-6073	44	12	of	of	ADP
aiua-6073	44	13	patients	patient	NOUN
aiua-6073	44	14	treated	treat	VERB
aiua-6073	44	15	by	by	ADP
aiua-6073	44	16	each	each	DET
aiua-6073	44	17	physician	physician	NOUN
aiua-6073	44	18	.	.	PUNCT
aiua-6073	45	1	table	table	NOUN
aiua-6073	45	2	1	1	NUM
aiua-6073	45	3	.	.	PUNCT
aiua-6073	46	1	characteristics	characteristic	NOUN
aiua-6073	46	2	of	of	ADP
aiua-6073	46	3	patients	patient	NOUN
aiua-6073	46	4	receiving	receive	VERB
aiua-6073	46	5	avanafil	avanafil	PROPN
aiua-6073	46	6	100	100	NUM
aiua-6073	46	7	mg	mg	NOUN
aiua-6073	46	8	and	and	CCONJ
aiua-6073	46	9	200	200	NUM
aiua-6073	46	10	mg	mg	NOUN
aiua-6073	46	11	as	as	SCONJ
aiua-6073	46	12	reported	report	VERB
aiua-6073	46	13	by	by	ADP
aiua-6073	46	14	physicians	physician	NOUN
aiua-6073	46	15	participating	participate	VERB
aiua-6073	46	16	in	in	ADP
aiua-6073	46	17	the	the	DET
aiua-6073	46	18	siu	siu	NOUN
aiua-6073	46	19	survey	survey	NOUN
aiua-6073	46	20	.	.	PUNCT
aiua-6073	47	1	mirone_stesura	mirone_stesura	NOUN
aiua-6073	47	2	seveso	seveso	NOUN
aiua-6073	47	3	01/07/16	01/07/16	PROPN
aiua-6073	47	4	11:08	11:08	NUM
aiua-6073	47	5	pagina	pagina	NOUN
aiua-6073	47	6	129	129	NUM
aiua-6073	47	7	archivio	archivio	NOUN
aiua-6073	47	8	italiano	italiano	X
aiua-6073	47	9	di	di	X
aiua-6073	47	10	urologia	urologia	PROPN
aiua-6073	47	11	e	e	PROPN
aiua-6073	47	12	andrologia	andrologia	NOUN
aiua-6073	47	13	2016	2016	NUM
aiua-6073	47	14	;	;	PUNCT
aiua-6073	47	15	88	88	NUM
aiua-6073	47	16	,	,	PUNCT
aiua-6073	47	17	2	2	NUM
aiua-6073	47	18	v.	v.	ADP
aiua-6073	47	19	mirone	mirone	PROPN
aiua-6073	47	20	,	,	PUNCT
aiua-6073	47	21	f.	f.	PROPN
aiua-6073	47	22	fusco	fusco	PROPN
aiua-6073	47	23	,	,	PUNCT
aiua-6073	47	24	f.	f.	PROPN
aiua-6073	47	25	parazzini	parazzini	PROPN
aiua-6073	47	26	,	,	PUNCT
aiua-6073	47	27	a.	a.	NOUN
aiua-6073	47	28	zucchi	zucchi	PROPN
aiua-6073	47	29	130	130	NUM
aiua-6073	47	30	rizing	rizing	ADJ
aiua-6073	47	31	scientific	scientific	ADJ
aiua-6073	47	32	knowledge	knowledge	NOUN
aiua-6073	47	33	on	on	ADP
aiua-6073	47	34	a	a	DET
aiua-6073	47	35	given	give	VERB
aiua-6073	47	36	topic	topic	NOUN
aiua-6073	47	37	.	.	PUNCT
aiua-6073	48	1	the	the	DET
aiua-6073	48	2	critical	critical	ADJ
aiua-6073	48	3	analysis	analysis	NOUN
aiua-6073	48	4	of	of	ADP
aiua-6073	48	5	the	the	DET
aiua-6073	48	6	literature	literature	NOUN
aiua-6073	48	7	enables	enable	VERB
aiua-6073	48	8	the	the	DET
aiua-6073	48	9	“	"	PUNCT
aiua-6073	48	10	jury	jury	NOUN
aiua-6073	48	11	”	"	PUNCT
aiua-6073	48	12	to	to	PART
aiua-6073	48	13	compare	compare	VERB
aiua-6073	48	14	the	the	DET
aiua-6073	48	15	available	available	ADJ
aiua-6073	48	16	evidence	evidence	NOUN
aiua-6073	48	17	with	with	ADP
aiua-6073	48	18	expert	expert	ADJ
aiua-6073	48	19	opinions	opinion	NOUN
aiua-6073	48	20	or	or	CCONJ
aiua-6073	48	21	reports	report	NOUN
aiua-6073	48	22	.	.	PUNCT
aiua-6073	49	1	this	this	DET
aiua-6073	49	2	method	method	NOUN
aiua-6073	49	3	implies	imply	VERB
aiua-6073	49	4	the	the	DET
aiua-6073	49	5	following	follow	VERB
aiua-6073	49	6	steps	step	NOUN
aiua-6073	49	7	:	:	PUNCT
aiua-6073	50	1	1	1	X
aiua-6073	50	2	.	.	X
aiua-6073	50	3	the	the	DET
aiua-6073	50	4	definition	definition	NOUN
aiua-6073	50	5	of	of	ADP
aiua-6073	50	6	the	the	DET
aiua-6073	50	7	themes	theme	NOUN
aiua-6073	50	8	of	of	ADP
aiua-6073	50	9	the	the	DET
aiua-6073	50	10	recommendations	recommendation	NOUN
aiua-6073	50	11	;	;	PUNCT
aiua-6073	50	12	2	2	X
aiua-6073	50	13	.	.	X
aiua-6073	50	14	the	the	DET
aiua-6073	50	15	search	search	NOUN
aiua-6073	50	16	for	for	ADP
aiua-6073	50	17	relevant	relevant	ADJ
aiua-6073	50	18	literature	literature	NOUN
aiua-6073	50	19	;	;	PUNCT
aiua-6073	50	20	3	3	X
aiua-6073	50	21	.	.	X
aiua-6073	51	1	the	the	DET
aiua-6073	51	2	preparation	preparation	NOUN
aiua-6073	51	3	of	of	ADP
aiua-6073	51	4	the	the	DET
aiua-6073	51	5	first	first	ADJ
aiua-6073	51	6	draft	draft	NOUN
aiua-6073	51	7	of	of	ADP
aiua-6073	51	8	the	the	DET
aiua-6073	51	9	consensus	consensus	NOUN
aiua-6073	51	10	statement	statement	NOUN
aiua-6073	51	11	by	by	ADP
aiua-6073	51	12	a	a	DET
aiua-6073	51	13	drafting	drafting	NOUN
aiua-6073	51	14	group	group	NOUN
aiua-6073	51	15	;	;	PUNCT
aiua-6073	51	16	4	4	X
aiua-6073	51	17	.	.	X
aiua-6073	52	1	the	the	DET
aiua-6073	52	2	discussion	discussion	NOUN
aiua-6073	52	3	by	by	ADP
aiua-6073	52	4	a	a	DET
aiua-6073	52	5	“	"	PUNCT
aiua-6073	52	6	jury	jury	NOUN
aiua-6073	52	7	”	"	PUNCT
aiua-6073	52	8	of	of	ADP
aiua-6073	52	9	experts	expert	NOUN
aiua-6073	52	10	,	,	PUNCT
aiua-6073	52	11	and	and	CCONJ
aiua-6073	52	12	the	the	DET
aiua-6073	52	13	preparation	preparation	NOUN
aiua-6073	52	14	of	of	ADP
aiua-6073	52	15	the	the	DET
aiua-6073	52	16	final	final	ADJ
aiua-6073	52	17	document	document	NOUN
aiua-6073	52	18	.	.	PUNCT
aiua-6073	53	1	in	in	ADP
aiua-6073	53	2	march	march	PROPN
aiua-6073	53	3	2016	2016	NUM
aiua-6073	53	4	,	,	PUNCT
aiua-6073	53	5	the	the	DET
aiua-6073	53	6	drafting	drafting	NOUN
aiua-6073	53	7	group	group	NOUN
aiua-6073	53	8	identified	identify	VERB
aiua-6073	53	9	the	the	DET
aiua-6073	53	10	themes	theme	NOUN
aiua-6073	53	11	of	of	ADP
aiua-6073	53	12	the	the	DET
aiua-6073	53	13	recommendations	recommendation	NOUN
aiua-6073	53	14	,	,	PUNCT
aiua-6073	53	15	searched	search	VERB
aiua-6073	53	16	pubmed	pubmed	PROPN
aiua-6073	53	17	using	use	VERB
aiua-6073	53	18	the	the	DET
aiua-6073	53	19	key	key	ADJ
aiua-6073	53	20	words	word	NOUN
aiua-6073	53	21	“	"	PUNCT
aiua-6073	53	22	avanafil	avanafil	PROPN
aiua-6073	53	23	,	,	PUNCT
aiua-6073	53	24	erectile	erectile	ADJ
aiua-6073	53	25	dysfunction	dysfunction	NOUN
aiua-6073	53	26	,	,	PUNCT
aiua-6073	53	27	treatment	treatment	NOUN
aiua-6073	53	28	”	"	PUNCT
aiua-6073	53	29	,	,	PUNCT
aiua-6073	53	30	and	and	CCONJ
aiua-6073	53	31	then	then	ADV
aiua-6073	53	32	prepared	prepare	VERB
aiua-6073	53	33	a	a	DET
aiua-6073	53	34	first	first	ADJ
aiua-6073	53	35	draft	draft	NOUN
aiua-6073	53	36	of	of	ADP
aiua-6073	53	37	the	the	DET
aiua-6073	53	38	recommendations	recommendation	NOUN
aiua-6073	53	39	.	.	PUNCT
aiua-6073	54	1	the	the	DET
aiua-6073	54	2	experts	expert	NOUN
aiua-6073	54	3	invited	invite	VERB
aiua-6073	54	4	to	to	PART
aiua-6073	54	5	take	take	VERB
aiua-6073	54	6	part	part	NOUN
aiua-6073	54	7	in	in	ADP
aiua-6073	54	8	the	the	DET
aiua-6073	54	9	production	production	NOUN
aiua-6073	54	10	of	of	ADP
aiua-6073	54	11	the	the	DET
aiua-6073	54	12	recommendations	recommendation	NOUN
aiua-6073	54	13	participated	participate	VERB
aiua-6073	54	14	in	in	ADP
aiua-6073	54	15	a	a	DET
aiua-6073	54	16	workshop	workshop	NOUN
aiua-6073	54	17	that	that	PRON
aiua-6073	54	18	was	be	AUX
aiua-6073	54	19	held	hold	VERB
aiua-6073	54	20	on	on	ADP
aiua-6073	54	21	april	april	PROPN
aiua-6073	54	22	21	21	NUM
aiua-6073	54	23	-	-	SYM
aiua-6073	54	24	22	22	NUM
aiua-6073	54	25	,	,	PUNCT
aiua-6073	54	26	2016	2016	NUM
aiua-6073	54	27	.	.	PUNCT
aiua-6073	55	1	during	during	ADP
aiua-6073	55	2	this	this	DET
aiua-6073	55	3	workshop	workshop	NOUN
aiua-6073	55	4	,	,	PUNCT
aiua-6073	55	5	the	the	DET
aiua-6073	55	6	results	result	NOUN
aiua-6073	55	7	of	of	ADP
aiua-6073	55	8	the	the	DET
aiua-6073	55	9	literature	literature	NOUN
aiua-6073	55	10	review	review	NOUN
aiua-6073	55	11	and	and	CCONJ
aiua-6073	55	12	the	the	DET
aiua-6073	55	13	findings	finding	NOUN
aiua-6073	55	14	of	of	ADP
aiua-6073	55	15	the	the	DET
aiua-6073	55	16	siu	siu	NOUN
aiua-6073	55	17	survey	survey	NOUN
aiua-6073	55	18	,	,	PUNCT
aiua-6073	55	19	reported	report	VERB
aiua-6073	55	20	in	in	ADP
aiua-6073	55	21	the	the	DET
aiua-6073	55	22	introduction	introduction	NOUN
aiua-6073	55	23	of	of	ADP
aiua-6073	55	24	this	this	DET
aiua-6073	55	25	paper	paper	NOUN
aiua-6073	55	26	,	,	PUNCT
aiua-6073	55	27	were	be	AUX
aiua-6073	55	28	presented	present	VERB
aiua-6073	55	29	.	.	PUNCT
aiua-6073	56	1	subsequently	subsequently	ADV
aiua-6073	56	2	,	,	PUNCT
aiua-6073	56	3	the	the	DET
aiua-6073	56	4	recommendations	recommendation	NOUN
aiua-6073	56	5	prepared	prepare	VERB
aiua-6073	56	6	by	by	ADP
aiua-6073	56	7	the	the	DET
aiua-6073	56	8	drafting	drafting	NOUN
aiua-6073	56	9	group	group	NOUN
aiua-6073	56	10	were	be	AUX
aiua-6073	56	11	also	also	ADV
aiua-6073	56	12	presented	present	VERB
aiua-6073	56	13	.	.	PUNCT
aiua-6073	57	1	the	the	DET
aiua-6073	57	2	expert	expert	ADJ
aiua-6073	57	3	panel	panel	NOUN
aiua-6073	57	4	was	be	AUX
aiua-6073	57	5	composed	compose	VERB
aiua-6073	57	6	of	of	ADP
aiua-6073	57	7	16	16	NUM
aiua-6073	57	8	siu	siu	ADJ
aiua-6073	57	9	local	local	ADJ
aiua-6073	57	10	chairpersons	chairperson	NOUN
aiua-6073	57	11	and	and	CCONJ
aiua-6073	57	12	32	32	NUM
aiua-6073	57	13	experts	expert	NOUN
aiua-6073	57	14	(	(	PUNCT
aiua-6073	57	15	2	2	NUM
aiua-6073	57	16	per	per	ADP
aiua-6073	57	17	local	local	ADJ
aiua-6073	57	18	area	area	NOUN
aiua-6073	57	19	)	)	PUNCT
aiua-6073	57	20	in	in	ADP
aiua-6073	57	21	the	the	DET
aiua-6073	57	22	treatment	treatment	NOUN
aiua-6073	57	23	of	of	ADP
aiua-6073	57	24	ed	ed	NOUN
aiua-6073	57	25	,	,	PUNCT
aiua-6073	57	26	identified	identify	VERB
aiua-6073	57	27	among	among	ADP
aiua-6073	57	28	the	the	DET
aiua-6073	57	29	siu	siu	NOUN
aiua-6073	57	30	members	member	NOUN
aiua-6073	57	31	by	by	ADP
aiua-6073	57	32	the	the	DET
aiua-6073	57	33	local	local	ADJ
aiua-6073	57	34	chairpersons	chairperson	NOUN
aiua-6073	57	35	of	of	ADP
aiua-6073	57	36	the	the	DET
aiua-6073	57	37	association	association	NOUN
aiua-6073	57	38	.	.	PUNCT
aiua-6073	58	1	results	result	VERB
aiua-6073	58	2	all	all	DET
aiua-6073	58	3	the	the	DET
aiua-6073	58	4	experts	expert	NOUN
aiua-6073	58	5	discussed	discuss	VERB
aiua-6073	58	6	,	,	PUNCT
aiua-6073	58	7	amended	amend	VERB
aiua-6073	58	8	,	,	PUNCT
aiua-6073	58	9	and	and	CCONJ
aiua-6073	58	10	approved	approve	VERB
aiua-6073	58	11	in	in	ADP
aiua-6073	58	12	plenary	plenary	ADJ
aiua-6073	58	13	session	session	NOUN
aiua-6073	58	14	the	the	DET
aiua-6073	58	15	recommendations	recommendation	NOUN
aiua-6073	58	16	that	that	PRON
aiua-6073	58	17	are	be	AUX
aiua-6073	58	18	presented	present	VERB
aiua-6073	58	19	herein	herein	NOUN
aiua-6073	58	20	,	,	PUNCT
aiua-6073	58	21	with	with	ADP
aiua-6073	58	22	comments	comment	NOUN
aiua-6073	58	23	illustrating	illustrate	VERB
aiua-6073	58	24	their	their	PRON
aiua-6073	58	25	rationale	rationale	NOUN
aiua-6073	58	26	and	and	CCONJ
aiua-6073	58	27	relevance	relevance	NOUN
aiua-6073	58	28	for	for	ADP
aiua-6073	58	29	the	the	DET
aiua-6073	58	30	clinical	clinical	ADJ
aiua-6073	58	31	practice	practice	NOUN
aiua-6073	58	32	.	.	PUNCT
aiua-6073	59	1	1	1	X
aiua-6073	59	2	.	.	X
aiua-6073	59	3	in	in	ADP
aiua-6073	59	4	patients	patient	NOUN
aiua-6073	59	5	who	who	PRON
aiua-6073	59	6	are	be	AUX
aiua-6073	59	7	candidates	candidate	NOUN
aiua-6073	59	8	for	for	ADP
aiua-6073	59	9	the	the	DET
aiua-6073	59	10	use	use	NOUN
aiua-6073	59	11	of	of	ADP
aiua-6073	59	12	avanafil	avanafil	PROPN
aiua-6073	59	13	,	,	PUNCT
aiua-6073	59	14	it	it	PRON
aiua-6073	59	15	is	be	AUX
aiua-6073	59	16	advisable	advisable	ADJ
aiua-6073	59	17	to	to	PART
aiua-6073	59	18	use	use	VERB
aiua-6073	59	19	the	the	DET
aiua-6073	59	20	200	200	NUM
aiua-6073	59	21	-	-	PUNCT
aiua-6073	59	22	mg	mg	NOUN
aiua-6073	59	23	dose	dose	NOUN
aiua-6073	59	24	from	from	ADP
aiua-6073	59	25	the	the	DET
aiua-6073	59	26	first	first	ADJ
aiua-6073	59	27	administration	administration	NOUN
aiua-6073	59	28	.	.	PUNCT
aiua-6073	60	1	the	the	DET
aiua-6073	60	2	data	datum	NOUN
aiua-6073	60	3	of	of	ADP
aiua-6073	60	4	this	this	DET
aiua-6073	60	5	survey	survey	NOUN
aiua-6073	60	6	indicate	indicate	VERB
aiua-6073	60	7	that	that	SCONJ
aiua-6073	60	8	the	the	DET
aiua-6073	60	9	200	200	NUM
aiua-6073	60	10	-	-	PUNCT
aiua-6073	60	11	mg	mg	NOUN
aiua-6073	60	12	dose	dose	PROPN
aiua-6073	60	13	of	of	ADP
aiua-6073	60	14	avanafil	avanafil	PROPN
aiua-6073	60	15	is	be	AUX
aiua-6073	60	16	the	the	DET
aiua-6073	60	17	most	most	ADV
aiua-6073	60	18	commonly	commonly	ADV
aiua-6073	60	19	used	use	VERB
aiua-6073	60	20	in	in	ADP
aiua-6073	60	21	clinical	clinical	ADJ
aiua-6073	60	22	practice	practice	NOUN
aiua-6073	60	23	.	.	PUNCT
aiua-6073	61	1	this	this	DET
aiua-6073	61	2	practice	practice	NOUN
aiua-6073	61	3	is	be	AUX
aiua-6073	61	4	supported	support	VERB
aiua-6073	61	5	at	at	ADP
aiua-6073	61	6	least	least	ADJ
aiua-6073	61	7	partly	partly	ADV
aiua-6073	61	8	by	by	ADP
aiua-6073	61	9	scientific	scientific	ADJ
aiua-6073	61	10	literature	literature	NOUN
aiua-6073	61	11	.	.	PUNCT
aiua-6073	62	1	corona	corona	PROPN
aiua-6073	62	2	et	et	PROPN
aiua-6073	62	3	al	al	PROPN
aiua-6073	62	4	.	.	PROPN
aiua-6073	63	1	(	(	PUNCT
aiua-6073	63	2	11	11	NUM
aiua-6073	63	3	)	)	PUNCT
aiua-6073	63	4	have	have	AUX
aiua-6073	63	5	recently	recently	ADV
aiua-6073	63	6	published	publish	VERB
aiua-6073	63	7	a	a	DET
aiua-6073	63	8	systematic	systematic	ADJ
aiua-6073	63	9	review	review	NOUN
aiua-6073	63	10	of	of	ADP
aiua-6073	63	11	the	the	DET
aiua-6073	63	12	literature	literature	NOUN
aiua-6073	63	13	on	on	ADP
aiua-6073	63	14	randomized	randomized	ADJ
aiua-6073	63	15	controlled	control	VERB
aiua-6073	63	16	trials	trial	NOUN
aiua-6073	63	17	(	(	PUNCT
aiua-6073	63	18	rcts	rct	NOUN
aiua-6073	63	19	)	)	PUNCT
aiua-6073	63	20	,	,	PUNCT
aiua-6073	63	21	evaluating	evaluate	VERB
aiua-6073	63	22	avanafil	avanafil	PROPN
aiua-6073	63	23	versus	versus	ADP
aiua-6073	63	24	placebo	placebo	NOUN
aiua-6073	63	25	in	in	ADP
aiua-6073	63	26	the	the	DET
aiua-6073	63	27	treatment	treatment	NOUN
aiua-6073	63	28	of	of	ADP
aiua-6073	63	29	erectile	erectile	ADJ
aiua-6073	63	30	dysfunction	dysfunction	NOUN
aiua-6073	63	31	.	.	PUNCT
aiua-6073	64	1	this	this	DET
aiua-6073	64	2	systematic	systematic	ADJ
aiua-6073	64	3	review	review	NOUN
aiua-6073	64	4	included	include	VERB
aiua-6073	64	5	five	five	NUM
aiua-6073	64	6	placebo	placebo	NOUN
aiua-6073	64	7	-	-	PUNCT
aiua-6073	64	8	controlled	control	VERB
aiua-6073	64	9	rcts	rct	NOUN
aiua-6073	64	10	,	,	PUNCT
aiua-6073	64	11	showing	show	VERB
aiua-6073	64	12	that	that	PRON
aiua-6073	64	13	avanafil	avanafil	PROPN
aiua-6073	64	14	was	be	AUX
aiua-6073	64	15	superior	superior	ADJ
aiua-6073	64	16	to	to	PART
aiua-6073	64	17	placebo	placebo	VERB
aiua-6073	64	18	in	in	ADP
aiua-6073	64	19	improving	improve	VERB
aiua-6073	64	20	vaginal	vaginal	ADJ
aiua-6073	64	21	penetration	penetration	NOUN
aiua-6073	64	22	and	and	CCONJ
aiua-6073	64	23	achieving	achieve	VERB
aiua-6073	64	24	a	a	DET
aiua-6073	64	25	successful	successful	ADJ
aiua-6073	64	26	sexual	sexual	ADJ
aiua-6073	64	27	intercourse	intercourse	NOUN
aiua-6073	64	28	.	.	PUNCT
aiua-6073	65	1	this	this	DET
aiua-6073	65	2	review	review	NOUN
aiua-6073	65	3	of	of	ADP
aiua-6073	65	4	the	the	DET
aiua-6073	65	5	literature	literature	NOUN
aiua-6073	65	6	concluded	conclude	VERB
aiua-6073	65	7	that	that	SCONJ
aiua-6073	65	8	both	both	CCONJ
aiua-6073	65	9	the	the	DET
aiua-6073	65	10	100and	100and	NUM
aiua-6073	65	11	200	200	NUM
aiua-6073	65	12	-	-	PUNCT
aiua-6073	65	13	mg	mg	PROPN
aiua-6073	65	14	doses	dose	NOUN
aiua-6073	65	15	of	of	ADP
aiua-6073	65	16	avanafil	avanafil	PROPN
aiua-6073	65	17	were	be	AUX
aiua-6073	65	18	effective	effective	ADJ
aiua-6073	65	19	and	and	CCONJ
aiua-6073	65	20	well	well	ADV
aiua-6073	65	21	tolerated	tolerate	VERB
aiua-6073	65	22	.	.	PUNCT
aiua-6073	66	1	actually	actually	ADV
aiua-6073	66	2	,	,	PUNCT
aiua-6073	66	3	the	the	DET
aiua-6073	66	4	single	single	ADJ
aiua-6073	66	5	most	most	ADV
aiua-6073	66	6	commonly	commonly	ADV
aiua-6073	66	7	reported	report	VERB
aiua-6073	66	8	adverse	adverse	ADJ
aiua-6073	66	9	effect	effect	NOUN
aiua-6073	66	10	with	with	ADP
aiua-6073	66	11	avanafil	avanafil	PROPN
aiua-6073	66	12	200	200	NUM
aiua-6073	66	13	mg	mg	NOUN
aiua-6073	66	14	was	be	AUX
aiua-6073	66	15	an	an	DET
aiua-6073	66	16	increased	increase	VERB
aiua-6073	66	17	frequency	frequency	NOUN
aiua-6073	66	18	of	of	ADP
aiua-6073	66	19	headache	headache	NOUN
aiua-6073	66	20	compared	compare	VERB
aiua-6073	66	21	to	to	ADP
aiua-6073	66	22	avanafil	avanafil	PROPN
aiua-6073	66	23	100	100	NUM
aiua-6073	66	24	mg	mg	NUM
aiua-6073	66	25	,	,	PUNCT
aiua-6073	66	26	although	although	SCONJ
aiua-6073	66	27	this	this	DET
aiua-6073	66	28	difference	difference	NOUN
aiua-6073	66	29	was	be	AUX
aiua-6073	66	30	not	not	PART
aiua-6073	66	31	statistically	statistically	ADV
aiua-6073	66	32	significant	significant	ADJ
aiua-6073	66	33	(	(	PUNCT
aiua-6073	66	34	this	this	DET
aiua-6073	66	35	finding	finding	NOUN
aiua-6073	66	36	has	have	AUX
aiua-6073	66	37	also	also	ADV
aiua-6073	66	38	been	be	AUX
aiua-6073	66	39	reported	report	VERB
aiua-6073	66	40	in	in	ADP
aiua-6073	66	41	the	the	DET
aiua-6073	66	42	present	present	ADJ
aiua-6073	66	43	survey	survey	NOUN
aiua-6073	66	44	on	on	ADP
aiua-6073	66	45	the	the	DET
aiua-6073	66	46	clinical	clinical	ADJ
aiua-6073	66	47	practice	practice	NOUN
aiua-6073	66	48	in	in	ADP
aiua-6073	66	49	italy	italy	PROPN
aiua-6073	66	50	)	)	PUNCT
aiua-6073	66	51	.	.	PUNCT
aiua-6073	67	1	no	no	DET
aiua-6073	67	2	differences	difference	NOUN
aiua-6073	67	3	were	be	AUX
aiua-6073	67	4	observed	observe	VERB
aiua-6073	67	5	between	between	ADP
aiua-6073	67	6	the	the	DET
aiua-6073	67	7	two	two	NUM
aiua-6073	67	8	groups	group	NOUN
aiua-6073	67	9	in	in	ADP
aiua-6073	67	10	the	the	DET
aiua-6073	67	11	rate	rate	NOUN
aiua-6073	67	12	of	of	ADP
aiua-6073	67	13	treatment	treatment	NOUN
aiua-6073	67	14	continuation	continuation	NOUN
aiua-6073	67	15	.	.	PUNCT
aiua-6073	68	1	with	with	ADP
aiua-6073	68	2	regard	regard	NOUN
aiua-6073	68	3	to	to	ADP
aiua-6073	68	4	efficacy	efficacy	NOUN
aiua-6073	68	5	,	,	PUNCT
aiua-6073	68	6	the	the	DET
aiua-6073	68	7	analysis	analysis	NOUN
aiua-6073	68	8	of	of	ADP
aiua-6073	68	9	published	publish	VERB
aiua-6073	68	10	studies	study	NOUN
aiua-6073	68	11	indicates	indicate	VERB
aiua-6073	68	12	a	a	DET
aiua-6073	68	13	greater	great	ADJ
aiua-6073	68	14	efficacy	efficacy	NOUN
aiua-6073	68	15	(	(	PUNCT
aiua-6073	68	16	although	although	SCONJ
aiua-6073	68	17	not	not	PART
aiua-6073	68	18	statistically	statistically	ADV
aiua-6073	68	19	significant	significant	ADJ
aiua-6073	68	20	)	)	PUNCT
aiua-6073	68	21	of	of	ADP
aiua-6073	68	22	the	the	DET
aiua-6073	68	23	treatment	treatment	NOUN
aiua-6073	68	24	with	with	ADP
aiua-6073	68	25	the	the	DET
aiua-6073	68	26	200	200	NUM
aiua-6073	68	27	-	-	PUNCT
aiua-6073	68	28	mg	mg	NOUN
aiua-6073	68	29	dose	dose	PROPN
aiua-6073	68	30	.	.	PUNCT
aiua-6073	69	1	the	the	DET
aiua-6073	69	2	effect	effect	NOUN
aiua-6073	69	3	of	of	ADP
aiua-6073	69	4	avanafil	avanafil	PROPN
aiua-6073	69	5	100	100	NUM
aiua-6073	69	6	mg	mg	NOUN
aiua-6073	69	7	was	be	AUX
aiua-6073	69	8	also	also	ADV
aiua-6073	69	9	lower	low	ADJ
aiua-6073	69	10	in	in	ADP
aiua-6073	69	11	elderly	elderly	ADJ
aiua-6073	69	12	subjects	subject	NOUN
aiua-6073	69	13	,	,	PUNCT
aiua-6073	69	14	while	while	SCONJ
aiua-6073	69	15	no	no	DET
aiua-6073	69	16	differences	difference	NOUN
aiua-6073	69	17	were	be	AUX
aiua-6073	69	18	observed	observe	VERB
aiua-6073	69	19	with	with	ADP
aiua-6073	69	20	avanafil	avanafil	PROPN
aiua-6073	69	21	200	200	NUM
aiua-6073	69	22	mg	mg	NOUN
aiua-6073	69	23	.	.	PUNCT
aiua-6073	70	1	the	the	DET
aiua-6073	70	2	observation	observation	NOUN
aiua-6073	70	3	that	that	SCONJ
aiua-6073	70	4	the	the	DET
aiua-6073	70	5	200	200	NUM
aiua-6073	70	6	-	-	PUNCT
aiua-6073	70	7	mg	mg	NOUN
aiua-6073	70	8	dose	dose	PROPN
aiua-6073	70	9	of	of	ADP
aiua-6073	70	10	avanafil	avanafil	PROPN
aiua-6073	70	11	shows	show	VERB
aiua-6073	70	12	greater	great	ADJ
aiua-6073	70	13	efficacy	efficacy	NOUN
aiua-6073	70	14	in	in	ADP
aiua-6073	70	15	all	all	DET
aiua-6073	70	16	patient	patient	ADJ
aiua-6073	70	17	categories	category	NOUN
aiua-6073	70	18	,	,	PUNCT
aiua-6073	70	19	while	while	SCONJ
aiua-6073	70	20	having	have	VERB
aiua-6073	70	21	a	a	DET
aiua-6073	70	22	substantially	substantially	ADV
aiua-6073	70	23	similar	similar	ADJ
aiua-6073	70	24	tolerability	tolerability	NOUN
aiua-6073	70	25	profile	profile	NOUN
aiua-6073	70	26	,	,	PUNCT
aiua-6073	70	27	clearly	clearly	ADV
aiua-6073	70	28	supports	support	VERB
aiua-6073	70	29	the	the	DET
aiua-6073	70	30	recommendations	recommendation	NOUN
aiua-6073	70	31	of	of	ADP
aiua-6073	70	32	our	our	PRON
aiua-6073	70	33	working	working	NOUN
aiua-6073	70	34	group	group	NOUN
aiua-6073	70	35	.	.	PUNCT
aiua-6073	71	1	2	2	X
aiua-6073	71	2	.	.	X
aiua-6073	71	3	when	when	SCONJ
aiua-6073	71	4	used	use	VERB
aiua-6073	71	5	at	at	ADP
aiua-6073	71	6	the	the	DET
aiua-6073	71	7	highest	high	ADJ
aiua-6073	71	8	dose	dose	NOUN
aiua-6073	71	9	(	(	PUNCT
aiua-6073	71	10	200	200	NUM
aiua-6073	71	11	mg	mg	NOUN
aiua-6073	71	12	)	)	PUNCT
aiua-6073	71	13	,	,	PUNCT
aiua-6073	71	14	avanafil	avanafil	PROPN
aiua-6073	71	15	shows	show	VERB
aiua-6073	71	16	a	a	DET
aiua-6073	71	17	favourable	favourable	ADJ
aiua-6073	71	18	tolerability	tolerability	NOUN
aiua-6073	71	19	profile	profile	NOUN
aiua-6073	71	20	with	with	ADP
aiua-6073	71	21	an	an	DET
aiua-6073	71	22	efficacy	efficacy	NOUN
aiua-6073	71	23	similar	similar	ADJ
aiua-6073	71	24	to	to	ADP
aiua-6073	71	25	that	that	PRON
aiua-6073	71	26	of	of	ADP
aiua-6073	71	27	other	other	ADJ
aiua-6073	71	28	agents	agent	NOUN
aiua-6073	71	29	.	.	PUNCT
aiua-6073	72	1	chen	chen	PROPN
aiua-6073	72	2	et	et	PROPN
aiua-6073	72	3	al	al	PROPN
aiua-6073	72	4	.	.	PUNCT
aiua-6073	73	1	(	(	PUNCT
aiua-6073	73	2	12	12	NUM
aiua-6073	73	3	)	)	PUNCT
aiua-6073	73	4	have	have	AUX
aiua-6073	73	5	recently	recently	ADV
aiua-6073	73	6	published	publish	VERB
aiua-6073	73	7	a	a	DET
aiua-6073	73	8	“	"	PUNCT
aiua-6073	73	9	network	network	NOUN
aiua-6073	73	10	metaanalysis	metaanalysis	NOUN
aiua-6073	73	11	”	"	PUNCT
aiua-6073	73	12	that	that	PRON
aiua-6073	73	13	included	include	VERB
aiua-6073	73	14	rcts	rct	NOUN
aiua-6073	73	15	evaluating	evaluate	VERB
aiua-6073	73	16	the	the	DET
aiua-6073	73	17	efficacy	efficacy	NOUN
aiua-6073	73	18	of	of	ADP
aiua-6073	73	19	sildenafil	sildenafil	NOUN
aiua-6073	73	20	,	,	PUNCT
aiua-6073	73	21	tadalafil	tadalafil	PROPN
aiua-6073	73	22	,	,	PUNCT
aiua-6073	73	23	vardenafil	vardenafil	NOUN
aiua-6073	73	24	,	,	PUNCT
aiua-6073	73	25	and	and	CCONJ
aiua-6073	73	26	avanafil	avanafil	PROPN
aiua-6073	73	27	,	,	PUNCT
aiua-6073	73	28	usually	usually	ADV
aiua-6073	73	29	in	in	ADP
aiua-6073	73	30	comparison	comparison	NOUN
aiua-6073	73	31	with	with	ADP
aiua-6073	73	32	placebo	placebo	NOUN
aiua-6073	73	33	.	.	PUNCT
aiua-6073	74	1	overall	overall	ADV
aiua-6073	74	2	,	,	PUNCT
aiua-6073	74	3	the	the	DET
aiua-6073	74	4	authors	author	NOUN
aiua-6073	74	5	included	include	VERB
aiua-6073	74	6	82	82	NUM
aiua-6073	74	7	rcts	rct	NOUN
aiua-6073	74	8	(	(	PUNCT
aiua-6073	74	9	for	for	ADP
aiua-6073	74	10	a	a	DET
aiua-6073	74	11	total	total	NOUN
aiua-6073	74	12	of	of	ADP
aiua-6073	74	13	47626	47626	NUM
aiua-6073	74	14	patients	patient	NOUN
aiua-6073	74	15	)	)	PUNCT
aiua-6073	74	16	for	for	ADP
aiua-6073	74	17	the	the	DET
aiua-6073	74	18	efficacy	efficacy	NOUN
aiua-6073	74	19	analysis	analysis	NOUN
aiua-6073	74	20	,	,	PUNCT
aiua-6073	74	21	and	and	CCONJ
aiua-6073	74	22	72	72	NUM
aiua-6073	74	23	rcts	rct	NOUN
aiua-6073	74	24	(	(	PUNCT
aiua-6073	74	25	20325	20325	NUM
aiua-6073	74	26	patients	patient	NOUN
aiua-6073	74	27	)	)	PUNCT
aiua-6073	74	28	for	for	ADP
aiua-6073	74	29	the	the	DET
aiua-6073	74	30	tolerability	tolerability	NOUN
aiua-6073	74	31	analysis	analysis	NOUN
aiua-6073	74	32	.	.	PUNCT
aiua-6073	75	1	the	the	DET
aiua-6073	75	2	authors	author	NOUN
aiua-6073	75	3	concluded	conclude	VERB
aiua-6073	75	4	that	that	SCONJ
aiua-6073	75	5	there	there	PRON
aiua-6073	75	6	were	be	VERB
aiua-6073	75	7	no	no	DET
aiua-6073	75	8	significant	significant	ADJ
aiua-6073	75	9	differences	difference	NOUN
aiua-6073	75	10	between	between	ADP
aiua-6073	75	11	avanafil	avanafil	PROPN
aiua-6073	75	12	,	,	PUNCT
aiua-6073	75	13	sildenafil	sildenafil	NOUN
aiua-6073	75	14	,	,	PUNCT
aiua-6073	75	15	tadalafil	tadalafil	PROPN
aiua-6073	75	16	,	,	PUNCT
aiua-6073	75	17	and	and	CCONJ
aiua-6073	75	18	vardenafil	vardenafil	NOUN
aiua-6073	75	19	,	,	PUNCT
aiua-6073	75	20	when	when	SCONJ
aiua-6073	75	21	the	the	DET
aiua-6073	75	22	maximum	maximum	ADJ
aiua-6073	75	23	recommended	recommend	VERB
aiua-6073	75	24	doses	dose	NOUN
aiua-6073	75	25	of	of	ADP
aiua-6073	75	26	these	these	DET
aiua-6073	75	27	drugs	drug	NOUN
aiua-6073	75	28	(	(	PUNCT
aiua-6073	75	29	200	200	NUM
aiua-6073	75	30	,	,	PUNCT
aiua-6073	75	31	100	100	NUM
aiua-6073	75	32	,	,	PUNCT
aiua-6073	75	33	20	20	NUM
aiua-6073	75	34	and	and	CCONJ
aiua-6073	75	35	20	20	NUM
aiua-6073	75	36	mg	mg	NUM
aiua-6073	75	37	,	,	PUNCT
aiua-6073	75	38	respectively	respectively	ADV
aiua-6073	75	39	)	)	PUNCT
aiua-6073	75	40	were	be	AUX
aiua-6073	75	41	administered	administer	VERB
aiua-6073	75	42	.	.	PUNCT
aiua-6073	76	1	with	with	ADP
aiua-6073	76	2	regard	regard	NOUN
aiua-6073	76	3	to	to	ADP
aiua-6073	76	4	tolerability	tolerability	NOUN
aiua-6073	76	5	,	,	PUNCT
aiua-6073	76	6	avanafil	avanafil	PROPN
aiua-6073	76	7	was	be	AUX
aiua-6073	76	8	significantly	significantly	ADV
aiua-6073	76	9	associated	associate	VERB
aiua-6073	76	10	with	with	ADP
aiua-6073	76	11	a	a	DET
aiua-6073	76	12	lower	low	ADJ
aiua-6073	76	13	incidence	incidence	NOUN
aiua-6073	76	14	of	of	ADP
aiua-6073	76	15	adverse	adverse	ADJ
aiua-6073	76	16	effects	effect	NOUN
aiua-6073	76	17	when	when	SCONJ
aiua-6073	76	18	drugs	drug	NOUN
aiua-6073	76	19	were	be	AUX
aiua-6073	76	20	given	give	VERB
aiua-6073	76	21	at	at	ADP
aiua-6073	76	22	the	the	DET
aiua-6073	76	23	maximum	maximum	ADJ
aiua-6073	76	24	recommended	recommend	VERB
aiua-6073	76	25	dosage	dosage	NOUN
aiua-6073	76	26	patients	patient	NOUN
aiua-6073	76	27	were	be	AUX
aiua-6073	76	28	treated	treat	VERB
aiua-6073	76	29	with	with	ADP
aiua-6073	76	30	the	the	DET
aiua-6073	76	31	maximum	maximum	ADJ
aiua-6073	76	32	recommended	recommend	VERB
aiua-6073	76	33	doses	dose	NOUN
aiua-6073	76	34	of	of	ADP
aiua-6073	76	35	these	these	DET
aiua-6073	76	36	drugs	drug	NOUN
aiua-6073	76	37	(	(	PUNCT
aiua-6073	76	38	200	200	NUM
aiua-6073	76	39	,	,	PUNCT
aiua-6073	76	40	100	100	NUM
aiua-6073	76	41	,	,	PUNCT
aiua-6073	76	42	20	20	NUM
aiua-6073	76	43	,	,	PUNCT
aiua-6073	76	44	and	and	CCONJ
aiua-6073	76	45	20	20	NUM
aiua-6073	76	46	mg	mg	NUM
aiua-6073	76	47	,	,	PUNCT
aiua-6073	76	48	respectively	respectively	ADV
aiua-6073	76	49	)	)	PUNCT
aiua-6073	76	50	.	.	PUNCT
aiua-6073	77	1	3	3	X
aiua-6073	77	2	.	.	X
aiua-6073	78	1	the	the	DET
aiua-6073	78	2	patient	patient	NOUN
aiua-6073	78	3	should	should	AUX
aiua-6073	78	4	be	be	AUX
aiua-6073	78	5	instructed	instruct	VERB
aiua-6073	78	6	to	to	PART
aiua-6073	78	7	take	take	VERB
aiua-6073	78	8	avanafil	avanafil	NOUN
aiua-6073	78	9	on	on	ADP
aiua-6073	78	10	an	an	DET
aiua-6073	78	11	empty	empty	ADJ
aiua-6073	78	12	stomach	stomach	NOUN
aiua-6073	78	13	,	,	PUNCT
aiua-6073	78	14	i.e.	i.e.	X
aiua-6073	78	15	,	,	PUNCT
aiua-6073	78	16	30	30	NUM
aiua-6073	78	17	-	-	SYM
aiua-6073	78	18	45	45	NUM
aiua-6073	78	19	minutes	minute	NOUN
aiua-6073	78	20	before	before	ADP
aiua-6073	78	21	or	or	CCONJ
aiua-6073	78	22	2	2	NUM
aiua-6073	78	23	hours	hour	NOUN
aiua-6073	78	24	after	after	ADP
aiua-6073	78	25	a	a	DET
aiua-6073	78	26	meal	meal	NOUN
aiua-6073	78	27	.	.	PUNCT
aiua-6073	79	1	it	it	PRON
aiua-6073	79	2	is	be	AUX
aiua-6073	79	3	important	important	ADJ
aiua-6073	79	4	to	to	PART
aiua-6073	79	5	adequately	adequately	ADV
aiua-6073	79	6	educate	educate	VERB
aiua-6073	79	7	the	the	DET
aiua-6073	79	8	patient	patient	NOUN
aiua-6073	79	9	about	about	ADP
aiua-6073	79	10	the	the	DET
aiua-6073	79	11	fact	fact	NOUN
aiua-6073	79	12	that	that	SCONJ
aiua-6073	79	13	avanafil	avanafil	PROPN
aiua-6073	79	14	should	should	AUX
aiua-6073	79	15	be	be	AUX
aiua-6073	79	16	taken	take	VERB
aiua-6073	79	17	on	on	ADP
aiua-6073	79	18	an	an	DET
aiua-6073	79	19	empty	empty	ADJ
aiua-6073	79	20	stomach	stomach	NOUN
aiua-6073	79	21	.	.	PUNCT
aiua-6073	80	1	in	in	ADP
aiua-6073	80	2	fact	fact	NOUN
aiua-6073	80	3	,	,	PUNCT
aiua-6073	80	4	the	the	DET
aiua-6073	80	5	median	median	ADJ
aiua-6073	80	6	time	time	NOUN
aiua-6073	80	7	to	to	ADP
aiua-6073	80	8	maximum	maximum	ADJ
aiua-6073	80	9	plasma	plasma	NOUN
aiua-6073	80	10	concentration	concentration	NOUN
aiua-6073	80	11	(	(	PUNCT
aiua-6073	80	12	tmax	tmax	ADV
aiua-6073	80	13	)	)	PUNCT
aiua-6073	80	14	is	be	AUX
aiua-6073	80	15	obtained	obtain	VERB
aiua-6073	80	16	within	within	ADP
aiua-6073	80	17	30	30	NUM
aiua-6073	80	18	-	-	SYM
aiua-6073	80	19	45	45	NUM
aiua-6073	80	20	minutes	minute	NOUN
aiua-6073	80	21	after	after	ADP
aiua-6073	80	22	dosing	dose	VERB
aiua-6073	80	23	,	,	PUNCT
aiua-6073	80	24	and	and	CCONJ
aiua-6073	80	25	the	the	DET
aiua-6073	80	26	concomitant	concomitant	PROPN
aiua-6073	80	27	intake	intake	NOUN
aiua-6073	80	28	with	with	ADP
aiua-6073	80	29	food	food	NOUN
aiua-6073	80	30	causes	cause	VERB
aiua-6073	80	31	a	a	DET
aiua-6073	80	32	delay	delay	NOUN
aiua-6073	80	33	in	in	ADP
aiua-6073	80	34	median	median	ADJ
aiua-6073	80	35	tmax	tmax	NOUN
aiua-6073	80	36	of	of	ADP
aiua-6073	80	37	1	1	NUM
aiua-6073	80	38	hour	hour	NOUN
aiua-6073	80	39	and	and	CCONJ
aiua-6073	80	40	25	25	NUM
aiua-6073	80	41	minutes	minute	NOUN
aiua-6073	80	42	,	,	PUNCT
aiua-6073	80	43	as	as	SCONJ
aiua-6073	80	44	reported	report	VERB
aiua-6073	80	45	in	in	ADP
aiua-6073	80	46	the	the	DET
aiua-6073	80	47	summary	summary	NOUN
aiua-6073	80	48	of	of	ADP
aiua-6073	80	49	product	product	NOUN
aiua-6073	80	50	characteristics	characteristic	NOUN
aiua-6073	80	51	(	(	PUNCT
aiua-6073	80	52	spc	spc	PROPN
aiua-6073	80	53	)	)	PUNCT
aiua-6073	80	54	of	of	ADP
aiua-6073	80	55	avanafil	avanafil	PROPN
aiua-6073	80	56	(	(	PUNCT
aiua-6073	80	57	13	13	NUM
aiua-6073	80	58	)	)	PUNCT
aiua-6073	80	59	.	.	PUNCT
aiua-6073	81	1	4	4	X
aiua-6073	81	2	.	.	X
aiua-6073	81	3	the	the	DET
aiua-6073	81	4	efficacy	efficacy	NOUN
aiua-6073	81	5	window	window	NOUN
aiua-6073	81	6	of	of	ADP
aiua-6073	81	7	avanafil	avanafil	PROPN
aiua-6073	81	8	is	be	AUX
aiua-6073	81	9	between	between	ADP
aiua-6073	81	10	30	30	NUM
aiua-6073	81	11	minutes	minute	NOUN
aiua-6073	81	12	and	and	CCONJ
aiua-6073	81	13	6	6	NUM
aiua-6073	81	14	hours	hour	NOUN
aiua-6073	81	15	after	after	ADP
aiua-6073	81	16	dosing	dose	VERB
aiua-6073	81	17	,	,	PUNCT
aiua-6073	81	18	which	which	PRON
aiua-6073	81	19	qualifies	qualify	VERB
aiua-6073	81	20	this	this	DET
aiua-6073	81	21	molecule	molecule	NOUN
aiua-6073	81	22	as	as	ADP
aiua-6073	81	23	a	a	DET
aiua-6073	81	24	new	new	ADJ
aiua-6073	81	25	drug	drug	NOUN
aiua-6073	81	26	with	with	ADP
aiua-6073	81	27	an	an	DET
aiua-6073	81	28	intermediate	intermediate	ADJ
aiua-6073	81	29	duration	duration	NOUN
aiua-6073	81	30	of	of	ADP
aiua-6073	81	31	action	action	NOUN
aiua-6073	81	32	.	.	PUNCT
aiua-6073	82	1	table	table	NOUN
aiua-6073	82	2	2	2	NUM
aiua-6073	82	3	shows	show	VERB
aiua-6073	82	4	the	the	DET
aiua-6073	82	5	median	median	PROPN
aiua-6073	82	6	tmax	tmax	ADP
aiua-6073	82	7	and	and	CCONJ
aiua-6073	82	8	the	the	DET
aiua-6073	82	9	plasma	plasma	NOUN
aiua-6073	82	10	half	half	ADJ
aiua-6073	82	11	-	-	PUNCT
aiua-6073	82	12	life	life	NOUN
aiua-6073	82	13	(	(	PUNCT
aiua-6073	82	14	in	in	ADP
aiua-6073	82	15	hours	hour	NOUN
aiua-6073	82	16	)	)	PUNCT
aiua-6073	82	17	of	of	ADP
aiua-6073	82	18	the	the	DET
aiua-6073	82	19	four	four	NUM
aiua-6073	82	20	pde5	pde5	NOUN
aiua-6073	82	21	inhibitors	inhibitor	NOUN
aiua-6073	82	22	available	available	ADJ
aiua-6073	82	23	today	today	NOUN
aiua-6073	82	24	in	in	ADP
aiua-6073	82	25	italy	italy	PROPN
aiua-6073	82	26	for	for	ADP
aiua-6073	82	27	the	the	DET
aiua-6073	82	28	treatment	treatment	NOUN
aiua-6073	82	29	of	of	ADP
aiua-6073	82	30	ed	ed	NOUN
aiua-6073	82	31	(	(	PUNCT
aiua-6073	82	32	13	13	NUM
aiua-6073	82	33	-	-	SYM
aiua-6073	82	34	17	17	NUM
aiua-6073	82	35	)	)	PUNCT
aiua-6073	82	36	.	.	PUNCT
aiua-6073	83	1	with	with	ADP
aiua-6073	83	2	regard	regard	NOUN
aiua-6073	83	3	to	to	ADP
aiua-6073	83	4	avanafil	avanafil	PROPN
aiua-6073	83	5	,	,	PUNCT
aiua-6073	83	6	discordant	discordant	ADJ
aiua-6073	83	7	data	datum	NOUN
aiua-6073	83	8	about	about	ADP
aiua-6073	83	9	half	half	ADJ
aiua-6073	83	10	-	-	PUNCT
aiua-6073	83	11	life	life	NOUN
aiua-6073	83	12	have	have	AUX
aiua-6073	83	13	been	be	AUX
aiua-6073	83	14	presented	present	VERB
aiua-6073	83	15	in	in	ADP
aiua-6073	83	16	the	the	DET
aiua-6073	83	17	literature	literature	NOUN
aiua-6073	83	18	.	.	PUNCT
aiua-6073	84	1	its	its	PRON
aiua-6073	84	2	terminal	terminal	ADJ
aiua-6073	84	3	half	half	ADJ
aiua-6073	84	4	-	-	PUNCT
aiua-6073	84	5	life	life	NOUN
aiua-6073	84	6	is	be	AUX
aiua-6073	84	7	6	6	NUM
aiua-6073	84	8	-	-	SYM
aiua-6073	84	9	17	17	NUM
aiua-6073	84	10	h	h	NOUN
aiua-6073	84	11	,	,	PUNCT
aiua-6073	84	12	as	as	SCONJ
aiua-6073	84	13	reported	report	VERB
aiua-6073	84	14	in	in	ADP
aiua-6073	84	15	the	the	DET
aiua-6073	84	16	spc	spc	PROPN
aiua-6073	84	17	,	,	PUNCT
aiua-6073	84	18	while	while	SCONJ
aiua-6073	84	19	the	the	DET
aiua-6073	84	20	apparent	apparent	ADJ
aiua-6073	84	21	t1/2	t1/2	NOUN
aiua-6073	84	22	is	be	AUX
aiua-6073	84	23	1.20	1.20	NUM
aiua-6073	84	24	to	to	PART
aiua-6073	84	25	parameter	parameter	PROPN
aiua-6073	84	26	avanafil	avanafil	PROPN
aiua-6073	84	27	sildenafil	sildenafil	PROPN
aiua-6073	84	28	vardenafil	vardenafil	PROPN
aiua-6073	85	1	tadalafil	tadalafil	PROPN
aiua-6073	85	2	tmax	tmax	ADP
aiua-6073	85	3	(	(	PUNCT
aiua-6073	85	4	median	median	NOUN
aiua-6073	85	5	)	)	PUNCT
aiua-6073	85	6	30	30	NUM
aiua-6073	85	7	-	-	SYM
aiua-6073	85	8	45	45	NUM
aiua-6073	85	9	min	min	NOUN
aiua-6073	85	10	1	1	NUM
aiua-6073	85	11	h	h	NOUN
aiua-6073	85	12	1	1	NUM
aiua-6073	85	13	h	h	NOUN
aiua-6073	85	14	2	2	NUM
aiua-6073	85	15	h	h	NOUN
aiua-6073	85	16	plasmatic	plasmatic	ADJ
aiua-6073	85	17	half	half	ADJ
aiua-6073	85	18	-	-	PUNCT
aiua-6073	85	19	life	life	NOUN
aiua-6073	85	20	1.20	1.20	NUM
aiua-6073	85	21	-	-	SYM
aiua-6073	85	22	5	5	NUM
aiua-6073	85	23	h	h	NOUN
aiua-6073	86	1	3–5	3–5	NUM
aiua-6073	86	2	h	h	NOUN
aiua-6073	86	3	4–5	4–5	PROPN
aiua-6073	86	4	h	h	NOUN
aiua-6073	86	5	17.5	17.5	NUM
aiua-6073	86	6	h	h	NOUN
aiua-6073	86	7	(	(	PUNCT
aiua-6073	86	8	mean	mean	ADJ
aiua-6073	86	9	)	)	PUNCT
aiua-6073	86	10	table	table	NOUN
aiua-6073	86	11	2	2	NUM
aiua-6073	86	12	.	.	X
aiua-6073	87	1	tmax	tmax	ADV
aiua-6073	87	2	and	and	CCONJ
aiua-6073	87	3	plasmatic	plasmatic	ADJ
aiua-6073	87	4	half	half	ADJ
aiua-6073	87	5	-	-	PUNCT
aiua-6073	87	6	life	life	NOUN
aiua-6073	87	7	of	of	ADP
aiua-6073	87	8	pde5	pde5	NOUN
aiua-6073	87	9	-	-	PUNCT
aiua-6073	87	10	inhibitors	inhibitor	NOUN
aiua-6073	87	11	(	(	PUNCT
aiua-6073	87	12	13	13	NUM
aiua-6073	87	13	-	-	SYM
aiua-6073	87	14	17	17	NUM
aiua-6073	87	15	)	)	PUNCT
aiua-6073	87	16	.	.	PUNCT
aiua-6073	88	1	mirone_stesura	mirone_stesura	NOUN
aiua-6073	88	2	seveso	seveso	VERB
aiua-6073	88	3	01/07/16	01/07/16	PROPN
aiua-6073	88	4	11:08	11:08	NUM
aiua-6073	88	5	pagina	pagina	NOUN
aiua-6073	88	6	130	130	NUM
aiua-6073	88	7	131archivio	131archivio	PROPN
aiua-6073	88	8	italiano	italiano	NOUN
aiua-6073	88	9	di	di	NOUN
aiua-6073	88	10	urologia	urologia	PROPN
aiua-6073	88	11	e	e	PROPN
aiua-6073	88	12	andrologia	andrologia	NOUN
aiua-6073	88	13	2016	2016	NUM
aiua-6073	88	14	;	;	PUNCT
aiua-6073	88	15	88	88	NUM
aiua-6073	88	16	,	,	PUNCT
aiua-6073	88	17	2	2	NUM
aiua-6073	88	18	avanafil	avanafil	NOUN
aiua-6073	88	19	and	and	CCONJ
aiua-6073	88	20	ed	ed	NOUN
aiua-6073	88	21	:	:	PUNCT
aiua-6073	88	22	a	a	DET
aiua-6073	88	23	survey	survey	NOUN
aiua-6073	88	24	on	on	ADP
aiua-6073	88	25	italian	italian	ADJ
aiua-6073	88	26	urologists	urologist	NOUN
aiua-6073	88	27	5	5	NUM
aiua-6073	88	28	hours	hour	NOUN
aiua-6073	88	29	(	(	PUNCT
aiua-6073	88	30	17	17	NUM
aiua-6073	88	31	)	)	PUNCT
aiua-6073	88	32	,	,	PUNCT
aiua-6073	88	33	in	in	ADP
aiua-6073	88	34	line	line	NOUN
aiua-6073	88	35	with	with	ADP
aiua-6073	88	36	the	the	DET
aiua-6073	88	37	duration	duration	NOUN
aiua-6073	88	38	of	of	ADP
aiua-6073	88	39	the	the	DET
aiua-6073	88	40	therapeutic	therapeutic	ADJ
aiua-6073	88	41	effect	effect	NOUN
aiua-6073	88	42	observed	observe	VERB
aiua-6073	88	43	in	in	ADP
aiua-6073	88	44	clinical	clinical	ADJ
aiua-6073	88	45	trials	trial	NOUN
aiua-6073	88	46	.	.	PUNCT
aiua-6073	89	1	it	it	PRON
aiua-6073	89	2	is	be	AUX
aiua-6073	89	3	quite	quite	ADV
aiua-6073	89	4	clear	clear	ADJ
aiua-6073	89	5	from	from	ADP
aiua-6073	89	6	above	above	ADP
aiua-6073	89	7	that	that	DET
aiua-6073	89	8	avanafil	avanafil	PROPN
aiua-6073	89	9	can	can	AUX
aiua-6073	89	10	be	be	AUX
aiua-6073	89	11	qualified	qualified	ADJ
aiua-6073	89	12	as	as	ADP
aiua-6073	89	13	a	a	DET
aiua-6073	89	14	new	new	ADJ
aiua-6073	89	15	agent	agent	NOUN
aiua-6073	89	16	with	with	ADP
aiua-6073	89	17	an	an	DET
aiua-6073	89	18	intermediate	intermediate	ADJ
aiua-6073	89	19	duration	duration	NOUN
aiua-6073	89	20	of	of	ADP
aiua-6073	89	21	action	action	NOUN
aiua-6073	89	22	,	,	PUNCT
aiua-6073	89	23	as	as	SCONJ
aiua-6073	89	24	compared	compare	VERB
aiua-6073	89	25	with	with	ADP
aiua-6073	89	26	other	other	ADJ
aiua-6073	89	27	active	active	ADJ
aiua-6073	89	28	substances	substance	NOUN
aiua-6073	89	29	.	.	PUNCT
aiua-6073	90	1	5	5	X
aiua-6073	90	2	.	.	NUM
aiua-6073	90	3	avanafil	avanafil	VERB
aiua-6073	90	4	at	at	ADP
aiua-6073	90	5	a	a	DET
aiua-6073	90	6	dose	dose	NOUN
aiua-6073	90	7	of	of	ADP
aiua-6073	90	8	50	50	NUM
aiua-6073	90	9	-	-	SYM
aiua-6073	90	10	100	100	NUM
aiua-6073	90	11	mg	mg	NUM
aiua-6073	90	12	/	/	SYM
aiua-6073	90	13	day	day	NOUN
aiua-6073	90	14	may	may	AUX
aiua-6073	90	15	be	be	AUX
aiua-6073	90	16	a	a	DET
aiua-6073	90	17	therapeutic	therapeutic	ADJ
aiua-6073	90	18	option	option	NOUN
aiua-6073	90	19	in	in	ADP
aiua-6073	90	20	chronic	chronic	ADJ
aiua-6073	90	21	rehabilitation	rehabilitation	NOUN
aiua-6073	90	22	.	.	PUNCT
aiua-6073	91	1	there	there	PRON
aiua-6073	91	2	is	be	VERB
aiua-6073	91	3	scientific	scientific	ADJ
aiua-6073	91	4	evidence	evidence	NOUN
aiua-6073	91	5	supporting	support	VERB
aiua-6073	91	6	the	the	DET
aiua-6073	91	7	use	use	NOUN
aiua-6073	91	8	of	of	ADP
aiua-6073	91	9	pde5	pde5	NOUN
aiua-6073	91	10	inhibitors	inhibitor	NOUN
aiua-6073	91	11	as	as	ADP
aiua-6073	91	12	on	on	ADP
aiua-6073	91	13	-	-	PUNCT
aiua-6073	91	14	demand	demand	NOUN
aiua-6073	91	15	or	or	CCONJ
aiua-6073	91	16	chronic	chronic	ADJ
aiua-6073	91	17	(	(	PUNCT
aiua-6073	91	18	daily	daily	ADJ
aiua-6073	91	19	)	)	PUNCT
aiua-6073	91	20	treatment	treatment	NOUN
aiua-6073	91	21	for	for	ADP
aiua-6073	91	22	penile	penile	ADJ
aiua-6073	91	23	rehabilitation	rehabilitation	NOUN
aiua-6073	91	24	following	follow	VERB
aiua-6073	91	25	radical	radical	ADJ
aiua-6073	91	26	prostatectomy	prostatectomy	NOUN
aiua-6073	91	27	.	.	PUNCT
aiua-6073	92	1	the	the	DET
aiua-6073	92	2	fibrosis	fibrosis	NOUN
aiua-6073	92	3	of	of	ADP
aiua-6073	92	4	cavernous	cavernous	ADJ
aiua-6073	92	5	bodies	body	NOUN
aiua-6073	92	6	has	have	AUX
aiua-6073	92	7	been	be	AUX
aiua-6073	92	8	associated	associate	VERB
aiua-6073	92	9	with	with	ADP
aiua-6073	92	10	reduced	reduced	ADJ
aiua-6073	92	11	penile	penile	ADJ
aiua-6073	92	12	length	length	NOUN
aiua-6073	92	13	:	:	PUNCT
aiua-6073	92	14	experimental	experimental	ADJ
aiua-6073	92	15	studies	study	NOUN
aiua-6073	92	16	have	have	AUX
aiua-6073	92	17	demonstrated	demonstrate	VERB
aiua-6073	92	18	that	that	SCONJ
aiua-6073	92	19	,	,	PUNCT
aiua-6073	92	20	following	follow	VERB
aiua-6073	92	21	bilateral	bilateral	ADJ
aiua-6073	92	22	cavernous	cavernous	ADJ
aiua-6073	92	23	nerve	nerve	NOUN
aiua-6073	92	24	injury	injury	NOUN
aiua-6073	92	25	,	,	PUNCT
aiua-6073	92	26	there	there	PRON
aiua-6073	92	27	is	be	VERB
aiua-6073	92	28	a	a	DET
aiua-6073	92	29	significant	significant	ADJ
aiua-6073	92	30	reduction	reduction	NOUN
aiua-6073	92	31	in	in	ADP
aiua-6073	92	32	the	the	DET
aiua-6073	92	33	cavernosal	cavernosal	ADJ
aiua-6073	92	34	smooth	smooth	ADJ
aiua-6073	92	35	muscle	muscle	NOUN
aiua-6073	92	36	/	/	SYM
aiua-6073	92	37	collagen	collagen	NOUN
aiua-6073	92	38	ratio	ratio	NOUN
aiua-6073	92	39	.	.	PUNCT
aiua-6073	93	1	chronic	chronic	ADJ
aiua-6073	93	2	use	use	NOUN
aiua-6073	93	3	of	of	ADP
aiua-6073	93	4	pde5is	pde5is	PROPN
aiua-6073	93	5	has	have	AUX
aiua-6073	93	6	been	be	AUX
aiua-6073	93	7	specifically	specifically	ADV
aiua-6073	93	8	studied	study	VERB
aiua-6073	93	9	with	with	ADP
aiua-6073	93	10	the	the	DET
aiua-6073	93	11	aim	aim	NOUN
aiua-6073	93	12	to	to	PART
aiua-6073	93	13	improve	improve	VERB
aiua-6073	93	14	this	this	DET
aiua-6073	93	15	clinical	clinical	ADJ
aiua-6073	93	16	problem	problem	NOUN
aiua-6073	93	17	.	.	PUNCT
aiua-6073	94	1	avanafil	avanafil	PROPN
aiua-6073	94	2	has	have	AUX
aiua-6073	94	3	been	be	AUX
aiua-6073	94	4	shown	show	VERB
aiua-6073	94	5	to	to	PART
aiua-6073	94	6	be	be	AUX
aiua-6073	94	7	effective	effective	ADJ
aiua-6073	94	8	in	in	ADP
aiua-6073	94	9	the	the	DET
aiua-6073	94	10	treatment	treatment	NOUN
aiua-6073	94	11	of	of	ADP
aiua-6073	94	12	patients	patient	NOUN
aiua-6073	94	13	with	with	ADP
aiua-6073	94	14	ed	ed	NOUN
aiua-6073	94	15	following	follow	VERB
aiua-6073	94	16	radical	radical	ADJ
aiua-6073	94	17	prostatectomy	prostatectomy	NOUN
aiua-6073	94	18	.	.	PUNCT
aiua-6073	95	1	when	when	SCONJ
aiua-6073	95	2	prescribed	prescribe	VERB
aiua-6073	95	3	for	for	ADP
aiua-6073	95	4	chronic	chronic	ADJ
aiua-6073	95	5	use	use	NOUN
aiua-6073	95	6	,	,	PUNCT
aiua-6073	95	7	these	these	DET
aiua-6073	95	8	agents	agent	NOUN
aiua-6073	95	9	are	be	AUX
aiua-6073	95	10	usually	usually	ADV
aiua-6073	95	11	given	give	VERB
aiua-6073	95	12	at	at	ADP
aiua-6073	95	13	the	the	DET
aiua-6073	95	14	lowest	low	ADJ
aiua-6073	95	15	dose	dose	NOUN
aiua-6073	95	16	available	available	ADJ
aiua-6073	95	17	(	(	PUNCT
aiua-6073	95	18	18	18	NUM
aiua-6073	95	19	)	)	PUNCT
aiua-6073	95	20	,	,	PUNCT
aiua-6073	95	21	and	and	CCONJ
aiua-6073	95	22	increasing	increase	VERB
aiua-6073	95	23	their	their	PRON
aiua-6073	95	24	dose	dose	NOUN
aiua-6073	95	25	does	do	AUX
aiua-6073	95	26	not	not	PART
aiua-6073	95	27	seem	seem	VERB
aiua-6073	95	28	to	to	PART
aiua-6073	95	29	improve	improve	VERB
aiua-6073	95	30	their	their	PRON
aiua-6073	95	31	efficacy	efficacy	NOUN
aiua-6073	95	32	(	(	PUNCT
aiua-6073	95	33	19	19	NUM
aiua-6073	95	34	)	)	PUNCT
aiua-6073	95	35	.	.	PUNCT
aiua-6073	96	1	discussion	discussion	NOUN
aiua-6073	96	2	as	as	SCONJ
aiua-6073	96	3	emphasized	emphasize	VERB
aiua-6073	96	4	by	by	ADP
aiua-6073	96	5	the	the	DET
aiua-6073	96	6	recent	recent	ADJ
aiua-6073	96	7	guidelines	guideline	NOUN
aiua-6073	96	8	of	of	ADP
aiua-6073	96	9	the	the	DET
aiua-6073	96	10	european	european	PROPN
aiua-6073	96	11	association	association	PROPN
aiua-6073	96	12	of	of	ADP
aiua-6073	96	13	urology	urology	NOUN
aiua-6073	96	14	(	(	PUNCT
aiua-6073	96	15	eau	eau	PROPN
aiua-6073	96	16	)	)	PUNCT
aiua-6073	96	17	,	,	PUNCT
aiua-6073	96	18	pde5is	pde5is	PROPN
aiua-6073	96	19	are	be	AUX
aiua-6073	96	20	the	the	DET
aiua-6073	96	21	first	first	ADJ
aiua-6073	96	22	-	-	PUNCT
aiua-6073	96	23	line	line	NOUN
aiua-6073	96	24	therapeutic	therapeutic	ADJ
aiua-6073	96	25	option	option	NOUN
aiua-6073	96	26	for	for	ADP
aiua-6073	96	27	most	most	ADJ
aiua-6073	96	28	men	man	NOUN
aiua-6073	96	29	with	with	ADP
aiua-6073	96	30	ed	ed	NOUN
aiua-6073	96	31	.	.	PUNCT
aiua-6073	97	1	currently	currently	ADV
aiua-6073	97	2	available	available	ADJ
aiua-6073	97	3	pde5is	pde5is	PROPN
aiua-6073	97	4	(	(	PUNCT
aiua-6073	97	5	sildenafil	sildenafil	X
aiua-6073	97	6	,	,	PUNCT
aiua-6073	97	7	tadalafil	tadalafil	PROPN
aiua-6073	97	8	,	,	PUNCT
aiua-6073	97	9	vardenafil	vardenafil	NOUN
aiua-6073	97	10	,	,	PUNCT
aiua-6073	97	11	and	and	CCONJ
aiua-6073	97	12	avanafil	avanafil	PROPN
aiua-6073	97	13	)	)	PUNCT
aiua-6073	97	14	have	have	VERB
aiua-6073	97	15	the	the	DET
aiua-6073	97	16	same	same	ADJ
aiua-6073	97	17	mechanism	mechanism	NOUN
aiua-6073	97	18	of	of	ADP
aiua-6073	97	19	action	action	NOUN
aiua-6073	97	20	;	;	PUNCT
aiua-6073	97	21	therefore	therefore	ADV
aiua-6073	97	22	,	,	PUNCT
aiua-6073	97	23	their	their	PRON
aiua-6073	97	24	efficacy	efficacy	NOUN
aiua-6073	97	25	is	be	AUX
aiua-6073	97	26	substantially	substantially	ADV
aiua-6073	97	27	similar	similar	ADJ
aiua-6073	97	28	at	at	ADP
aiua-6073	97	29	comparable	comparable	ADJ
aiua-6073	97	30	doses	dose	NOUN
aiua-6073	97	31	.	.	PUNCT
aiua-6073	98	1	there	there	PRON
aiua-6073	98	2	are	be	VERB
aiua-6073	98	3	,	,	PUNCT
aiua-6073	98	4	however	however	ADV
aiua-6073	98	5	,	,	PUNCT
aiua-6073	98	6	relevant	relevant	ADJ
aiua-6073	98	7	differences	difference	NOUN
aiua-6073	98	8	in	in	ADP
aiua-6073	98	9	the	the	DET
aiua-6073	98	10	pharmacokinetic	pharmacokinetic	ADJ
aiua-6073	98	11	profile	profile	NOUN
aiua-6073	98	12	and	and	CCONJ
aiua-6073	98	13	degree	degree	NOUN
aiua-6073	98	14	of	of	ADP
aiua-6073	98	15	selectivity	selectivity	NOUN
aiua-6073	98	16	between	between	ADP
aiua-6073	98	17	different	different	ADJ
aiua-6073	98	18	agents	agent	NOUN
aiua-6073	98	19	,	,	PUNCT
aiua-6073	98	20	and	and	CCONJ
aiua-6073	98	21	this	this	PRON
aiua-6073	98	22	should	should	AUX
aiua-6073	98	23	be	be	AUX
aiua-6073	98	24	taken	take	VERB
aiua-6073	98	25	in	in	ADP
aiua-6073	98	26	account	account	NOUN
aiua-6073	98	27	in	in	ADP
aiua-6073	98	28	the	the	DET
aiua-6073	98	29	therapeutic	therapeutic	ADJ
aiua-6073	98	30	decision	decision	NOUN
aiua-6073	98	31	-	-	PUNCT
aiua-6073	98	32	making	make	VERB
aiua-6073	98	33	process	process	NOUN
aiua-6073	98	34	.	.	PUNCT
aiua-6073	99	1	the	the	DET
aiua-6073	99	2	high	high	ADJ
aiua-6073	99	3	selectivity	selectivity	NOUN
aiua-6073	99	4	of	of	ADP
aiua-6073	99	5	avanafil	avanafil	PROPN
aiua-6073	99	6	,	,	PUNCT
aiua-6073	99	7	in	in	ADP
aiua-6073	99	8	particular	particular	ADJ
aiua-6073	99	9	,	,	PUNCT
aiua-6073	99	10	gives	give	VERB
aiua-6073	99	11	this	this	DET
aiua-6073	99	12	agent	agent	NOUN
aiua-6073	99	13	a	a	DET
aiua-6073	99	14	very	very	ADV
aiua-6073	99	15	satisfactory	satisfactory	ADJ
aiua-6073	99	16	tolerability	tolerability	NOUN
aiua-6073	99	17	profile	profile	NOUN
aiua-6073	99	18	,	,	PUNCT
aiua-6073	99	19	as	as	SCONJ
aiua-6073	99	20	pointed	point	VERB
aiua-6073	99	21	out	out	ADP
aiua-6073	99	22	also	also	ADV
aiua-6073	99	23	by	by	ADP
aiua-6073	99	24	one	one	NUM
aiua-6073	99	25	of	of	ADP
aiua-6073	99	26	the	the	DET
aiua-6073	99	27	recommendations	recommendation	NOUN
aiua-6073	99	28	in	in	ADP
aiua-6073	99	29	this	this	DET
aiua-6073	99	30	paper	paper	NOUN
aiua-6073	99	31	,	,	PUNCT
aiua-6073	99	32	which	which	PRON
aiua-6073	99	33	suggests	suggest	VERB
aiua-6073	99	34	that	that	SCONJ
aiua-6073	99	35	good	good	ADJ
aiua-6073	99	36	tolerability	tolerability	NOUN
aiua-6073	99	37	is	be	AUX
aiua-6073	99	38	one	one	NUM
aiua-6073	99	39	of	of	ADP
aiua-6073	99	40	the	the	DET
aiua-6073	99	41	main	main	ADJ
aiua-6073	99	42	“	"	PUNCT
aiua-6073	99	43	strengths	strength	NOUN
aiua-6073	99	44	”	"	PUNCT
aiua-6073	99	45	of	of	ADP
aiua-6073	99	46	avanafil	avanafil	PROPN
aiua-6073	99	47	compared	compare	VERB
aiua-6073	99	48	to	to	ADP
aiua-6073	99	49	other	other	ADJ
aiua-6073	99	50	molecules	molecule	NOUN
aiua-6073	99	51	.	.	PUNCT
aiua-6073	100	1	the	the	DET
aiua-6073	100	2	prevailing	prevail	VERB
aiua-6073	100	3	opinion	opinion	NOUN
aiua-6073	100	4	among	among	ADP
aiua-6073	100	5	the	the	DET
aiua-6073	100	6	participants	participant	NOUN
aiua-6073	100	7	in	in	ADP
aiua-6073	100	8	this	this	DET
aiua-6073	100	9	survey	survey	NOUN
aiua-6073	100	10	is	be	AUX
aiua-6073	100	11	that	that	SCONJ
aiua-6073	100	12	,	,	PUNCT
aiua-6073	100	13	in	in	ADP
aiua-6073	100	14	patients	patient	NOUN
aiua-6073	100	15	who	who	PRON
aiua-6073	100	16	are	be	AUX
aiua-6073	100	17	candidates	candidate	NOUN
aiua-6073	100	18	for	for	ADP
aiua-6073	100	19	the	the	DET
aiua-6073	100	20	use	use	NOUN
aiua-6073	100	21	of	of	ADP
aiua-6073	100	22	avanafil	avanafil	PROPN
aiua-6073	100	23	,	,	PUNCT
aiua-6073	100	24	the	the	DET
aiua-6073	100	25	200	200	NUM
aiua-6073	100	26	-	-	PUNCT
aiua-6073	100	27	mg	mg	NOUN
aiua-6073	100	28	dose	dose	NOUN
aiua-6073	100	29	should	should	AUX
aiua-6073	100	30	be	be	AUX
aiua-6073	100	31	used	use	VERB
aiua-6073	100	32	from	from	ADP
aiua-6073	100	33	the	the	DET
aiua-6073	100	34	start	start	NOUN
aiua-6073	100	35	of	of	ADP
aiua-6073	100	36	the	the	DET
aiua-6073	100	37	treatment	treatment	NOUN
aiua-6073	100	38	;	;	PUNCT
aiua-6073	100	39	in	in	ADP
aiua-6073	100	40	fact	fact	NOUN
aiua-6073	100	41	,	,	PUNCT
aiua-6073	100	42	this	this	DET
aiua-6073	100	43	dose	dose	NOUN
aiua-6073	100	44	provides	provide	VERB
aiua-6073	100	45	an	an	DET
aiua-6073	100	46	appropriate	appropriate	ADJ
aiua-6073	100	47	balance	balance	NOUN
aiua-6073	100	48	between	between	ADP
aiua-6073	100	49	the	the	DET
aiua-6073	100	50	efficacy	efficacy	NOUN
aiua-6073	100	51	and	and	CCONJ
aiua-6073	100	52	tolerability	tolerability	NOUN
aiua-6073	100	53	of	of	ADP
aiua-6073	100	54	pde5is	pde5is	PROPN
aiua-6073	100	55	,	,	PUNCT
aiua-6073	100	56	in	in	ADP
aiua-6073	100	57	combination	combination	NOUN
aiua-6073	100	58	with	with	ADP
aiua-6073	100	59	satisfactory	satisfactory	ADJ
aiua-6073	100	60	response	response	NOUN
aiua-6073	100	61	and	and	CCONJ
aiua-6073	100	62	compliance	compliance	NOUN
aiua-6073	100	63	rates	rate	NOUN
aiua-6073	100	64	.	.	PUNCT
aiua-6073	101	1	according	accord	VERB
aiua-6073	101	2	to	to	ADP
aiua-6073	101	3	the	the	DET
aiua-6073	101	4	findings	finding	NOUN
aiua-6073	101	5	of	of	ADP
aiua-6073	101	6	this	this	DET
aiua-6073	101	7	survey	survey	NOUN
aiua-6073	101	8	,	,	PUNCT
aiua-6073	101	9	there	there	PRON
aiua-6073	101	10	seem	seem	VERB
aiua-6073	101	11	to	to	PART
aiua-6073	101	12	be	be	AUX
aiua-6073	101	13	no	no	DET
aiua-6073	101	14	significant	significant	ADJ
aiua-6073	101	15	differences	difference	NOUN
aiua-6073	101	16	in	in	ADP
aiua-6073	101	17	terms	term	NOUN
aiua-6073	101	18	of	of	ADP
aiua-6073	101	19	efficacy	efficacy	NOUN
aiua-6073	101	20	between	between	ADP
aiua-6073	101	21	avanafil	avanafil	PROPN
aiua-6073	101	22	,	,	PUNCT
aiua-6073	101	23	sildenafil	sildenafil	NOUN
aiua-6073	101	24	,	,	PUNCT
aiua-6073	101	25	tadalafil	tadalafil	NOUN
aiua-6073	101	26	,	,	PUNCT
aiua-6073	101	27	and	and	CCONJ
aiua-6073	101	28	vardenafil	vardenafil	NOUN
aiua-6073	101	29	when	when	SCONJ
aiua-6073	101	30	the	the	DET
aiua-6073	101	31	maximum	maximum	ADJ
aiua-6073	101	32	recommended	recommend	VERB
aiua-6073	101	33	doses	dose	NOUN
aiua-6073	101	34	of	of	ADP
aiua-6073	101	35	these	these	DET
aiua-6073	101	36	drugs	drug	NOUN
aiua-6073	101	37	are	be	AUX
aiua-6073	101	38	used	use	VERB
aiua-6073	101	39	(	(	PUNCT
aiua-6073	101	40	200	200	NUM
aiua-6073	101	41	,	,	PUNCT
aiua-6073	101	42	100	100	NUM
aiua-6073	101	43	,	,	PUNCT
aiua-6073	101	44	20	20	NUM
aiua-6073	101	45	,	,	PUNCT
aiua-6073	101	46	and	and	CCONJ
aiua-6073	101	47	20	20	NUM
aiua-6073	101	48	mg	mg	NUM
aiua-6073	101	49	,	,	PUNCT
aiua-6073	101	50	respectively	respectively	ADV
aiua-6073	101	51	)	)	PUNCT
aiua-6073	101	52	;	;	PUNCT
aiua-6073	101	53	moreover	moreover	ADV
aiua-6073	101	54	,	,	PUNCT
aiua-6073	101	55	avanafil	avanafil	PROPN
aiua-6073	101	56	shows	show	VERB
aiua-6073	101	57	a	a	DET
aiua-6073	101	58	favourable	favourable	ADJ
aiua-6073	101	59	tolerability	tolerability	NOUN
aiua-6073	101	60	profile	profile	NOUN
aiua-6073	101	61	when	when	SCONJ
aiua-6073	101	62	used	use	VERB
aiua-6073	101	63	at	at	ADP
aiua-6073	101	64	the	the	DET
aiua-6073	101	65	highest	high	ADJ
aiua-6073	101	66	dose	dose	NOUN
aiua-6073	101	67	(	(	PUNCT
aiua-6073	101	68	200	200	NUM
aiua-6073	101	69	mg	mg	NOUN
aiua-6073	101	70	)	)	PUNCT
aiua-6073	101	71	,	,	PUNCT
aiua-6073	101	72	with	with	ADP
aiua-6073	101	73	an	an	DET
aiua-6073	101	74	efficacy	efficacy	NOUN
aiua-6073	101	75	similar	similar	ADJ
aiua-6073	101	76	to	to	ADP
aiua-6073	101	77	that	that	PRON
aiua-6073	101	78	of	of	ADP
aiua-6073	101	79	other	other	ADJ
aiua-6073	101	80	agents	agent	NOUN
aiua-6073	101	81	.	.	PUNCT
aiua-6073	102	1	a	a	DET
aiua-6073	102	2	crucial	crucial	ADJ
aiua-6073	102	3	point	point	NOUN
aiua-6073	102	4	for	for	ADP
aiua-6073	102	5	the	the	DET
aiua-6073	102	6	successful	successful	ADJ
aiua-6073	102	7	treatment	treatment	NOUN
aiua-6073	102	8	of	of	ADP
aiua-6073	102	9	ed	ed	NOUN
aiua-6073	102	10	with	with	ADP
aiua-6073	102	11	pde5is	pde5is	PROPN
aiua-6073	102	12	is	be	AUX
aiua-6073	102	13	the	the	DET
aiua-6073	102	14	effectiveness	effectiveness	NOUN
aiua-6073	102	15	of	of	ADP
aiua-6073	102	16	doctor	doctor	NOUN
aiua-6073	102	17	-	-	PUNCT
aiua-6073	102	18	patient	patient	NOUN
aiua-6073	102	19	communication	communication	NOUN
aiua-6073	102	20	in	in	ADP
aiua-6073	102	21	relation	relation	NOUN
aiua-6073	102	22	to	to	ADP
aiua-6073	102	23	the	the	DET
aiua-6073	102	24	proper	proper	ADJ
aiua-6073	102	25	administration	administration	NOUN
aiua-6073	102	26	of	of	ADP
aiua-6073	102	27	prescribed	prescribed	ADJ
aiua-6073	102	28	medications	medication	NOUN
aiua-6073	102	29	and	and	CCONJ
aiua-6073	102	30	the	the	DET
aiua-6073	102	31	outcomes	outcome	NOUN
aiua-6073	102	32	to	to	PART
aiua-6073	102	33	be	be	AUX
aiua-6073	102	34	expected	expect	VERB
aiua-6073	102	35	,	,	PUNCT
aiua-6073	102	36	both	both	CCONJ
aiua-6073	102	37	in	in	ADP
aiua-6073	102	38	terms	term	NOUN
aiua-6073	102	39	of	of	ADP
aiua-6073	102	40	efficacy	efficacy	NOUN
aiua-6073	102	41	and	and	CCONJ
aiua-6073	102	42	response	response	NOUN
aiua-6073	102	43	times	time	NOUN
aiua-6073	102	44	.	.	PUNCT
aiua-6073	103	1	in	in	ADP
aiua-6073	103	2	fact	fact	NOUN
aiua-6073	103	3	,	,	PUNCT
aiua-6073	103	4	if	if	SCONJ
aiua-6073	103	5	these	these	DET
aiua-6073	103	6	issues	issue	NOUN
aiua-6073	103	7	are	be	AUX
aiua-6073	103	8	not	not	PART
aiua-6073	103	9	adequately	adequately	ADV
aiua-6073	103	10	explained	explain	VERB
aiua-6073	103	11	to	to	ADP
aiua-6073	103	12	the	the	DET
aiua-6073	103	13	patients	patient	NOUN
aiua-6073	103	14	,	,	PUNCT
aiua-6073	103	15	they	they	PRON
aiua-6073	103	16	may	may	AUX
aiua-6073	103	17	mistakenly	mistakenly	ADV
aiua-6073	103	18	believe	believe	VERB
aiua-6073	103	19	that	that	SCONJ
aiua-6073	103	20	the	the	DET
aiua-6073	103	21	treatment	treatment	NOUN
aiua-6073	103	22	prescribed	prescribe	VERB
aiua-6073	103	23	is	be	AUX
aiua-6073	103	24	ineffective	ineffective	ADJ
aiua-6073	103	25	and/or	and/or	CCONJ
aiua-6073	103	26	may	may	AUX
aiua-6073	103	27	inappropriately	inappropriately	ADV
aiua-6073	103	28	stop	stop	VERB
aiua-6073	103	29	or	or	CCONJ
aiua-6073	103	30	change	change	VERB
aiua-6073	103	31	their	their	PRON
aiua-6073	103	32	medications	medication	NOUN
aiua-6073	103	33	on	on	ADP
aiua-6073	103	34	their	their	PRON
aiua-6073	103	35	own	own	ADJ
aiua-6073	103	36	initiative	initiative	NOUN
aiua-6073	103	37	.	.	PUNCT
aiua-6073	104	1	in	in	ADP
aiua-6073	104	2	particular	particular	ADJ
aiua-6073	104	3	,	,	PUNCT
aiua-6073	104	4	the	the	DET
aiua-6073	104	5	patient	patient	NOUN
aiua-6073	104	6	should	should	AUX
aiua-6073	104	7	be	be	AUX
aiua-6073	104	8	instructed	instruct	VERB
aiua-6073	104	9	to	to	PART
aiua-6073	104	10	take	take	VERB
aiua-6073	104	11	avanafil	avanafil	NOUN
aiua-6073	104	12	on	on	ADP
aiua-6073	104	13	an	an	DET
aiua-6073	104	14	empty	empty	ADJ
aiua-6073	104	15	stomach	stomach	NOUN
aiua-6073	104	16	,	,	PUNCT
aiua-6073	104	17	i.e.	i.e.	X
aiua-6073	104	18	,	,	PUNCT
aiua-6073	104	19	30	30	NUM
aiua-6073	104	20	-	-	SYM
aiua-6073	104	21	45	45	NUM
aiua-6073	104	22	minutes	minute	NOUN
aiua-6073	104	23	before	before	ADP
aiua-6073	104	24	or	or	CCONJ
aiua-6073	104	25	2	2	NUM
aiua-6073	104	26	hours	hour	NOUN
aiua-6073	104	27	after	after	ADP
aiua-6073	104	28	a	a	DET
aiua-6073	104	29	meal	meal	NOUN
aiua-6073	104	30	,	,	PUNCT
aiua-6073	104	31	in	in	ADP
aiua-6073	104	32	order	order	NOUN
aiua-6073	104	33	to	to	PART
aiua-6073	104	34	obtain	obtain	VERB
aiua-6073	104	35	an	an	DET
aiua-6073	104	36	optimal	optimal	ADJ
aiua-6073	104	37	therapeutic	therapeutic	ADJ
aiua-6073	104	38	effect	effect	NOUN
aiua-6073	104	39	;	;	PUNCT
aiua-6073	104	40	it	it	PRON
aiua-6073	104	41	is	be	AUX
aiua-6073	104	42	also	also	ADV
aiua-6073	104	43	necessary	necessary	ADJ
aiua-6073	104	44	to	to	PART
aiua-6073	104	45	explain	explain	VERB
aiua-6073	104	46	that	that	SCONJ
aiua-6073	104	47	the	the	DET
aiua-6073	104	48	efficacy	efficacy	NOUN
aiua-6073	104	49	window	window	NOUN
aiua-6073	104	50	of	of	ADP
aiua-6073	104	51	avanafil	avanafil	PROPN
aiua-6073	104	52	is	be	AUX
aiua-6073	104	53	between	between	ADP
aiua-6073	104	54	30	30	NUM
aiua-6073	104	55	minutes	minute	NOUN
aiua-6073	104	56	and	and	CCONJ
aiua-6073	104	57	6	6	NUM
aiua-6073	104	58	hours	hour	NOUN
aiua-6073	104	59	after	after	ADP
aiua-6073	104	60	dosing	dose	VERB
aiua-6073	104	61	,	,	PUNCT
aiua-6073	104	62	which	which	PRON
aiua-6073	104	63	qualifies	qualify	VERB
aiua-6073	104	64	this	this	DET
aiua-6073	104	65	new	new	ADJ
aiua-6073	104	66	pde5i	pde5i	PROPN
aiua-6073	104	67	as	as	ADP
aiua-6073	104	68	an	an	DET
aiua-6073	104	69	agent	agent	NOUN
aiua-6073	104	70	with	with	ADP
aiua-6073	104	71	intermediate	intermediate	ADJ
aiua-6073	104	72	duration	duration	NOUN
aiua-6073	104	73	of	of	ADP
aiua-6073	104	74	action	action	NOUN
aiua-6073	104	75	.	.	PUNCT
aiua-6073	105	1	finally	finally	ADV
aiua-6073	105	2	,	,	PUNCT
aiua-6073	105	3	a	a	DET
aiua-6073	105	4	topic	topic	NOUN
aiua-6073	105	5	of	of	ADP
aiua-6073	105	6	great	great	ADJ
aiua-6073	105	7	interest	interest	NOUN
aiua-6073	105	8	that	that	PRON
aiua-6073	105	9	has	have	AUX
aiua-6073	105	10	emerged	emerge	VERB
aiua-6073	105	11	from	from	ADP
aiua-6073	105	12	this	this	DET
aiua-6073	105	13	survey	survey	NOUN
aiua-6073	105	14	is	be	AUX
aiua-6073	105	15	that	that	SCONJ
aiua-6073	105	16	avanafil	avanafil	PROPN
aiua-6073	105	17	,	,	PUNCT
aiua-6073	105	18	used	use	VERB
aiua-6073	105	19	at	at	ADP
aiua-6073	105	20	a	a	DET
aiua-6073	105	21	dose	dose	NOUN
aiua-6073	105	22	of	of	ADP
aiua-6073	105	23	50	50	NUM
aiua-6073	105	24	-	-	SYM
aiua-6073	105	25	100	100	NUM
aiua-6073	105	26	mg	mg	NUM
aiua-6073	105	27	/	/	SYM
aiua-6073	105	28	day	day	NOUN
aiua-6073	105	29	,	,	PUNCT
aiua-6073	105	30	can	can	AUX
aiua-6073	105	31	be	be	AUX
aiua-6073	105	32	a	a	DET
aiua-6073	105	33	therapeutic	therapeutic	ADJ
aiua-6073	105	34	option	option	NOUN
aiua-6073	105	35	for	for	ADP
aiua-6073	105	36	long	long	ADJ
aiua-6073	105	37	-	-	PUNCT
aiua-6073	105	38	term	term	NOUN
aiua-6073	105	39	penile	penile	ADJ
aiua-6073	105	40	rehabilitation	rehabilitation	NOUN
aiua-6073	105	41	,	,	PUNCT
aiua-6073	105	42	confirming	confirm	VERB
aiua-6073	105	43	the	the	DET
aiua-6073	105	44	literature	literature	NOUN
aiua-6073	105	45	data	datum	NOUN
aiua-6073	105	46	that	that	PRON
aiua-6073	105	47	support	support	VERB
aiua-6073	105	48	the	the	DET
aiua-6073	105	49	use	use	NOUN
aiua-6073	105	50	of	of	ADP
aiua-6073	105	51	pde5	pde5	NOUN
aiua-6073	105	52	-	-	PUNCT
aiua-6073	105	53	inhibitors	inhibitor	NOUN
aiua-6073	105	54	as	as	ADP
aiua-6073	105	55	on	on	ADP
aiua-6073	105	56	-	-	PUNCT
aiua-6073	105	57	demand	demand	NOUN
aiua-6073	105	58	or	or	CCONJ
aiua-6073	105	59	chronic	chronic	ADJ
aiua-6073	105	60	treatment	treatment	NOUN
aiua-6073	105	61	for	for	ADP
aiua-6073	105	62	penile	penile	ADJ
aiua-6073	105	63	rehabilitation	rehabilitation	NOUN
aiua-6073	105	64	after	after	ADP
aiua-6073	105	65	radical	radical	ADJ
aiua-6073	105	66	prostatectomy	prostatectomy	NOUN
aiua-6073	105	67	(	(	PUNCT
aiua-6073	105	68	20	20	NUM
aiua-6073	105	69	)	)	PUNCT
aiua-6073	105	70	.	.	PUNCT
aiua-6073	106	1	conclusions	conclusion	NOUN
aiua-6073	106	2	avanafil	avanafil	PROPN
aiua-6073	106	3	,	,	PUNCT
aiua-6073	106	4	a	a	DET
aiua-6073	106	5	highly	highly	ADV
aiua-6073	106	6	selective	selective	ADJ
aiua-6073	106	7	pde5	pde5	NOUN
aiua-6073	106	8	inhibitor	inhibitor	NOUN
aiua-6073	106	9	,	,	PUNCT
aiua-6073	106	10	characterized	characterize	VERB
aiua-6073	106	11	by	by	ADP
aiua-6073	106	12	rapid	rapid	ADJ
aiua-6073	106	13	onset	onset	NOUN
aiua-6073	106	14	of	of	ADP
aiua-6073	106	15	action	action	NOUN
aiua-6073	106	16	and	and	CCONJ
aiua-6073	106	17	prolonged	prolonged	ADJ
aiua-6073	106	18	therapeutic	therapeutic	ADJ
aiua-6073	106	19	effect	effect	NOUN
aiua-6073	106	20	,	,	PUNCT
aiua-6073	106	21	is	be	AUX
aiua-6073	106	22	an	an	DET
aiua-6073	106	23	effective	effective	ADJ
aiua-6073	106	24	and	and	CCONJ
aiua-6073	106	25	well	well	ADV
aiua-6073	106	26	tolerated	tolerate	VERB
aiua-6073	106	27	option	option	NOUN
aiua-6073	106	28	for	for	ADP
aiua-6073	106	29	the	the	DET
aiua-6073	106	30	treatment	treatment	NOUN
aiua-6073	106	31	of	of	ADP
aiua-6073	106	32	ed	ed	NOUN
aiua-6073	106	33	.	.	PUNCT
aiua-6073	107	1	the	the	DET
aiua-6073	107	2	present	present	ADJ
aiua-6073	107	3	survey	survey	NOUN
aiua-6073	107	4	,	,	PUNCT
aiua-6073	107	5	conducted	conduct	VERB
aiua-6073	107	6	by	by	ADP
aiua-6073	107	7	siu	siu	NOUN
aiua-6073	107	8	among	among	ADP
aiua-6073	107	9	italian	italian	ADJ
aiua-6073	107	10	urologists	urologist	NOUN
aiua-6073	107	11	,	,	PUNCT
aiua-6073	107	12	largely	largely	ADV
aiua-6073	107	13	confirms	confirm	VERB
aiua-6073	107	14	the	the	DET
aiua-6073	107	15	clinical	clinical	ADJ
aiua-6073	107	16	efficacy	efficacy	NOUN
aiua-6073	107	17	and	and	CCONJ
aiua-6073	107	18	tolerability	tolerability	NOUN
aiua-6073	107	19	of	of	ADP
aiua-6073	107	20	avanafil	avanafil	PROPN
aiua-6073	107	21	in	in	ADP
aiua-6073	107	22	a	a	DET
aiua-6073	107	23	real	real	ADJ
aiua-6073	107	24	-	-	PUNCT
aiua-6073	107	25	life	life	NOUN
aiua-6073	107	26	setting	setting	NOUN
aiua-6073	107	27	,	,	PUNCT
aiua-6073	107	28	even	even	ADV
aiua-6073	107	29	at	at	ADP
aiua-6073	107	30	the	the	DET
aiua-6073	107	31	highest	high	ADJ
aiua-6073	107	32	dose	dose	NOUN
aiua-6073	107	33	(	(	PUNCT
aiua-6073	107	34	200	200	NUM
aiua-6073	107	35	mg	mg	NOUN
aiua-6073	107	36	)	)	PUNCT
aiua-6073	107	37	,	,	PUNCT
aiua-6073	107	38	in	in	ADP
aiua-6073	107	39	line	line	NOUN
aiua-6073	107	40	with	with	ADP
aiua-6073	107	41	the	the	DET
aiua-6073	107	42	results	result	NOUN
aiua-6073	107	43	of	of	ADP
aiua-6073	107	44	previous	previous	ADJ
aiua-6073	107	45	international	international	ADJ
aiua-6073	107	46	clinical	clinical	ADJ
aiua-6073	107	47	trials	trial	NOUN
aiua-6073	107	48	conducted	conduct	VERB
aiua-6073	107	49	to	to	PART
aiua-6073	107	50	evaluate	evaluate	VERB
aiua-6073	107	51	this	this	DET
aiua-6073	107	52	pde5	pde5	NOUN
aiua-6073	107	53	inhibitor	inhibitor	NOUN
aiua-6073	107	54	.	.	PUNCT
aiua-6073	108	1	references	reference	NOUN
aiua-6073	108	2	1	1	NUM
aiua-6073	108	3	.	.	PUNCT
aiua-6073	109	1	hatzimouratidis	hatzimouratidis	PROPN
aiua-6073	109	2	k	k	PROPN
aiua-6073	109	3	,	,	PUNCT
aiua-6073	109	4	eardley	eardley	PROPN
aiua-6073	109	5	i	i	PRON
aiua-6073	109	6	,	,	PUNCT
aiua-6073	109	7	giuliano	giuliano	PROPN
aiua-6073	109	8	f	f	PROPN
aiua-6073	109	9	,	,	PUNCT
aiua-6073	109	10	et	et	PROPN
aiua-6073	109	11	al	al	PROPN
aiua-6073	109	12	.	.	PUNCT
aiua-6073	109	13	guidelines	guideline	NOUN
aiua-6073	109	14	on	on	ADP
aiua-6073	109	15	male	male	ADJ
aiua-6073	109	16	sexual	sexual	ADJ
aiua-6073	109	17	dysfunction	dysfunction	NOUN
aiua-6073	109	18	:	:	PUNCT
aiua-6073	109	19	erectile	erectile	ADJ
aiua-6073	109	20	dysfunction	dysfunction	NOUN
aiua-6073	109	21	and	and	CCONJ
aiua-6073	109	22	premature	premature	ADJ
aiua-6073	109	23	ejaculation	ejaculation	NOUN
aiua-6073	109	24	.	.	PUNCT
aiua-6073	110	1	european	european	PROPN
aiua-6073	110	2	association	association	PROPN
aiua-6073	110	3	of	of	ADP
aiua-6073	110	4	urology	urology	NOUN
aiua-6073	110	5	web	web	NOUN
aiua-6073	110	6	site	site	NOUN
aiua-6073	110	7	.	.	PUNCT
aiua-6073	111	1	http://uroweb.org/guideline/male-sexual-dysfunction/.	http://uroweb.org/guideline/male-sexual-dysfunction/.	PROPN
aiua-6073	111	2	updated	update	VERB
aiua-6073	111	3	2015	2015	NUM
aiua-6073	111	4	.	.	PUNCT
aiua-6073	112	1	2	2	X
aiua-6073	112	2	.	.	X
aiua-6073	112	3	ali	ali	PROPN
aiua-6073	112	4	w	w	PROPN
aiua-6073	112	5	,	,	PUNCT
aiua-6073	112	6	besarani	besarani	ADJ
aiua-6073	112	7	d	d	PROPN
aiua-6073	112	8	,	,	PUNCT
aiua-6073	112	9	kirby	kirby	PROPN
aiua-6073	112	10	r.	r.	PROPN
aiua-6073	112	11	modern	modern	ADJ
aiua-6073	112	12	treatment	treatment	NOUN
aiua-6073	112	13	of	of	ADP
aiua-6073	112	14	erectile	erectile	ADJ
aiua-6073	112	15	dysfunction	dysfunction	NOUN
aiua-6073	112	16	.	.	PUNCT
aiua-6073	113	1	br	br	PROPN
aiua-6073	113	2	j	j	PROPN
aiua-6073	113	3	diabetes	diabetes	PROPN
aiua-6073	113	4	vasc	vasc	ADP
aiua-6073	113	5	dis	dis	PROPN
aiua-6073	113	6	.	.	PUNCT
aiua-6073	113	7	2002	2002	NUM
aiua-6073	113	8	;	;	PUNCT
aiua-6073	113	9	2:255	2:255	NUM
aiua-6073	113	10	.	.	NOUN
aiua-6073	114	1	3	3	NUM
aiua-6073	114	2	.	.	X
aiua-6073	114	3	limin	limin	PROPN
aiua-6073	114	4	m	m	PROPN
aiua-6073	114	5	,	,	PUNCT
aiua-6073	114	6	johnsen	johnsen	PROPN
aiua-6073	114	7	n	n	CCONJ
aiua-6073	114	8	,	,	PUNCT
aiua-6073	114	9	hellstrom	hellstrom	ADP
aiua-6073	114	10	wj	wj	PROPN
aiua-6073	114	11	.	.	PUNCT
aiua-6073	114	12	avanafil	avanafil	PROPN
aiua-6073	114	13	,	,	PUNCT
aiua-6073	114	14	a	a	DET
aiua-6073	114	15	new	new	ADJ
aiua-6073	114	16	rapid	rapid	ADJ
aiua-6073	114	17	-	-	PUNCT
aiua-6073	114	18	onset	onset	NOUN
aiua-6073	114	19	phosphodiesterase	phosphodiesterase	NOUN
aiua-6073	114	20	5	5	NUM
aiua-6073	114	21	inhibitor	inhibitor	NOUN
aiua-6073	114	22	for	for	ADP
aiua-6073	114	23	the	the	DET
aiua-6073	114	24	treatment	treatment	NOUN
aiua-6073	114	25	of	of	ADP
aiua-6073	114	26	erectile	erectile	ADJ
aiua-6073	114	27	dysfunction	dysfunction	NOUN
aiua-6073	114	28	.	.	PUNCT
aiua-6073	115	1	expert	expert	NOUN
aiua-6073	115	2	opin	opin	NOUN
aiua-6073	115	3	investig	investig	NOUN
aiua-6073	115	4	drugs	drug	NOUN
aiua-6073	115	5	.	.	PUNCT
aiua-6073	116	1	2010	2010	NUM
aiua-6073	116	2	;	;	PUNCT
aiua-6073	116	3	19:1427	19:1427	X
aiua-6073	116	4	.	.	NOUN
aiua-6073	116	5	4	4	NUM
aiua-6073	116	6	.	.	NOUN
aiua-6073	116	7	bruzziches	bruzziche	VERB
aiua-6073	116	8	r	r	VERB
aiua-6073	116	9	,	,	PUNCT
aiua-6073	116	10	francomano	francomano	NOUN
aiua-6073	116	11	d	d	NOUN
aiua-6073	116	12	,	,	PUNCT
aiua-6073	116	13	gareri	gareri	NOUN
aiua-6073	116	14	p	p	NOUN
aiua-6073	116	15	,	,	PUNCT
aiua-6073	116	16	et	et	PROPN
aiua-6073	116	17	al	al	PROPN
aiua-6073	116	18	.	.	PUNCT
aiua-6073	117	1	an	an	DET
aiua-6073	117	2	update	update	NOUN
aiua-6073	117	3	on	on	ADP
aiua-6073	117	4	pharmacological	pharmacological	ADJ
aiua-6073	117	5	treatment	treatment	NOUN
aiua-6073	117	6	of	of	ADP
aiua-6073	117	7	erectile	erectile	ADJ
aiua-6073	117	8	dysfunction	dysfunction	NOUN
aiua-6073	117	9	with	with	ADP
aiua-6073	117	10	phosphodiesterase	phosphodiesterase	NOUN
aiua-6073	117	11	type	type	NOUN
aiua-6073	117	12	5	5	NUM
aiua-6073	117	13	inhibitors	inhibitor	NOUN
aiua-6073	117	14	.	.	PUNCT
aiua-6073	118	1	expert	expert	NOUN
aiua-6073	118	2	opin	opin	NOUN
aiua-6073	118	3	pharmacother	pharmacother	NOUN
aiua-6073	118	4	.	.	PUNCT
aiua-6073	119	1	2013	2013	NUM
aiua-6073	119	2	;	;	PUNCT
aiua-6073	119	3	14:1333	14:1333	NUM
aiua-6073	119	4	.	.	NOUN
aiua-6073	120	1	5	5	X
aiua-6073	120	2	.	.	X
aiua-6073	120	3	gupta	gupta	PROPN
aiua-6073	120	4	r	r	PROPN
aiua-6073	120	5	,	,	PUNCT
aiua-6073	120	6	kumar	kumar	PROPN
aiua-6073	120	7	g	g	PROPN
aiua-6073	120	8	,	,	PUNCT
aiua-6073	120	9	kumar	kumar	PROPN
aiua-6073	120	10	rs	rs	PROPN
aiua-6073	120	11	.	.	PUNCT
aiua-6073	121	1	an	an	DET
aiua-6073	121	2	update	update	NOUN
aiua-6073	121	3	on	on	ADP
aiua-6073	121	4	cyclic	cyclic	ADJ
aiua-6073	121	5	nucleotide	nucleotide	NOUN
aiua-6073	121	6	phosphodiesterase	phosphodiesterase	NOUN
aiua-6073	121	7	(	(	PUNCT
aiua-6073	121	8	pde	pde	NOUN
aiua-6073	121	9	)	)	PUNCT
aiua-6073	121	10	inhibitors	inhibitor	NOUN
aiua-6073	121	11	:	:	PUNCT
aiua-6073	121	12	phosphodiesterases	phosphodiesterase	NOUN
aiua-6073	121	13	and	and	CCONJ
aiua-6073	121	14	drug	drug	NOUN
aiua-6073	121	15	selectivity	selectivity	NOUN
aiua-6073	121	16	.	.	PUNCT
aiua-6073	122	1	methods	method	NOUN
aiua-6073	122	2	find	find	VERB
aiua-6073	122	3	exp	exp	NOUN
aiua-6073	122	4	clin	clin	PROPN
aiua-6073	122	5	pharmacol	pharmacol	PROPN
aiua-6073	122	6	.	.	PUNCT
aiua-6073	123	1	2005	2005	NUM
aiua-6073	123	2	;	;	PUNCT
aiua-6073	123	3	27:101	27:101	NUM
aiua-6073	123	4	.	.	PUNCT
aiua-6073	124	1	6	6	NUM
aiua-6073	124	2	.	.	X
aiua-6073	124	3	omori	omori	PROPN
aiua-6073	124	4	k	k	PROPN
aiua-6073	124	5	,	,	PUNCT
aiua-6073	124	6	kotera	kotera	PROPN
aiua-6073	124	7	j.	j.	PROPN
aiua-6073	124	8	overview	overview	PROPN
aiua-6073	124	9	of	of	ADP
aiua-6073	124	10	pdes	pde	NOUN
aiua-6073	124	11	and	and	CCONJ
aiua-6073	124	12	their	their	PRON
aiua-6073	124	13	regulation	regulation	NOUN
aiua-6073	124	14	.	.	PUNCT
aiua-6073	125	1	circ	circ	PROPN
aiua-6073	125	2	res	re	NOUN
aiua-6073	125	3	.	.	PUNCT
aiua-6073	125	4	2007	2007	NUM
aiua-6073	125	5	;	;	PUNCT
aiua-6073	125	6	100:309	100:309	NOUN
aiua-6073	125	7	.	.	PUNCT
aiua-6073	126	1	7	7	X
aiua-6073	126	2	.	.	X
aiua-6073	126	3	goldstein	goldstein	PROPN
aiua-6073	126	4	i	i	PROPN
aiua-6073	126	5	,	,	PUNCT
aiua-6073	126	6	mccullough	mccullough	PROPN
aiua-6073	126	7	ar	ar	PROPN
aiua-6073	126	8	,	,	PUNCT
aiua-6073	126	9	jones	jones	PROPN
aiua-6073	126	10	la	la	PROPN
aiua-6073	126	11	,	,	PUNCT
aiua-6073	126	12	et	et	PROPN
aiua-6073	126	13	al	al	PROPN
aiua-6073	126	14	.	.	PUNCT
aiua-6073	127	1	a	a	DET
aiua-6073	127	2	randomized	randomized	ADJ
aiua-6073	127	3	,	,	PUNCT
aiua-6073	127	4	double	double	ADJ
aiua-6073	127	5	-	-	PUNCT
aiua-6073	127	6	blind	blind	ADJ
aiua-6073	127	7	,	,	PUNCT
aiua-6073	127	8	placebo	placebo	NOUN
aiua-6073	127	9	-	-	PUNCT
aiua-6073	127	10	controlled	control	VERB
aiua-6073	127	11	evaluation	evaluation	NOUN
aiua-6073	127	12	of	of	ADP
aiua-6073	127	13	the	the	DET
aiua-6073	127	14	safety	safety	NOUN
aiua-6073	127	15	and	and	CCONJ
aiua-6073	127	16	efficacy	efficacy	NOUN
aiua-6073	127	17	of	of	ADP
aiua-6073	127	18	avanafil	avanafil	PROPN
aiua-6073	127	19	in	in	ADP
aiua-6073	127	20	subjects	subject	NOUN
aiua-6073	127	21	with	with	ADP
aiua-6073	127	22	erectile	erectile	ADJ
aiua-6073	127	23	dysfunction	dysfunction	NOUN
aiua-6073	127	24	.	.	PUNCT
aiua-6073	128	1	j	j	PROPN
aiua-6073	128	2	sex	sex	PROPN
aiua-6073	128	3	med	med	PROPN
aiua-6073	128	4	.	.	PUNCT
aiua-6073	128	5	2012	2012	NUM
aiua-6073	128	6	;	;	PUNCT
aiua-6073	128	7	9:1122	9:1122	NUM
aiua-6073	128	8	.	.	NOUN
aiua-6073	128	9	8	8	NUM
aiua-6073	128	10	.	.	X
aiua-6073	129	1	goldstein	goldstein	PROPN
aiua-6073	129	2	i	i	PROPN
aiua-6073	129	3	,	,	PUNCT
aiua-6073	129	4	jones	jones	PROPN
aiua-6073	129	5	la	la	PROPN
aiua-6073	129	6	,	,	PUNCT
aiua-6073	129	7	belkoff	belkoff	PROPN
aiua-6073	129	8	lh	lh	PROPN
aiua-6073	129	9	,	,	PUNCT
aiua-6073	129	10	et	et	PROPN
aiua-6073	129	11	al	al	PROPN
aiua-6073	129	12	.	.	PROPN
aiua-6073	129	13	avanafil	avanafil	PROPN
aiua-6073	129	14	for	for	ADP
aiua-6073	129	15	the	the	DET
aiua-6073	129	16	treatment	treatment	NOUN
aiua-6073	129	17	of	of	ADP
aiua-6073	129	18	erectile	erectile	ADJ
aiua-6073	129	19	dysfunction	dysfunction	NOUN
aiua-6073	129	20	:	:	PUNCT
aiua-6073	129	21	a	a	DET
aiua-6073	129	22	multicenter	multicenter	NOUN
aiua-6073	129	23	,	,	PUNCT
aiua-6073	129	24	randomized	randomize	VERB
aiua-6073	129	25	,	,	PUNCT
aiua-6073	129	26	double	double	ADJ
aiua-6073	129	27	-	-	PUNCT
aiua-6073	129	28	blind	blind	ADJ
aiua-6073	129	29	study	study	NOUN
aiua-6073	129	30	in	in	ADP
aiua-6073	129	31	men	man	NOUN
aiua-6073	129	32	with	with	ADP
aiua-6073	129	33	diabetes	diabetes	NOUN
aiua-6073	129	34	mellitus	mellitus	NOUN
aiua-6073	129	35	.	.	PUNCT
aiua-6073	130	1	mayo	mayo	PROPN
aiua-6073	130	2	clin	clin	PROPN
aiua-6073	130	3	proc	proc	PROPN
aiua-6073	130	4	.	.	PUNCT
aiua-6073	131	1	2012	2012	NUM
aiua-6073	131	2	;	;	PUNCT
aiua-6073	131	3	87:843	87:843	NUM
aiua-6073	131	4	.	.	PUNCT
aiua-6073	132	1	9	9	X
aiua-6073	132	2	.	.	X
aiua-6073	132	3	mulhall	mulhall	NOUN
aiua-6073	132	4	jp	jp	PROPN
aiua-6073	132	5	,	,	PUNCT
aiua-6073	132	6	burnett	burnett	PROPN
aiua-6073	132	7	al	al	PROPN
aiua-6073	132	8	,	,	PUNCT
aiua-6073	132	9	wang	wang	PROPN
aiua-6073	132	10	r	r	PROPN
aiua-6073	132	11	,	,	PUNCT
aiua-6073	132	12	et	et	PROPN
aiua-6073	132	13	al	al	PROPN
aiua-6073	132	14	.	.	PUNCT
aiua-6073	133	1	a	a	DET
aiua-6073	133	2	phase	phase	NOUN
aiua-6073	133	3	3	3	NUM
aiua-6073	133	4	,	,	PUNCT
aiua-6073	133	5	placebo	placebo	NOUN
aiua-6073	133	6	controlled	control	VERB
aiua-6073	133	7	study	study	NOUN
aiua-6073	133	8	of	of	ADP
aiua-6073	133	9	the	the	DET
aiua-6073	133	10	safety	safety	NOUN
aiua-6073	133	11	and	and	CCONJ
aiua-6073	133	12	efficacy	efficacy	NOUN
aiua-6073	133	13	of	of	ADP
aiua-6073	133	14	avanafil	avanafil	PROPN
aiua-6073	133	15	for	for	ADP
aiua-6073	133	16	the	the	DET
aiua-6073	133	17	treatment	treatment	NOUN
aiua-6073	133	18	of	of	ADP
aiua-6073	133	19	erectile	erectile	ADJ
aiua-6073	133	20	dysfunction	dysfunction	NOUN
aiua-6073	133	21	after	after	ADP
aiua-6073	133	22	nerve	nerve	NOUN
aiua-6073	133	23	sparing	spare	VERB
aiua-6073	133	24	radical	radical	ADJ
aiua-6073	133	25	prostatectomy	prostatectomy	NOUN
aiua-6073	133	26	.	.	PUNCT
aiua-6073	134	1	j	j	PROPN
aiua-6073	134	2	urol	urol	PROPN
aiua-6073	134	3	.	.	PUNCT
aiua-6073	134	4	2012	2012	NUM
aiua-6073	134	5	;	;	PUNCT
aiua-6073	134	6	189:2229	189:2229	X
aiua-6073	134	7	.	.	PUNCT
aiua-6073	135	1	mirone_stesura	mirone_stesura	NOUN
aiua-6073	135	2	seveso	seveso	VERB
aiua-6073	135	3	01/07/16	01/07/16	PROPN
aiua-6073	135	4	11:08	11:08	NUM
aiua-6073	135	5	pagina	pagina	NOUN
aiua-6073	135	6	131	131	NUM
aiua-6073	135	7	archivio	archivio	NOUN
aiua-6073	135	8	italiano	italiano	X
aiua-6073	135	9	di	di	X
aiua-6073	135	10	urologia	urologia	PROPN
aiua-6073	135	11	e	e	PROPN
aiua-6073	135	12	andrologia	andrologia	NOUN
aiua-6073	135	13	2016	2016	NUM
aiua-6073	135	14	;	;	PUNCT
aiua-6073	135	15	88	88	NUM
aiua-6073	135	16	,	,	PUNCT
aiua-6073	135	17	2	2	NUM
aiua-6073	135	18	v.	v.	ADP
aiua-6073	135	19	mirone	mirone	PROPN
aiua-6073	135	20	,	,	PUNCT
aiua-6073	135	21	f.	f.	PROPN
aiua-6073	135	22	fusco	fusco	PROPN
aiua-6073	135	23	,	,	PUNCT
aiua-6073	135	24	f.	f.	PROPN
aiua-6073	135	25	parazzini	parazzini	PROPN
aiua-6073	135	26	,	,	PUNCT
aiua-6073	135	27	a.	a.	NOUN
aiua-6073	135	28	zucchi	zucchi	PROPN
aiua-6073	135	29	132	132	NUM
aiua-6073	135	30	10	10	NUM
aiua-6073	135	31	.	.	PUNCT
aiua-6073	136	1	belkoff	belkoff	PROPN
aiua-6073	136	2	lh	lh	PROPN
aiua-6073	136	3	,	,	PUNCT
aiua-6073	136	4	mccullough	mccullough	PROPN
aiua-6073	136	5	a	a	PRON
aiua-6073	136	6	,	,	PUNCT
aiua-6073	136	7	goldstein	goldstein	PROPN
aiua-6073	136	8	i	i	PROPN
aiua-6073	136	9	,	,	PUNCT
aiua-6073	136	10	et	et	PROPN
aiua-6073	136	11	al	al	PROPN
aiua-6073	136	12	.	.	PUNCT
aiua-6073	137	1	an	an	DET
aiua-6073	137	2	open	open	ADJ
aiua-6073	137	3	-	-	PUNCT
aiua-6073	137	4	label	label	NOUN
aiua-6073	137	5	,	,	PUNCT
aiua-6073	137	6	longterm	longterm	ADJ
aiua-6073	137	7	evaluation	evaluation	NOUN
aiua-6073	137	8	of	of	ADP
aiua-6073	137	9	the	the	DET
aiua-6073	137	10	safety	safety	NOUN
aiua-6073	137	11	,	,	PUNCT
aiua-6073	137	12	efficacy	efficacy	NOUN
aiua-6073	137	13	and	and	CCONJ
aiua-6073	137	14	tolerability	tolerability	NOUN
aiua-6073	137	15	of	of	ADP
aiua-6073	137	16	avanafil	avanafil	PROPN
aiua-6073	137	17	in	in	ADP
aiua-6073	137	18	male	male	ADJ
aiua-6073	137	19	patients	patient	NOUN
aiua-6073	137	20	with	with	ADP
aiua-6073	137	21	mild	mild	ADJ
aiua-6073	137	22	to	to	ADP
aiua-6073	137	23	severe	severe	ADJ
aiua-6073	137	24	erectile	erectile	NOUN
aiua-6073	137	25	dysfunction	dysfunction	NOUN
aiua-6073	137	26	.	.	PUNCT
aiua-6073	138	1	int	int	PROPN
aiua-6073	139	1	j	j	PROPN
aiua-6073	139	2	clin	clin	PROPN
aiua-6073	139	3	pract	pract	PROPN
aiua-6073	139	4	.	.	PUNCT
aiua-6073	140	1	2013	2013	NUM
aiua-6073	140	2	;	;	PUNCT
aiua-6073	140	3	67:333	67:333	NUM
aiua-6073	140	4	.	.	PUNCT
aiua-6073	141	1	11	11	NUM
aiua-6073	141	2	.	.	X
aiua-6073	142	1	corona	corona	NOUN
aiua-6073	142	2	g	g	PROPN
aiua-6073	142	3	,	,	PUNCT
aiua-6073	142	4	rastrelli	rastrelli	ADJ
aiua-6073	142	5	g	g	NOUN
aiua-6073	142	6	,	,	PUNCT
aiua-6073	142	7	burri	burri	NOUN
aiua-6073	142	8	a	a	NOUN
aiua-6073	142	9	,	,	PUNCT
aiua-6073	142	10	et	et	PROPN
aiua-6073	142	11	al	al	PROPN
aiua-6073	142	12	.	.	PUNCT
aiua-6073	143	1	the	the	DET
aiua-6073	143	2	safety	safety	NOUN
aiua-6073	143	3	and	and	CCONJ
aiua-6073	143	4	efficacy	efficacy	NOUN
aiua-6073	143	5	of	of	ADP
aiua-6073	143	6	avanafil	avanafil	PROPN
aiua-6073	143	7	,	,	PUNCT
aiua-6073	143	8	a	a	DET
aiua-6073	143	9	new	new	ADJ
aiua-6073	143	10	2(nd	2(nd	NUM
aiua-6073	143	11	)	)	PUNCT
aiua-6073	143	12	generation	generation	NOUN
aiua-6073	143	13	pde5i	pde5i	PROPN
aiua-6073	143	14	:	:	PUNCT
aiua-6073	143	15	comprehensive	comprehensive	ADJ
aiua-6073	143	16	review	review	NOUN
aiua-6073	143	17	and	and	CCONJ
aiua-6073	143	18	meta	meta	ADJ
aiua-6073	143	19	-	-	PUNCT
aiua-6073	143	20	analysis	analysis	NOUN
aiua-6073	143	21	.	.	PUNCT
aiua-6073	144	1	expert	expert	NOUN
aiua-6073	144	2	opin	opin	NOUN
aiua-6073	144	3	drug	drug	NOUN
aiua-6073	144	4	saf	saf	PROPN
aiua-6073	144	5	.	.	PROPN
aiua-6073	144	6	2016	2016	NUM
aiua-6073	144	7	;	;	PUNCT
aiua-6073	144	8	15:237	15:237	NUM
aiua-6073	144	9	.	.	PUNCT
aiua-6073	145	1	12	12	NUM
aiua-6073	145	2	.	.	PUNCT
aiua-6073	146	1	chen	chen	PROPN
aiua-6073	146	2	l	l	PROPN
aiua-6073	146	3	,	,	PUNCT
aiua-6073	146	4	staubli	staubli	PROPN
aiua-6073	146	5	se	se	PROPN
aiua-6073	146	6	,	,	PUNCT
aiua-6073	146	7	schneider	schneider	PROPN
aiua-6073	146	8	mp	mp	PROPN
aiua-6073	146	9	,	,	PUNCT
aiua-6073	146	10	et	et	PROPN
aiua-6073	146	11	al	al	PROPN
aiua-6073	146	12	.	.	PROPN
aiua-6073	146	13	phosphodiesterase	phosphodiesterase	NOUN
aiua-6073	146	14	5	5	NUM
aiua-6073	146	15	inhibitors	inhibitor	NOUN
aiua-6073	146	16	for	for	ADP
aiua-6073	146	17	the	the	DET
aiua-6073	146	18	treatment	treatment	NOUN
aiua-6073	146	19	of	of	ADP
aiua-6073	146	20	erectile	erectile	ADJ
aiua-6073	146	21	dysfunction	dysfunction	NOUN
aiua-6073	146	22	:	:	PUNCT
aiua-6073	146	23	a	a	DET
aiua-6073	146	24	trade	trade	NOUN
aiua-6073	146	25	-	-	PUNCT
aiua-6073	146	26	off	off	ADP
aiua-6073	146	27	network	network	NOUN
aiua-6073	146	28	meta	meta	NOUN
aiua-6073	146	29	-	-	PUNCT
aiua-6073	146	30	analysis	analysis	NOUN
aiua-6073	146	31	.	.	PUNCT
aiua-6073	147	1	eur	eur	PROPN
aiua-6073	147	2	urol	urol	PROPN
aiua-6073	147	3	.	.	PUNCT
aiua-6073	148	1	2015	2015	NUM
aiua-6073	148	2	;	;	PUNCT
aiua-6073	148	3	68:674	68:674	NUM
aiua-6073	148	4	.	.	PUNCT
aiua-6073	149	1	13	13	NUM
aiua-6073	149	2	.	.	PUNCT
aiua-6073	149	3	avanafil	avanafil	PROPN
aiua-6073	149	4	summary	summary	NOUN
aiua-6073	149	5	of	of	ADP
aiua-6073	149	6	product	product	NOUN
aiua-6073	149	7	characteristics	characteristic	NOUN
aiua-6073	149	8	(	(	PUNCT
aiua-6073	149	9	spc	spc	PROPN
aiua-6073	149	10	)	)	PUNCT
aiua-6073	149	11	.	.	PUNCT
aiua-6073	150	1	14	14	NUM
aiua-6073	150	2	.	.	PUNCT
aiua-6073	151	1	sildenafil	sildenafil	NOUN
aiua-6073	151	2	summary	summary	NOUN
aiua-6073	151	3	of	of	ADP
aiua-6073	151	4	product	product	NOUN
aiua-6073	151	5	characteristics	characteristic	NOUN
aiua-6073	151	6	(	(	PUNCT
aiua-6073	151	7	spc	spc	PROPN
aiua-6073	151	8	)	)	PUNCT
aiua-6073	151	9	.	.	PUNCT
aiua-6073	152	1	15	15	NUM
aiua-6073	152	2	.	.	X
aiua-6073	153	1	vardenafil	vardenafil	PROPN
aiua-6073	153	2	summary	summary	NOUN
aiua-6073	153	3	of	of	ADP
aiua-6073	153	4	product	product	NOUN
aiua-6073	153	5	characteristics	characteristic	NOUN
aiua-6073	153	6	(	(	PUNCT
aiua-6073	153	7	spc	spc	PROPN
aiua-6073	153	8	)	)	PUNCT
aiua-6073	153	9	.	.	PUNCT
aiua-6073	154	1	16	16	NUM
aiua-6073	154	2	.	.	PUNCT
aiua-6073	155	1	tadalafil	tadalafil	PROPN
aiua-6073	155	2	summary	summary	NOUN
aiua-6073	155	3	of	of	ADP
aiua-6073	155	4	product	product	NOUN
aiua-6073	155	5	characteristics	characteristic	NOUN
aiua-6073	155	6	(	(	PUNCT
aiua-6073	155	7	spc	spc	PROPN
aiua-6073	155	8	)	)	PUNCT
aiua-6073	155	9	.	.	PUNCT
aiua-6073	156	1	17	17	NUM
aiua-6073	156	2	.	.	PUNCT
aiua-6073	157	1	kedia	kedia	PROPN
aiua-6073	157	2	gt	gt	PROPN
aiua-6073	157	3	,	,	PUNCT
aiua-6073	157	4	ückert	ückert	VERB
aiua-6073	157	5	s	s	PROPN
aiua-6073	157	6	,	,	PUNCT
aiua-6073	157	7	assadi	assadi	NOUN
aiua-6073	157	8	-	-	PUNCT
aiua-6073	157	9	pour	pour	NOUN
aiua-6073	157	10	f	f	PROPN
aiua-6073	157	11	,	,	PUNCT
aiua-6073	157	12	et	et	PROPN
aiua-6073	157	13	al	al	PROPN
aiua-6073	157	14	.	.	PROPN
aiua-6073	157	15	avanafil	avanafil	PROPN
aiua-6073	157	16	for	for	ADP
aiua-6073	157	17	the	the	DET
aiua-6073	157	18	treatment	treatment	NOUN
aiua-6073	157	19	of	of	ADP
aiua-6073	157	20	erectile	erectile	ADJ
aiua-6073	157	21	dysfunction	dysfunction	NOUN
aiua-6073	157	22	:	:	PUNCT
aiua-6073	157	23	initial	initial	ADJ
aiua-6073	157	24	data	datum	NOUN
aiua-6073	157	25	and	and	CCONJ
aiua-6073	157	26	clinical	clinical	ADJ
aiua-6073	157	27	key	key	ADJ
aiua-6073	157	28	properties	property	NOUN
aiua-6073	157	29	.	.	PUNCT
aiua-6073	158	1	ther	ther	INTJ
aiua-6073	158	2	adv	adv	PROPN
aiua-6073	158	3	urol	urol	PROPN
aiua-6073	158	4	.	.	PUNCT
aiua-6073	159	1	2013	2013	NUM
aiua-6073	159	2	;	;	PUNCT
aiua-6073	159	3	5:35	5:35	NUM
aiua-6073	159	4	.	.	NOUN
aiua-6073	159	5	18	18	NUM
aiua-6073	159	6	.	.	PUNCT
aiua-6073	160	1	bannowsky	bannowsky	PROPN
aiua-6073	160	2	a	a	PROPN
aiua-6073	160	3	,	,	PUNCT
aiua-6073	160	4	van	van	PROPN
aiua-6073	160	5	ahlen	ahlen	PROPN
aiua-6073	160	6	h	h	NOUN
aiua-6073	160	7	,	,	PUNCT
aiua-6073	160	8	loch	loch	NOUN
aiua-6073	160	9	t.	t.	NOUN
aiua-6073	160	10	increasing	increase	VERB
aiua-6073	160	11	the	the	DET
aiua-6073	160	12	dose	dose	NOUN
aiua-6073	160	13	of	of	ADP
aiua-6073	160	14	vardenafil	vardenafil	NOUN
aiua-6073	160	15	on	on	ADP
aiua-6073	160	16	a	a	DET
aiua-6073	160	17	daily	daily	ADJ
aiua-6073	160	18	basis	basis	NOUN
aiua-6073	160	19	does	do	AUX
aiua-6073	160	20	not	not	PART
aiua-6073	160	21	improve	improve	VERB
aiua-6073	160	22	erectile	erectile	ADJ
aiua-6073	160	23	function	function	NOUN
aiua-6073	160	24	after	after	ADP
aiua-6073	160	25	unilateral	unilateral	ADJ
aiua-6073	160	26	nerve	nerve	NOUN
aiua-6073	160	27	-	-	PUNCT
aiua-6073	160	28	sparing	spare	VERB
aiua-6073	160	29	radical	radical	ADJ
aiua-6073	160	30	prostatectomy	prostatectomy	NOUN
aiua-6073	160	31	.	.	PUNCT
aiua-6073	161	1	j	j	PROPN
aiua-6073	161	2	sex	sex	PROPN
aiua-6073	161	3	med	med	PROPN
aiua-6073	161	4	.	.	PUNCT
aiua-6073	161	5	2012	2012	NUM
aiua-6073	161	6	;	;	PUNCT
aiua-6073	161	7	9:1448	9:1448	NUM
aiua-6073	161	8	.	.	X
aiua-6073	162	1	19	19	NUM
aiua-6073	162	2	.	.	PUNCT
aiua-6073	162	3	bannowsky	bannowsky	PROPN
aiua-6073	162	4	a	a	PROPN
aiua-6073	162	5	,	,	PUNCT
aiua-6073	162	6	schulze	schulze	NOUN
aiua-6073	162	7	h	h	NOUN
aiua-6073	162	8	,	,	PUNCT
aiua-6073	162	9	van	van	PROPN
aiua-6073	162	10	der	der	PROPN
aiua-6073	162	11	horst	horst	PROPN
aiua-6073	162	12	c	c	PROPN
aiua-6073	162	13	,	,	PUNCT
aiua-6073	162	14	et	et	PROPN
aiua-6073	162	15	al	al	PROPN
aiua-6073	162	16	.	.	PUNCT
aiua-6073	162	17	recovery	recovery	NOUN
aiua-6073	162	18	of	of	ADP
aiua-6073	162	19	erectile	erectile	ADJ
aiua-6073	162	20	function	function	NOUN
aiua-6073	162	21	after	after	ADP
aiua-6073	162	22	nerve	nerve	NOUN
aiua-6073	162	23	-	-	PUNCT
aiua-6073	162	24	sparing	spare	VERB
aiua-6073	162	25	radical	radical	ADJ
aiua-6073	162	26	prostatectomy	prostatectomy	NOUN
aiua-6073	162	27	:	:	PUNCT
aiua-6073	162	28	improvement	improvement	NOUN
aiua-6073	162	29	with	with	ADP
aiua-6073	162	30	nightly	nightly	ADJ
aiua-6073	162	31	low	low	ADV
aiua-6073	162	32	-	-	PUNCT
aiua-6073	162	33	dose	dose	NOUN
aiua-6073	162	34	sildenafil	sildenafil	NOUN
aiua-6073	162	35	.	.	PUNCT
aiua-6073	163	1	bju	bju	NOUN
aiua-6073	163	2	int	int	PROPN
aiua-6073	163	3	.	.	PUNCT
aiua-6073	164	1	2008	2008	NUM
aiua-6073	164	2	;	;	PUNCT
aiua-6073	165	1	101:1279	101:1279	NUM
aiua-6073	165	2	.	.	NOUN
aiua-6073	165	3	20	20	NUM
aiua-6073	165	4	.	.	PUNCT
aiua-6073	166	1	cui	cui	PROPN
aiua-6073	166	2	ys	ys	PROPN
aiua-6073	166	3	,	,	PUNCT
aiua-6073	166	4	li	li	PROPN
aiua-6073	166	5	n	n	PROPN
aiua-6073	166	6	,	,	PUNCT
aiua-6073	166	7	zong	zong	PROPN
aiua-6073	166	8	ht	ht	PROPN
aiua-6073	166	9	,	,	PUNCT
aiua-6073	166	10	et	et	PROPN
aiua-6073	166	11	al	al	PROPN
aiua-6073	166	12	.	.	PROPN
aiua-6073	166	13	avanafil	avanafil	PROPN
aiua-6073	166	14	for	for	ADP
aiua-6073	166	15	male	male	ADJ
aiua-6073	166	16	erectile	erectile	NOUN
aiua-6073	166	17	dysfunction	dysfunction	NOUN
aiua-6073	166	18	:	:	PUNCT
aiua-6073	166	19	a	a	DET
aiua-6073	166	20	systematic	systematic	ADJ
aiua-6073	166	21	review	review	NOUN
aiua-6073	166	22	and	and	CCONJ
aiua-6073	166	23	meta	meta	ADJ
aiua-6073	166	24	-	-	PUNCT
aiua-6073	166	25	analysis	analysis	NOUN
aiua-6073	166	26	.	.	PUNCT
aiua-6073	167	1	asian	asian	ADJ
aiua-6073	167	2	journal	journal	PROPN
aiua-6073	167	3	of	of	ADP
aiua-6073	167	4	andrology	andrology	PROPN
aiua-6073	167	5	.	.	PUNCT
aiua-6073	168	1	2014	2014	NUM
aiua-6073	168	2	;	;	PUNCT
aiua-6073	168	3	16:472	16:472	NUM
aiua-6073	168	4	.	.	PUNCT
aiua-6073	169	1	correspondence	correspondence	NOUN
aiua-6073	169	2	vincenzo	vincenzo	PROPN
aiua-6073	169	3	mirone	mirone	PROPN
aiua-6073	169	4	,	,	PUNCT
aiua-6073	169	5	md	md	PROPN
aiua-6073	169	6	mirone@unina.it	mirone@unina.it	PROPN
aiua-6073	169	7	ferdinando	ferdinando	PROPN
aiua-6073	169	8	fusco	fusco	PROPN
aiua-6073	169	9	,	,	PUNCT
aiua-6073	169	10	md	md	PROPN
aiua-6073	169	11	(	(	PUNCT
aiua-6073	169	12	corresponding	correspond	VERB
aiua-6073	169	13	author	author	NOUN
aiua-6073	169	14	)	)	PUNCT
aiua-6073	170	1	ferdinando-fusco@libero.it	ferdinando-fusco@libero.it	NOUN
aiua-6073	170	2	dipartimento	dipartimento	VERB
aiua-6073	170	3	ostetricia	ostetricia	NOUN
aiua-6073	170	4	,	,	PUNCT
aiua-6073	170	5	ginecologia	ginecologia	NOUN
aiua-6073	170	6	,	,	PUNCT
aiua-6073	170	7	urologia	urologia	PROPN
aiua-6073	170	8	clinica	clinica	PROPN
aiua-6073	170	9	urologica	urologica	PROPN
aiua-6073	170	10	università	università	PROPN
aiua-6073	170	11	di	di	PROPN
aiua-6073	170	12	napoli	napoli	PROPN
aiua-6073	170	13	federico	federico	PROPN
aiua-6073	170	14	ii	ii	PROPN
aiua-6073	170	15	,	,	PUNCT
aiua-6073	170	16	italy	italy	PROPN
aiua-6073	170	17	fabio	fabio	PROPN
aiua-6073	170	18	parazzini	parazzini	PROPN
aiua-6073	170	19	,	,	PUNCT
aiua-6073	170	20	md	md	PROPN
aiua-6073	170	21	fabio.parazzini@unimi.it	fabio.parazzini@unimi.it	PROPN
aiua-6073	170	22	i	i	PRON
aiua-6073	170	23	clinica	clinica	PROPN
aiua-6073	170	24	ginecologica	ginecologica	PROPN
aiua-6073	170	25	,	,	PUNCT
aiua-6073	170	26	fondazione	fondazione	PROPN
aiua-6073	170	27	irccs	irccs	NOUN
aiua-6073	170	28	ca	ca	NOUN
aiua-6073	170	29	'	'	PART
aiua-6073	170	30	granda	granda	PROPN
aiua-6073	170	31	ospedale	ospedale	PROPN
aiua-6073	170	32	maggiore	maggiore	PROPN
aiua-6073	170	33	policlinico	policlinico	NOUN
aiua-6073	170	34	,	,	PUNCT
aiua-6073	170	35	università	università	PROPN
aiua-6073	170	36	di	di	PROPN
aiua-6073	170	37	milano	milano	PROPN
aiua-6073	170	38	,	,	PUNCT
aiua-6073	170	39	italy	italy	PROPN
aiua-6073	170	40	alessandro	alessandro	PROPN
aiua-6073	170	41	zucchi	zucchi	PROPN
aiua-6073	170	42	,	,	PUNCT
aiua-6073	170	43	md	md	PROPN
aiua-6073	170	44	zucchi.urologia@gmail.com	zucchi.urologia@gmail.com	PROPN
aiua-6073	170	45	clinica	clinica	PROPN
aiua-6073	170	46	urologica	urologica	PROPN
aiua-6073	170	47	ed	ed	PROPN
aiua-6073	170	48	andrologica	andrologica	PROPN
aiua-6073	170	49	,	,	PUNCT
aiua-6073	170	50	università	università	PROPN
aiua-6073	170	51	di	di	PROPN
aiua-6073	170	52	perugia	perugia	PROPN
aiua-6073	170	53	,	,	PUNCT
aiua-6073	170	54	italy	italy	PROPN
aiua-6073	170	55	mirone_stesura	mirone_stesura	NOUN
aiua-6073	170	56	seveso	seveso	VERB
aiua-6073	170	57	01/07/16	01/07/16	PROPN
aiua-6073	170	58	11:08	11:08	NUM
aiua-6073	170	59	pagina	pagina	NOUN
aiua-6073	170	60	132	132	NUM